FedInvent™ Patents

Patent Details for Tuesday, January 10, 2017 

This page was updated on Monday, March 27, 2023 at 05:08 AM GMT

Department of Health and Human Services (HHS) 

US 09538745 He et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Xiaoming He (Winchester, Massachusetts);  Thomas L. Toth (Sudbury, Massachusetts);  Mehmet Toner (Wellesley, Massachusetts);  Jon Edd (Arlington, Massachusetts)
ASSIGNEE(S) The General Hospital Corporation (Boston, Massachusetts)
INVENTOR(S) Xiaoming He (Winchester, Massachusetts);  Thomas L. Toth (Sudbury, Massachusetts);  Mehmet Toner (Wellesley, Massachusetts);  Jon Edd (Arlington, Massachusetts)
ABSTRACT The present invention features novel methods for the cryopreservation of mammalian cell that combine the advantages of the slow-freezing and vitrification approaches while avoiding their shortcomings. Generally, the methods include the use of a capillary tube made of a thermally conductive wall material and a thin wall such that the ratio of the thermal conductivity of the wall material to the wall thickness is at least 1,000-500,000. The solution is then exposed to temperatures equal to or less than −80° C. and the vitrification solution containing the mammalian cells is cooled at a rate equal to or greater than 30,000-100,000,000° C./minute. The exposure of the capillary tube with a thermally conductive and thin wall allows for vitrification of the solution in the absence of ice formation. Cryoprotectants can also be added to the vitrification solution to further prevent ice formation.
FILED Thursday, April 12, 2007
APPL NO 12/226300
ART UNIT 1651 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 1/02 (20130101) Original (OR) Class
A01N 1/0221 (20130101)
A01N 1/0268 (20130101)
A01N 1/0278 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09538950 Bibian et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Army Medical Research Acquisition Activity (USAMRAA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) NeuroWave Systems Inc. (Cleveland, Ohio)
ASSIGNEE(S) NeuroWave Systems Inc. (Cleveland Heights, Ohio)
INVENTOR(S) Stéphane Bibian (Cleveland Heights, Ohio);  Tatjana Zikov (Cleveland Heights, Ohio);  Mo Modarres (Tampa, Florida)
ABSTRACT The present invention relates to a brain dysfunction and seizure detector monitor and system, and a method of detecting brain dysfunction and/or seizure of a subject. Preferably, the present invention also includes one or more seizure detection algorithms. The analysis method is specifically optimized to amplify abnormal brain activity and minimize normal background activity yielding a seizure index directly related to the current presence of ictal activity in the signal. Additionally, a seizure probability index based on historical values of the aforementioned seizure index, is derived for diagnostic purposes. The seizure probability index quantifies the probability that the patient has exhibited abnormal brain activity since the beginning of the recording. These indexes can be used in the context of emergency and/or clinical situations to assess the status and well-being of a patient's brain, or can be used to automatically administer treatment to stop the seizure before clinical signs appear.
FILED Monday, December 31, 2012
APPL NO 13/731315
ART UNIT 3735 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/048 (20130101)
A61B 5/0476 (20130101)
A61B 5/04012 (20130101)
A61B 5/4094 (20130101) Original (OR) Class
A61B 5/4839 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09538976 Keall et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Paul J. Keall (Greenwich, Australia);  Ricky O'Brien (Rozelle, Australia);  Benjamin J. Cooper (Chifley, Australia);  Jun Lu (Fayetteville, New York);  Jeffrey F. Williamson (Richmond, Virginia)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, California);  The University of Sydney (Sydney, New South Wales, None)
INVENTOR(S) Paul J. Keall (Greenwich, Australia);  Ricky O'Brien (Rozelle, Australia);  Benjamin J. Cooper (Chifley, Australia);  Jun Lu (Fayetteville, New York);  Jeffrey F. Williamson (Richmond, Virginia)
ABSTRACT A method of optimizing 4D cone beam computed tomography (4DCBCT) imaging is provided that includes using a scanner to generate projections of a target, where the projections are used to form a cone beam computed tomography (CBCT) scan of the target, where the CBCT includes a 3D image of the target, and using an appropriately programmed computer to control rotation speed of a gantry and projection acquisition of the CBCT in real-time according to a measured patient respiratory signal, where the real-time acquisition of the 4CBCT forms an optimized 4DCBCT image set.
FILED Friday, July 27, 2012
APPL NO 14/131896
ART UNIT 2881 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 6/486 (20130101)
A61B 6/541 (20130101) Original (OR) Class
A61B 6/583 (20130101)
A61B 6/4085 (20130101)
A61B 6/5205 (20130101)
A61B 6/5264 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 2005/1061 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539210 von Andrian et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  The Brigham and Women's Hospital, Inc. (Boston, Massachusetts);  President and Fellows of Harvard College (Cambridge, Massachusetts);  The Children's Medical Center Corporation (Boston, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts);  The Brigham and Women's Hospital, Inc. (Boston, Massachusetts);  President and Fellows of Harvard College (Cambridge, Massachusetts);  The Children's Medical Center Corporation (Boston, Massachusetts)
INVENTOR(S) Ulrich H. von Andrian (Chestnut Hill, Massachusetts);  Omid C. Farokhzad (Waban, Massachusetts);  Robert S. Langer (Newton, Massachusetts);  Tobias Junt (Schorndorf, Germany);  Elliott Ashley Moseman (Jamaica Plain, Massachusetts);  Liangfang Zhang (San Diego, California);  Pamela Basto (Cambridge, Massachusetts);  Matteo Iannacone (Milan, Italy);  Frank Alexis (Greenville, South Carolina)
ABSTRACT The present invention provides compositions and systems for delivery of nanocarriers to cells of the immune system. The invention provides vaccine nanocarriers capable of stimulating an immune response in T cells and/or B cells, in some embodiments, comprising at least one immunomodulatory agent, and optionally comprising at last one targeting moiety and optionally at least one immunostimulatory agent. The invention provides pharmaceutical compositions comprising inventive vaccine nanocarriers. The present invention provides methods of designing, manufacturing, and using inventive vaccine nanocarriers and pharmaceutical compositions thereof. The invention provides methods of prophylaxis and/or treatment of diseases, disorders, and conditions comprising administering at least one inventive vaccine nanocarrier to a subject in need thereof.
FILED Friday, March 15, 2013
APPL NO 13/844382
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/14 (20130101) Original (OR) Class
A61K 39/00 (20130101)
A61K 39/0011 (20130101)
A61K 39/12 (20130101)
A61K 39/39 (20130101)
A61K 47/48815 (20130101)
A61K 47/48915 (20130101)
A61K 2039/60 (20130101)
A61K 2039/555 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539220 Charney et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) Icahn School of Medicine at Mount Sinai (New York, New York);  Yale University (New Haven, Connecticut);  The United States of America, as represented by the Secretary, Department of Health and Human Services (Rockville, Maryland)
ASSIGNEE(S) Icahn School of Medicine at Mount Sinai (New York, New York);  Yale University (New Haven, Connecticut);  The United States of America, as represented by The Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Dennis S. Charney (New York, New York);  Sanjay J. Mathew (New York, New York);  Husseini K. Manji (Rockville, Maryland);  Carlos A. Zarate (Rockville, Maryland);  John H. Krystal (New Haven, Connecticut)
ABSTRACT Methods and compositions for the treatment of treatment-resistant depression are described. More specifically, the invention demonstrates that intranasal administration of ketamine is effective to ameliorate the symptoms of depression in a patient who has not responded to an adequate trial of one antidepressant in the current episode and has recurrent or chronic depressive symptoms (>2 years).
FILED Wednesday, March 05, 2014
APPL NO 14/197767
ART UNIT 1628 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 9/0043 (20130101)
A61K 9/7023 (20130101)
A61K 31/135 (20130101) Original (OR) Class
A61K 31/137 (20130101)
A61K 45/06 (20130101)

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 15/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539221 Bond
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Richard A. Bond (Houston, Texas)
ASSIGNEE(S) EGB ADVISORS, LLC (Wilmington, Delaware);  INVION, INC. (Melbourne, Australia)
INVENTOR(S) Richard A. Bond (Houston, Texas)
ABSTRACT The use of β-adrenergic inverse agonists provides a new and highly efficient way of treating a number of pulmonary airway diseases, including asthma, emphysema, and chronic obstructive pulmonary diseases. In general, such a method comprises administering a therapeutically effective amount of a β-adrenergic inverse agonist to the subject to treat the pulmonary airway disease. Particularly preferred inverse agonists include nadolol and carvedilol.
FILED Friday, October 08, 2004
APPL NO 10/574677
ART UNIT 1629 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/46 (20130101)
A61K 31/47 (20130101)
A61K 31/56 (20130101)
A61K 31/137 (20130101)
A61K 31/138 (20130101) Original (OR) Class
A61K 31/192 (20130101)
A61K 31/403 (20130101)
A61K 31/522 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539233 Ohtake et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Satoshi Ohtake (Milpitas, California);  Vu Truong-Le (Campbell, California);  David Lechuga-Ballesteros (San Jose, California);  Luisa Yee (Los Altos, California);  Binh Pham (Mountain View, California);  Russell Martin (Los Gatos, California);  Atul Saxena (Milpitas, California)
ASSIGNEE(S) Aridis Pharmaceuticals Inc. (San Jose, California)
INVENTOR(S) Satoshi Ohtake (Milpitas, California);  Vu Truong-Le (Campbell, California);  David Lechuga-Ballesteros (San Jose, California);  Luisa Yee (Los Altos, California);  Binh Pham (Mountain View, California);  Russell Martin (Los Gatos, California);  Atul Saxena (Milpitas, California)
ABSTRACT A method and composition for treatment of bacterial infections caused by gram negative or gram positive bacteria such as Staphylococcus aureus, Rhodococcus equi, Mycobacterium tuberculosis, Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species, Serratia marcescens as well as those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and multidrug resistant Pseudomonas aeruginosa, using a formulation containing gallium (III), in a pharmaceutically acceptable salt or complex thereof.
FILED Monday, May 03, 2010
APPL NO 12/772854
ART UNIT 1628 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/08 (20130101)
A61K 9/14 (20130101)
A61K 9/0078 (20130101)
A61K 9/1617 (20130101)
A61K 9/1623 (20130101)
A61K 31/28 (20130101) Original (OR) Class
A61K 33/24 (20130101)
A61K 47/12 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 428/2982 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539239 Zack et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Donald Jeffrey Zack (Baltimore, Maryland);  Thomas Bannister (Palm Beach Gardens, Florida);  Tomas Vojkovsky (Palm Beach Gardens, Florida);  Zhiyong Yang (San Diego, California);  Cynthia Berlinicke (Baltimore, Maryland)
ASSIGNEE(S)
INVENTOR(S) Donald Jeffrey Zack (Baltimore, Maryland);  Thomas Bannister (Palm Beach Gardens, Florida);  Tomas Vojkovsky (Palm Beach Gardens, Florida);  Zhiyong Yang (San Diego, California);  Cynthia Berlinicke (Baltimore, Maryland)
ABSTRACT Compounds, compositions, kits and methods for treating conditions related to neurodegeneration or ocular disease, are disclosed.
FILED Monday, October 19, 2015
APPL NO 14/886938
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/404 (20130101) Original (OR) Class
A61K 45/06 (20130101)

Heterocyclic Compounds
C07D 403/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539242 Johnson
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
APPLICANT(S) University of Virginia Patent Foundation (Charlottesville, Virginia)
ASSIGNEE(S) University of Virginia Patent Foundation (Charlottesville, Virginia)
INVENTOR(S) Bankole A. Johnson (Charlottesville, California)
ABSTRACT Compositions and methods are provided that are useful for diagnosing, treating, and monitoring alcohol dependence and disorders, susceptibility to alcohol dependence disorders, as well as drug related dependence and disorders. The methods include treating patients with an antagonist of the serotonin receptor 5-HT3 for such disorders, wherein the patient's serotonin transporter gene SLC6A4 is known to have particular genotypes.
FILED Wednesday, April 30, 2014
APPL NO 14/266313
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/4178 (20130101) Original (OR) Class

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6883 (20130101)
C12Q 1/6888 (20130101)
C12Q 2600/106 (20130101)
C12Q 2600/172 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539259 Zack et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland)
ASSIGNEE(S) THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland)
INVENTOR(S) Donald J. Zack (Baltimore, Maryland);  Derek Stuart Welsbie (Lutherville-Timonium, Maryland);  Zhiyong Yang (Baltimore, Maryland)
ABSTRACT Compounds, compositions, kits and methods for treating conditions related to neurodegeneration or ocular disease, are disclosed.
FILED Thursday, May 23, 2013
APPL NO 14/403523
ART UNIT 1629 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/47 (20130101)
A61K 31/496 (20130101)
A61K 31/506 (20130101)
A61K 31/517 (20130101)
A61K 31/4439 (20130101)
A61K 31/4545 (20130101)
A61K 31/5377 (20130101) Original (OR) Class
A61K 45/06 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6876 (20130101)
C12Q 2600/158 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/573 (20130101)
G01N 2333/912 (20130101)
G01N 2333/91205 (20130101)
G01N 2800/16 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539272 Marks et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Paul A. Marks (Washington, Connecticut);  Weisheng Xu (Forest Hills, New York);  Mandana Namdar (London, United Kingdom)
ASSIGNEE(S) SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (New York, New York)
INVENTOR(S) Paul A. Marks (Washington, Connecticut);  Weisheng Xu (Forest Hills, New York);  Mandana Namdar (London, United Kingdom)
ABSTRACT This invention provides methods for treating a subject afflicted with cancer, comprising concurrently administering (i) an HDAC 6-selective inhibitor and (ii) a suitable cytotoxic agent such as SAHA, doxorubicin or etoposide. This invention also provides methods for inducing the death of a transformed cell such as a cancer cell, comprising concurrently contacting the cell with (i) an HDAC 6-selective inhibitor and (ii) a suitable cytotoxic agent such as SAHA, doxorubicin or etoposide.
FILED Friday, July 02, 2010
APPL NO 13/382336
ART UNIT 1600 — Biotechnology and Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/19 (20130101)
A61K 31/19 (20130101)
A61K 31/167 (20130101)
A61K 31/167 (20130101)
A61K 31/422 (20130101)
A61K 31/422 (20130101)
A61K 31/704 (20130101) Original (OR) Class
A61K 31/704 (20130101)
A61K 31/7048 (20130101)
A61K 31/7048 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539300 Fogelman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Alan M. Fogelman (Los Angeles, California);  Srinivasa T. Reddy (Cerritos, California);  Mohamad Navab (Los Angeles, California)
ABSTRACT In certain embodiments transgenic plants (e.g., transgenic tomatoes) are provided that comprise cells that express a peptide one or more domains of which comprise the amino acid sequence of an apolipoprotein or apolipoprotein mimetic peptide where the peptide has biological activity (e.g., lowers SAA, and/or increases paroxonase activity, and/or improves HDL inflammatory index, etc.) when the plant and/or the peptide is fed to a mammal.
FILED Thursday, March 07, 2013
APPL NO 13/789513
ART UNIT 1662 — Plants
CURRENT CPC
Fodder
A23K 10/30 (20160501)

Foods, Foodstuffs, or Non-alcoholic Beverages, Not Covered by Subclasses A23B - A23J; Their Preparation or Treatment, e.g Cooking, Modification of Nutritive Qualities, Physical Treatment; Preservation of Foods or Foodstuffs, in General
A23L 19/00 (20160801)
A23L 33/10 (20160801)
A23L 33/185 (20160801)

Preparations for Medical, Dental, or Toilet Purposes
A61K 36/81 (20130101)
A61K 38/10 (20130101) Original (OR) Class

Peptides
C07K 14/775 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/8247 (20130101)
C12N 15/8257 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539301 Cai et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (Tucson, Arizona)
ASSIGNEE(S) THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (Tucson, Arizona)
INVENTOR(S) Minying Cai (Tucson, Arizona);  Victor J. Hruby (Tucson, Arizona);  Sean Shelby (Boulder, Colorado)
ABSTRACT A melanocortin 1 receptor (MC1R) peptide ligand-elastic vesicle complex. The MC1R peptide ligand is modified by coupling the MC1R ligand to a functionality or linker, such as a click functionality, for conjugation to a surface or agent. The modified MC1R peptide ligand can be coupled, e.g., via a click reaction with a complementary click functionality attached, to a moiety to form an MC1R-targeted agent. Drugs, contrast agents, polymers, particles, micelles, elastic vesicles, surfaces of larger structures, or other moieties can be targeted to the MC1R. The MC1R peptide ligand-elastic vesicle complex is prepared as a topical formulation.
FILED Tuesday, February 23, 2016
APPL NO 15/050671
ART UNIT 1675 — Plants
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/00 (20130101)
A61K 38/10 (20130101) Original (OR) Class

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 15/00 (20130101)

Peptides
C07K 7/08 (20130101)
C07K 14/68 (20130101)
C07K 14/685 (20130101)
C07K 14/723 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539304 LaRusso et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Mayo Foundation for Medical Education and Research (Rochester, Minnesota)
ASSIGNEE(S) Mayo Foundation for Medical Education and Research (Rochester, Minnesota)
INVENTOR(S) Nicholas F. LaRusso (Rochester, Minnesota);  Tetyana V. Masyuk (Rochester, Minnesota);  Melissa Muff-Luett (North Liberty, Iowa)
ABSTRACT This document provides methods and materials related to treating liver conditions. For example, the methods and materials relating to the use of cAMP inhibitors to treat liver conditions are provided.
FILED Tuesday, October 27, 2015
APPL NO 14/924032
ART UNIT 1675 — Plants
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/12 (20130101) Original (OR) Class
A61K 38/31 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539307 Kaspar
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (Columbus, Ohio)
ASSIGNEE(S) The Research Institute at Nationwide Children's Hospital (Columbus, Ohio)
INVENTOR(S) Brian Kaspar (New Albany, Ohio)
ABSTRACT The invention relates to pharmaceutical compositions, kits, methods, and uses for the treatment of amyotrophic lateral sclerosis. In particular, the invention relates to pharmaceutical compositions, kits, methods, and uses for the treatment of amyotrophic lateral sclerosis by decreasing the expression of a cytoplasmic granule toxin in astrocytes of a patient, or by increasing the expression of MHC class I in motor neurons of the patient.
FILED Tuesday, September 17, 2013
APPL NO 14/428765
ART UNIT 1674 — Plants
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/7105 (20130101)
A61K 38/1774 (20130101) Original (OR) Class
A61K 48/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539309 Cao et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Lan Cao (Stoughton, Massachusetts);  David J. Mooney (Sudbury, Massachusetts)
ABSTRACT The present invention comprises compositions, methods, and devices for delivering angiogenic factors and signaling molecules to a target tissue, and controlling the release of these factors and signaling molecules to spatially and temporally restrict their release and dissemination, for the purpose of promoting angiogenesis in target tissues wherein increased blood supply is needed.
FILED Monday, April 06, 2015
APPL NO 14/679723
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/06 (20130101)
A61K 9/0019 (20130101)
A61K 38/05 (20130101)
A61K 38/1858 (20130101)
A61K 38/1866 (20130101) Original (OR) Class
A61K 45/06 (20130101)
A61K 47/48784 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/54 (20130101)
A61L 2300/45 (20130101)
A61L 2300/412 (20130101)
A61L 2300/414 (20130101)
A61L 2300/426 (20130101)
A61L 2300/432 (20130101)
A61L 2300/602 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539315 Godefroy et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Emmanuelle Godefroy (New York, New York);  Nina Bhardwaj (West Orange, New Jersey)
ASSIGNEE(S) New York University (New York, New York)
INVENTOR(S) Emmanuelle Godefroy (New York, New York);  Nina Bhardwaj (West Orange, New Jersey)
ABSTRACT Screening assays and methods of using same for screening to identify modulator agents or compounds that affect matrix metalloproteinase-2 (MMP-2) mediated activation of toll-like receptor-2 (TLR-2) are described herein. Pharmaceutical and immunogenic compositions comprising agents or compounds that modulate MMP-2 mediated activation of TLR-2 are also encompassed. Methods for modulating MMP-2 mediated activation of TLR-2 using MMP-2 peptides in pharmaceutical and immunogenic compositions, as well as vaccines, are also envisioned. Melanoma is an exemplary tumor type that expresses MMP-2 and for which such pharmaceutical and immunogenic compositions, as well as vaccines, would confer benefit to patients. Also encompassed are methods for reducing MMP-2 mediated activation of TLR-2 and downstream signaling therefrom so as to achieve more effective T cell responses to MMP-2 expressing tumors.
FILED Monday, September 10, 2012
APPL NO 14/343123
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/00 (20130101)
A61K 39/0011 (20130101) Original (OR) Class

Peptides
C07K 16/2896 (20130101)
C07K 2317/76 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/6491 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/37 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/566 (20130101)
G01N 33/573 (20130101)
G01N 2333/52 (20130101)
G01N 2333/96494 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539321 Messmer et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Development Command (USAMRDC)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Davorka Messmer (San Diego, California);  Rebecca Saenz (San Diego, California)
ABSTRACT The invention provides an immtmostimulatory peptide containing the amino acid sequence SAFFLFCSE and uses thereof. The invention also provides an immunostimulatory peptide containing the amino acid sequence DPNAPKRPPSAFFLX1X2X3X4 or derivatives thereof. In one embodiment, when X1 is alanine (A), glycine (G), or valine (V) then X2 is C, X3 is S and X4 is E; wherein when X2 is alanine (A), glycine (G), or valine (V) then X1 is F, X3 is S and X4 is E; wherein when X3 is alanine (A), glycine (G), or valine (V) then X1 is F, X2 is C and X4 is E; or wherein when X4 is alanine (A), glycine (G), or valine (V) then X1 is F, X2 is C and X3 is S.
FILED Monday, March 09, 2015
APPL NO 14/642527
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 38/00 (20130101)
A61K 38/08 (20130101)
A61K 38/10 (20130101)
A61K 39/0011 (20130101)
A61K 39/39 (20130101) Original (OR) Class
A61K 2039/57 (20130101)
A61K 2039/575 (20130101)
A61K 2039/55505 (20130101)
A61K 2039/55516 (20130101)
A61K 2039/55555 (20130101)

Peptides
C07K 7/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539323 Sukhatme et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Vikas P. Sukhatme (Newton, Massachusetts);  Jian-Guo Ren (West Roxbury, Massachusetts)
ASSIGNEE(S) Beth Israel Deaconess Medical Center, Inc. (Boston, Massachusetts)
INVENTOR(S) Vikas P. Sukhatme (Newton, Massachusetts);  Jian-Guo Ren (West Roxbury, Massachusetts)
ABSTRACT The present invention relates to methods, compositions, and diagnostic tests for treating and diagnosing cancer and other related diseases that result in dysregulation of malic enzyme 2. In particular, the methods and compositions include combination therapy, such as with a combination of two or more ME2 inhibitors or a combination of an ME2 inhibitor and an anticancer agent.
FILED Friday, August 05, 2011
APPL NO 13/814614
ART UNIT 1674 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/56 (20130101)
A61K 31/196 (20130101)
A61K 31/198 (20130101)
A61K 31/282 (20130101)
A61K 31/335 (20130101)
A61K 31/336 (20130101)
A61K 31/337 (20130101)
A61K 31/506 (20130101)
A61K 31/555 (20130101)
A61K 31/713 (20130101)
A61K 31/7052 (20130101)
A61K 31/7105 (20130101)
A61K 33/00 (20130101)
A61K 33/24 (20130101)
A61K 38/52 (20130101)
A61K 39/3955 (20130101) Original (OR) Class
A61K 45/06 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1137 (20130101)
C12N 2310/14 (20130101)
C12N 2310/531 (20130101)
C12N 2330/51 (20130101)

Enzymes
C12Y 101/01037 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/57484 (20130101)
G01N 2333/904 (20130101)
G01N 2500/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539327 Pincus et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
U.S. Public Health Service (USPHS)
APPLICANT(S) Matthew R. Pincus (Brooklyn, New York);  Josef Michl (Little Neck, New York);  Ehsan Sarafraz-Yazdi (New York, New York)
ASSIGNEE(S) THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (Albany, New York)
INVENTOR(S) Matthew R. Pincus (Brooklyn, New York);  Josef Michl (Little Neck, New York);  Ehsan Sarafraz-Yazdi (New York, New York)
ABSTRACT A method of treating cancer in a subject, including: providing a subject having a plurality of cancer cells; and administering to the subject, a therapeutically effective amount of a composition including: an HDM-2 binding component; and a membrane resident component, the membrane resident component bound to the HDM-2 binding component. Also provided are a method of selectively necrosing cancer cells, a method of causing membranolysis in cancer cells, and a cancer treatment composition.
FILED Wednesday, November 26, 2008
APPL NO 12/744831
ART UNIT 1676 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/155 (20130101)
A61K 31/155 (20130101)
A61K 31/4995 (20130101)
A61K 31/4995 (20130101)
A61K 38/10 (20130101)
A61K 38/10 (20130101)
A61K 38/1709 (20130101)
A61K 38/1758 (20130101)
A61K 45/06 (20130101) Original (OR) Class
A61K 47/48023 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Peptides
C07K 14/4746 (20130101)
C07K 2319/03 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539329 Yun et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
APPLICANT(S) The General Hospital Corporation (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Seok-Hyun Yun (Cambridge, Massachusetts);  Myunghwan Choi (Cambridge, Massachusetts)
ABSTRACT A hydrogel-lightguide based sensory system susceptible to a stimulus signal produced by ambient and stimulating sensory cells embedded in a hydrogel body of the system. Sensory cells generate an optical signal (in response to a user-defined triggering with excitation light or, alternatively, due to bioluminescence) the properties of which, determined based on detection of such signal with an optical detector device, provide characterization of the stimulus and information required for user-defined activation of emitter cells encapsulated in the hydrogel. When activated, emitter cells generate matter and/or light directed to interact with the ambient.
FILED Friday, October 17, 2014
APPL NO 14/516874
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0059 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0024 (20130101)
A61K 47/10 (20130101) Original (OR) Class
A61K 49/0054 (20130101)
A61K 49/0073 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/0601 (20130101)
A61N 2005/063 (20130101)
A61N 2005/0626 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539334 Wood et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Research Resources (NCRR)
APPLICANT(S) THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland)
ASSIGNEE(S) John Hopkins University (Baltimore, Maryland)
INVENTOR(S) Robert Wood (Lutherville, Maryland);  Hai-Quan Mao (Baltimore, Maryland);  Corinne Keet (Baltimore, Maryland);  Russell Martin (Los Gatos, California)
ABSTRACT The present invention provides a thin mucoadhesive sublingual film composition which provides improved allergen delivery and efficacy at a smaller dose while prolonging the contact time between the allergen and oral antigen presenting cells (APCs), and therefore minimizing the risk of systemic side effects. The thin film compositions of the present invention are also easier to standardize, and removes any need for measuring allergen doses at the physician's office, and which allows for a simplified dosing schedule. Methods of making the thin film compositions and methods for their use are also disclosed.
FILED Friday, May 17, 2013
APPL NO 14/400856
ART UNIT 1616 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/006 (20130101)
A61K 9/7007 (20130101)
A61K 9/7015 (20130101)
A61K 39/35 (20130101)
A61K 45/06 (20130101)
A61K 47/10 (20130101)
A61K 47/26 (20130101)
A61K 47/32 (20130101)
A61K 47/38 (20130101) Original (OR) Class

Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 39/02 (20130101)

Indexing Scheme Associated With Subclass B29C, Relating to Particular Articles
B29L 2007/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539342 Pettit et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
U.S. State Government
State of Arizona
APPLICANT(S) ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (Scottsdale, Arizona)
ASSIGNEE(S) Arizona Board of Regents, a body corporate of the State of Arizona, acting for and on behlaf of Arizona State University (Scottsdale, Arizona)
INVENTOR(S) George R. Pettit (Paradise Valley, Arizona);  Fiona Hogan (Gilbert, Arizona);  Steven Toms (Wellington, New Zealand)
ABSTRACT The present invention relates to new auristatin compounds and prodrugs thereof, compositions comprising them and uses thereof.
FILED Wednesday, May 06, 2015
APPL NO 14/705651
ART UNIT 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/472 (20130101)
A61K 31/472 (20130101)
A61K 31/4709 (20130101)
A61K 31/4709 (20130101)
A61K 38/00 (20130101)
A61K 38/08 (20130101)
A61K 45/06 (20130101)
A61K 47/48415 (20130101) Original (OR) Class
A61K 47/48715 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Heterocyclic Compounds
C07D 207/12 (20130101)
C07D 401/12 (20130101)

Peptides
C07K 5/0205 (20130101)
C07K 7/02 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5014 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539359 Bose et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical and Transport Systems (CTS)
APPLICANT(S) Washington State University (Pullman, Washington)
ASSIGNEE(S) Washington State University (Pullman, Washington)
INVENTOR(S) Susmita Bose (Pullman, Washington);  Amit Bandyopadhyay (Pullman, Washington);  Weichang Xue (Suzhou, China PRC)
ABSTRACT Mesoporous calcium silicate compositions for controlled release of bioactive agents and methods for producing such compositions are disclosed herein. In one embodiment, mesoporous calcium silicate is synthesized by acid modification of wollastonite particles using hydrochloric acid. A hydrated silica gel layer having abundant Si—OH functional groups can be formed on the surface of wollastonite after acid modification. Bruhauer-Emmett-Teller (BET) surface area increased significantly due to acid modification and, in one arrangement, reached over 350 m2/g. Acid modified mesoporous calcium silicate compositions show a higher ability to adsorb protein compared to unmodified particles and demonstrate controlled release kinetics of these proteins.
FILED Tuesday, November 11, 2014
APPL NO 14/538418
ART UNIT 1615 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/5115 (20130101)
A61K 47/48861 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/10 (20130101)
A61L 27/025 (20130101) Original (OR) Class
A61L 27/54 (20130101)
A61L 27/56 (20130101)
A61L 27/58 (20130101)
A61L 27/227 (20130101)
A61L 27/306 (20130101)
A61L 2300/45 (20130101)
A61L 2300/252 (20130101)
A61L 2300/254 (20130101)
A61L 2300/414 (20130101)
A61L 2300/428 (20130101)
A61L 2300/602 (20130101)
A61L 2430/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539362 Kaplan et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Dental and Craniofacial Research (NIDCR)
APPLICANT(S) David L. Kaplan (Concord, Massachusetts);  Chunmei Li (Stoneham, Massachusetts)
ASSIGNEE(S) Trustees of Tufts College (Medford, Massachusetts)
INVENTOR(S) David L. Kaplan (Concord, Massachusetts);  Chunmei Li (Stoneham, Massachusetts)
ABSTRACT The present invention is directed to a method for forming an inorganic coating on a protein template. The method comprises contacting the template with an anionic polymer interface followed by an inorganic material for a sufficient period of time to allow mineralization of the inorganic material thus forming an inorganic coating on the template. Preferably, the coating is aligned.
FILED Monday, April 19, 2010
APPL NO 12/762515
ART UNIT 1616 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/24 (20130101)
A61L 27/30 (20130101)
A61L 27/46 (20130101)
A61L 27/227 (20130101) Original (OR) Class
A61L 27/446 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 428/2933 (20150115)
Y10T 428/24999 (20150401)
Y10T 428/31768 (20150401)
Y10T 442/10 (20150401)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539367 Britigan et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Bradley E. Britigan (Cincinnati, Ohio);  Pradeep K. Singh (Iowa City, Iowa)
ASSIGNEE(S) University of Iowa Research Foundation (Iowa City, Iowa)
INVENTOR(S) Bradley E. Britigan (Cincinnati, Ohio);  Pradeep K. Singh (Iowa City, Iowa)
ABSTRACT The present invention provides a gallium-containing composition for coating/impregnating a device or device surface to prevent biofilm growth formation. The present invention also provides a method of preventing or inhibiting biofilm growth formation. The present invention also provides methods for killing established biofilms.
FILED Friday, December 03, 2004
APPL NO 11/004049
ART UNIT 1629 — Organic Chemistry
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 59/16 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 31/28 (20130101)
A61K 33/24 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/54 (20130101) Original (OR) Class
A61L 27/306 (20130101)
A61L 29/16 (20130101)
A61L 29/106 (20130101)
A61L 2300/102 (20130101)
A61L 2300/404 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539371 Wen et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Innovative Surface Technologies, Inc. (St. Paul, Minnesota)
ASSIGNEE(S) INNOVATIVE SURFACE TECHNOLOGIES, INC. (St. Paul, Minnesota)
INVENTOR(S) Jie Wen (St. Johns, Florida);  Kristin Taton (Little Canada, Minnesota);  Laurie Lawin (New Brighton, Minnesota);  William Knopke (Minneapolis, Minnesota);  Eric Guire (St. Paul, Minnesota);  Patrick Guire (Hopkins, Minnesota)
ABSTRACT The invention describes novel coating agents that include a polymer, one or more latent reactive groups and one or more noncovalent linking groups, the noncovalent linking groups selected to interact with a substrate to which the coating agent is applied.
FILED Thursday, June 25, 2015
APPL NO 14/749815
ART UNIT 1765 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 31/06 (20130101)
A61L 31/10 (20130101) Original (OR) Class
A61L 31/14 (20130101)
A61L 31/16 (20130101)
A61L 31/022 (20130101)
A61L 33/0005 (20130101)
A61L 2300/42 (20130101)
A61L 2300/404 (20130101)
A61L 2400/10 (20130101)
A61L 2420/02 (20130101)
A61L 2420/08 (20130101)

Processes for Applying Fluent Materials to Surfaces, in General
B05D 3/06 (20130101)

Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 8/30 (20130101)
C08F 8/30 (20130101)
C08F 8/42 (20130101)
C08F 8/42 (20130101)
C08F 222/06 (20130101)
C08F 222/06 (20130101)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 131/00 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 428/3175 (20150401)
Y10T 428/31507 (20150401)
Y10T 428/31511 (20150401)
Y10T 428/31573 (20150401)
Y10T 428/31598 (20150401)
Y10T 428/31663 (20150401)
Y10T 428/31667 (20150401)
Y10T 428/31721 (20150401)
Y10T 428/31797 (20150401)
Y10T 428/31855 (20150401)
Y10T 428/31884 (20150401)
Y10T 428/31909 (20150401)
Y10T 428/31913 (20150401)
Y10T 428/31928 (20150401)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539427 Kass et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of General Medical Sciences (NIGMS)
NIH Office of the Director (NIHOD)
APPLICANT(S) David Kass (Columbia, Maryland);  Gordon Tomaselli (Lutherville, Maryland);  Jonathan Kirk (Baltimore, Maryland)
ASSIGNEE(S) THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland)
INVENTOR(S) David Kass (Columbia, Maryland);  Gordon Tomaselli (Lutherville, Maryland);  Jonathan Kirk (Baltimore, Maryland)
ABSTRACT The invention provides methods related to improving heart function.
FILED Tuesday, November 08, 2011
APPL NO 13/884144
ART UNIT 3762 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/365 (20130101)
A61N 1/3627 (20130101)
A61N 1/3682 (20130101) Original (OR) Class
A61N 1/3684 (20130101)
A61N 1/3688 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6876 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/447 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540317 Mazitschek et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts);  Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts);  Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) Ralph Mazitschek (Belmont, Massachusetts);  James E. Bradner (Weston, Massachusetts)
ABSTRACT The present invention is drawn to compounds of Formula (I) below:
and the pharmaceutically acceptable salts thereof, wherein R and R″ are defined herein. The compounds are useful inhibitors of histone deacetylases (HDAC).
FILED Tuesday, May 06, 2014
APPL NO 14/271170
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/175 (20130101)
A61K 31/495 (20130101)
A61K 38/05 (20130101)
A61K 45/06 (20130101)

Acyclic or Carbocyclic Compounds
C07C 243/38 (20130101) Original (OR) Class

Heterocyclic Compounds
C07D 239/42 (20130101)
C07D 401/04 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/48 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540320 Bradner et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Human Genome Research Institute (NHGRI)
APPLICANT(S) Whitehead Institute for Biomedical Research (Cambridge, Massachusetts);  Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
ASSIGNEE(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts);  Whitehead Institute for Biomedical Research (Cambridge, Massachusetts)
INVENTOR(S) James E. Bradner (Weston, Massachusetts);  Michael R. McKeown (Brookline, Massachusetts);  Peter B. Rahl (Natick, Massachusetts);  Richard A. Young (Boston, Massachusetts);  Jason J. Marineau (Franklin, Massachusetts)
ABSTRACT The present invention provides compounds of Formula (I-A), (I-B), and (I-C), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting Myc (e.g., c-Myc) activity. The present invention further provides methods of using the compounds described herein for treating Myc-mediated disorders (e.g., cancer and other proliferative diseases). The present invention also provides assays for identifying Myc inhibitors.
FILED Friday, November 01, 2013
APPL NO 14/440200
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 207/27 (20130101)
C07D 207/327 (20130101) Original (OR) Class
C07D 209/04 (20130101)
C07D 401/12 (20130101)
C07D 403/06 (20130101)
C07D 409/04 (20130101)
C07D 413/12 (20130101)
C07D 417/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540322 Jorgensen et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) William L. Jorgensen (Deep River, Connecticut);  Richard J. Bucala (Cos Cob, Connecticut)
ASSIGNEE(S) Yale University (New Haven, Connecticut)
INVENTOR(S) William L. Jorgensen (Deep River, Connecticut);  Richard J. Bucala (Cos Cob, Connecticut)
ABSTRACT The invention provides novel heterocyclic compounds, pharmaceutical compositions and methods of treatment that modulate levels of MIF expression and treat disorders associated with high or low levels of MIF expression.
FILED Wednesday, May 04, 2011
APPL NO 13/100922
ART UNIT 1627 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 209/18 (20130101) Original (OR) Class
C07D 235/12 (20130101)
C07D 235/24 (20130101)
C07D 249/06 (20130101)
C07D 263/58 (20130101)
C07D 275/04 (20130101)
C07D 307/80 (20130101)
C07D 307/83 (20130101)
C07D 401/04 (20130101)
C07D 401/06 (20130101)
C07D 403/04 (20130101)
C07D 405/06 (20130101)
C07D 413/04 (20130101)
C07D 417/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540336 Rubin et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) Harvey Rubin (Philadelphia, Pennsylvania);  Takahiro Yano (Narberth, Pennsylvania);  Sacha Kassovska-Bratinova (Havertown, Pennsylvania);  Norman Schechter (Philadelphia, Pennsylvania);  Jiah Shin Teh (Baltimore, Maryland);  Jeffrey Winkler (Wynnewood, Pennsylvania)
ABSTRACT The present invention includes a method of treating or preventing a disease or disorder such as a mycobacterial infection, a Gram-positive bacterium infection, a yeast infection, an inflammatory condition, an auto-immune disorder and/or a proliferative disorder in a subject in need thereof. The method comprises administering to the subject a therapeutically effective amount of at least one compound of the invention, which includes clofazimine derivatives.
FILED Friday, December 21, 2012
APPL NO 14/366879
ART UNIT 1627 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/498 (20130101)

Heterocyclic Compounds
C07D 241/46 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540337 Hanigan et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Board of Regents of the University of Oklahoma (Norman, Oklahoma);  Ohio State Innovation Foundation (Columbus, Ohio)
ASSIGNEE(S) The Board of Regents of the University of Oklahoma (Norman, Oklahoma)
INVENTOR(S) Marie H. Hanigan (Edmond, Oklahoma);  Pui Kai Li (Galloway, Ohio)
ABSTRACT Compositions that are effective in inhibiting gamma-glutamyl transpeptidase are disclosed. Methods of producing and using these compositions are also disclosed.
FILED Friday, August 23, 2013
APPL NO 13/974704
ART UNIT 1629 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/433 (20130101)

Heterocyclic Compounds
C07D 285/135 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540355 Smith, III et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Trustees of The University of Pennsylvania (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees Of The University Of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) Amos B. Smith, III (Merion, Pennsylvania);  Chihui An (Philadelphia, Pennsylvania);  Adam T. Hoye (Bala Cynwyd, Pennsylvania)
ABSTRACT The present invention is directed to irciniastatin analogs. Uses of these analogs also described.
FILED Wednesday, January 15, 2014
APPL NO 14/761030
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 407/06 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540369 Striker et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S) WISCONSIN ALUMNI RESEARCH FOUNDATION (Madison, Wisconsin)
INVENTOR(S) Robert Todd Striker (Madison, Wisconsin);  John-Demian Sauer (Madison, Wisconsin);  Nathan Wlodarchak (Madison, Wisconsin)
ABSTRACT Methods of using certain kinase inhibitors for treating Gram positive bacterial infections are disclosed. When co-administered with a β-lactam antibiotic, the disclosed compounds increase the susceptibility of infectious Gram positive bacteria to the β-lactam antibiotic. The disclosed kinase inhibitors have either of the general formulas:
or the specific formula:
FILED Friday, April 24, 2015
APPL NO 14/695813
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 471/04 (20130101) Original (OR) Class
C07D 487/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540371 Lindsley et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) Vanderbilt University (Nashville, Tennessee)
ASSIGNEE(S) Vanderbilt University (Nashville, Tennessee)
INVENTOR(S) Craig W. Lindsley (Brentwood, Tennessee);  P. Jeffrey Conn (Nashville, Tennessee);  Shaun R. Stauffer (Brentwood, Tennessee);  Joseph David Panarese (Nashville, Tennessee)
ABSTRACT In one aspect, the invention relates to 3-benzylquinazolin-4(3H)-one analogs, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M1 (mAChR M1); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention. Exemplary 3-benzylquinazolin-4(3H)-one compounds include compounds of formula (I):
FILED Monday, April 28, 2014
APPL NO 14/787722
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 401/10 (20130101)
C07D 403/10 (20130101)
C07D 471/04 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540375 Aube et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Human Genome Research Institute (NHGRI)
National Institute on Drug Abuse (NIDA)
APPLICANT(S) University of Kansas (Lawrence, Kansas);  The Scripps Research Institute (Jupiter, Florida)
ASSIGNEE(S) University of Kansas (Lawrence, Kansas);  The Scripps Research Institute (Jupiter, Florida)
INVENTOR(S) Jeffrey Aube (Lawrence, Kansas);  Laura Bohn (Jupiter, Florida);  Thomas Edward Prisinzano (Lawrence, Kansas);  Frank John Schoenen (Lawrence, Kansas);  Kevin J. Frankowski (Lawrence, Kansas)
ABSTRACT The present invention is a selective kappa opioid receptor effector, or a pharmaceutically acceptable salt thereof, useful for treating ethanol use disorder withdrawal, anxiety and/or depression, schizophrenia, mania or post-traumatic stress disorder.
FILED Tuesday, May 17, 2016
APPL NO 15/156887
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/444 (20130101)
A61K 31/444 (20130101)
A61K 31/4196 (20130101)
A61K 31/4196 (20130101)
A61K 31/4439 (20130101)
A61K 31/4439 (20130101)
A61K 31/4985 (20130101)
A61K 31/4985 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Heterocyclic Compounds
C07D 401/04 (20130101)
C07D 401/14 (20130101)
C07D 405/14 (20130101)
C07D 409/14 (20130101)
C07D 471/04 (20130101)
C07D 471/14 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540389 Opperman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) MICROBIOTIX, INC. (Worcester, Massachusetts)
ASSIGNEE(S) Microbiotix, Inc. (Worcester, Massachusetts)
INVENTOR(S) Timothy J. Opperman (Arlington, Massachusetts);  Son T. Nguyen (West Boylston, Massachusetts);  Steven M. Kwasny (Blackstone, Massachusetts);  Xiaoyuan Ding (North Providence, Rhode Island)
ABSTRACT Novel compounds are disclosed having the structure of Formula I:
wherein, n is an integer from 1 to 5; X is —CN, —F, —Cl, —Br, —I, —NO2; W is S, SO, SO2, O, NH, or NR5; R5 is alkyl, aralkyl, alkenyl, or alkynyl; Y is O, S; Z is NR1R2 or heterocycloalkyl; R1, R2 are, independently, hydrogen, alkyl, aralkyl, alkenyl, alkynyl, or cycloalkyl and may be optionally substituted with halo, hydroxy, alkoxy, amino, alkylamino, carboxy, alkoxycarbonyl, or nitrile groups; R3 and R4 are, independently, hydrogen, alkyl, aralkyl, alkenyl, alkynyl, or cycloalkyl and may be optionally substituted with halo, hydroxy, alkoxy, amino, alkylamino, carboxy, alkoxycarbonyl, or nitrile groups, and may together form a cyclic structure; and Ar is mono-, di-, or tri-substituted phenyl or heteroaryl, a pharmaceutically acceptable salts thereof. The compounds are potent bacterial efflux pump inhibitors (EPIs). Such compounds are useful to potentiate the antimicrobial activity of antimicrobial compounds such as beta-lactam antibiotics and quinolone antibiotics against Gram-negative bacteria.
FILED Saturday, May 03, 2014
APPL NO 14/888022
ART UNIT 1617 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 43/90 (20130101)
A01N 47/44 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 31/436 (20130101)
A61K 31/436 (20130101)
A61K 31/496 (20130101)
A61K 31/496 (20130101)
A61K 31/541 (20130101)
A61K 31/541 (20130101)
A61K 31/551 (20130101)
A61K 31/551 (20130101)
A61K 31/553 (20130101)
A61K 31/5377 (20130101)
A61K 31/5377 (20130101)
A61K 31/5383 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Heterocyclic Compounds
C07D 491/052 (20130101) Original (OR) Class
C07D 493/04 (20130101)
C07D 513/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540409 Gellman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin);  The Board of Trustees of the Leland Stanford Junior University (Palo Alto, California)
ASSIGNEE(S) WIsconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Samuel Helmer Gellman (Madison, Wisconsin);  Pil Seok Chae (Ansan-si, South Korea);  Brian Kobilka (Palo Alto, California);  Soren Rasumssen (Gentofte, Denmark)
ABSTRACT The invention provides amphiphilic compounds and methods for manipulating membrane proteins. Compounds of the invention, for example, the compounds of Formulas I-XIX, can be prepared from readily available starting materials. The amphiphilic compounds can manipulate membrane protein at relatively low concentrations compared to many known detergents. The compounds can be used to aid the isolation of membrane proteins, for example, to aid their solubilization and/or purification. The compounds can also be used to aid the functional and structural determination of membrane proteins, including their stabilization and crystallization.
FILED Wednesday, August 07, 2013
APPL NO 13/961757
ART UNIT 1673 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 15/04 (20130101) Original (OR) Class
C07H 15/18 (20130101)
C07H 15/26 (20130101)

Peptides
C07K 1/145 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540415 Gonzalez et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
Department of Agriculture (USDA)
APPLICANT(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia);  The Penn State Research Foundation (University Park, Pennsylvania)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia);  The Penn State Research Foundation (University Park, Pennsylvania)
INVENTOR(S) Frank J. Gonzalez (Bethesda, Maryland);  Changtao Jiang (Beijing, China PRC);  Cen Xie (Rockville, Maryland);  Andrew D. Patterson (State College, Pennsylvania);  Fei Li (Rockville, Maryland);  James B. Mitchell (Damascus, Maryland)
ABSTRACT Disclosed are inhibitors of the farnesoid X receptor, for example of formula (I), wherein R1, R2, R4, X, Y, Z, m, and n are as defined herein, which are useful in treating or preventing obesity, type 2 diabetes/insulin resistance and non alcoholic fatty liver disease in a mammal in need thereof. Also disclosed is a composition comprising a pharmaceutically suitable carrier and at least Cone compound of the invention, a method of method of inhibiting a farnesoid X receptor in a mammal, and a method of treating or preventing obesity in a mammal.
FILED Friday, August 01, 2014
APPL NO 14/909263
ART UNIT 1672 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Steroids
C07J 9/005 (20130101)
C07J 41/0055 (20130101)
C07J 41/0061 (20130101) Original (OR) Class
C07J 41/0066 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540422 Gundlach et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Human Genome Research Institute (NHGRI)
APPLICANT(S) University of Washington (Seattle, Washington);  The UAB Research Foundation (Birmingham, Alabama)
ASSIGNEE(S) University of Washington (Seattle, Washington);  The UAB Research Foundation (Birmingham, Alabama)
INVENTOR(S) Jens H. Gundlach (Seattle, Washington);  Michael Niederweis (Homewood, Alabama);  Thomas Z. Butler (Seattle, Washington);  Mikhail Pavlenok (Birmingham, Alabama);  Mark A. Troll (Seattle, Washington);  Suja Sukumaran (Dublin, California)
ABSTRACT Provided herein are Mycobacterium smegmatis porin nanopores, systems that comprise these nanopores, and methods of using and making these nanopores. Such nanopores may be wild-type MspA porins, mutant MspA porins, wild-type MspA paralog porins, wild-type MspA homolog porins, mutant MspA paralog porins, mutant MspA homolog porins, or single-chain Msp porins. Also provided are bacterial strains capable of inducible Msp porin expression.
FILED Tuesday, January 12, 2016
APPL NO 14/993952
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/04 (20130101)

Peptides
C07K 14/35 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 13/00 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6869 (20130101)
C12Q 1/6869 (20130101)
C12Q 2523/31 (20130101)
C12Q 2565/631 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/44704 (20130101)
G01N 33/6872 (20130101)
G01N 33/48721 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540427 Tarasova et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) Nadya I. Tarasova (Frederick, Maryland);  Olga Timofeeva (North Potomac, Maryland);  Vadim Gaponenko (Naperville, Illinois);  Christopher J. Michejda (North Potomac, Maryland);  Maria Michejda (North Potomac, Maryland);  Alan O. Perantoni (Fairfield, Pennsylvania);  Sergey G. Tarasov (Frederick, Maryland)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Nadya I. Tarasova (Frederick, Maryland);  Olga Timofeeva (North Potomac, Maryland);  Vadim Gaponenko (Naperville, Illinois);  Christopher J. Michejda (North Potomac, Maryland);  Alan O. Perantoni (Fairfield, Pennsylvania);  Sergey G. Tarasov (Frederick, Maryland)
ABSTRACT A peptide or peptidomimetic comprising the amino acid sequence of the second helix of a STAT protein, or a variant of such sequence, wherein the peptide or peptidomimetic comprises about 40 or fewer amino acids and binds to a STAT protein, as well as a method of inhibiting a STAT protein in a cell, a method of treating or preventing a disease associated with STAT overexpression in a host, and related compounds, compositions, and methods.
FILED Friday, May 30, 2008
APPL NO 12/601711
ART UNIT 1676 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/04 (20130101)

Peptides
C07K 14/4705 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540430 Schellenberger et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Amunix Operating Inc. (Mountain View, California)
ASSIGNEE(S) Amunix Operating Inc. (Mountain View, California)
INVENTOR(S) Volker Schellenberger (Palo Alto, California);  Joshua Silverman (Sunnyvale, California);  Willem P. Stemmer (Los Gatos, California);  Chia-wei Wang (Milpitas, California);  Nathan Geething (Santa Clara, California);  Jeffrey L. Cleland (San Carlos, California)
ABSTRACT The present invention relates to compositions comprising glucose regulating peptides linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of glucose regulating peptide-related diseases, disorders, and conditions.
FILED Friday, December 05, 2014
APPL NO 14/562406
ART UNIT 1676 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 14/575 (20130101)
C07K 14/605 (20130101) Original (OR) Class
C07K 14/57563 (20130101)
C07K 2319/00 (20130101)
C07K 2319/31 (20130101)
C07K 2319/50 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/70 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 21/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540439 Vignali et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) ST. JUDE CHILDREN'S RESEARCH HOSPITAL (Memphis, Tennessee)
ASSIGNEE(S) St. Jude Children's Research Hospital (Memphis, Tennessee)
INVENTOR(S) Dario A. A. Vignali (Germantown, Tennessee);  Seng-ryong Woo (Chicago, Illinois);  Greg M. Delgoffe (Memphis, Tennessee)
ABSTRACT The invention is directed to treatment of cancer, infections and various inflammatory and autoimmune conditions by affecting regulatory T cell stability and function via a Neuropilin-1:Semaphorin axis. The present invention satisfies this and other needs by demonstrating that the regulatory T cell (Treg)-restricted neuropilin-1 (Nrp 1) interacts with the cell surface ligand semaphorin-4a (Sema4a) (e.g., on conventional T cells (Tconv), conventional dendritic cells (cDCs), and/or plasmacytoid dendritic cells (pDCs)) to potentiate reg function and enhance their survival at inflammatory sites.
FILED Tuesday, October 08, 2013
APPL NO 14/434129
ART UNIT 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 2217/075 (20130101)
A01K 2227/105 (20130101)
A01K 2267/0387 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 31/713 (20130101)
A61K 38/1709 (20130101)
A61K 2039/505 (20130101)

Peptides
C07K 16/2803 (20130101)
C07K 16/2863 (20130101) Original (OR) Class
C07K 2317/73 (20130101)
C07K 2317/76 (20130101)
C07K 2319/30 (20130101)
C07K 2319/32 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0637 (20130101)
C12N 15/1138 (20130101)
C12N 2310/14 (20130101)
C12N 2501/165 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540445 June et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) Carl H. June (Merion Station, Pennsylvania);  Bruce L. Levine (Cherry Hill, New Jersey);  David L. Porter (Springfield, Pennsylvania);  Michael D. Kalos (Philadelphia, Pennsylvania);  Michael C. Milone (Cherry Hill, New Jersey)
ABSTRACT The present invention provides compositions and methods for treating cancer in a human. The invention includes relates to administering a genetically modified T cell to express a CAR wherein the CAR comprises an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and a CD3 zeta signaling domain.
FILED Friday, January 15, 2016
APPL NO 14/997136
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/17 (20130101)
A61K 38/177 (20130101)
A61K 38/1774 (20130101)
A61K 39/0011 (20130101)
A61K 39/39558 (20130101)
A61K 39/39558 (20130101)
A61K 45/06 (20130101)
A61K 48/005 (20130101)
A61K 2039/505 (20130101)
A61K 2039/585 (20130101)
A61K 2039/5156 (20130101)
A61K 2039/5158 (20130101)
A61K 2039/5256 (20130101)
A61K 2300/00 (20130101)

Peptides
C07K 14/525 (20130101)
C07K 14/7051 (20130101)
C07K 14/70517 (20130101)
C07K 14/70521 (20130101)
C07K 14/70578 (20130101)
C07K 14/70596 (20130101)
C07K 16/30 (20130101)
C07K 16/2803 (20130101)
C07K 16/2896 (20130101) Original (OR) Class
C07K 16/3061 (20130101)
C07K 2317/53 (20130101)
C07K 2317/76 (20130101)
C07K 2317/80 (20130101)
C07K 2317/622 (20130101)
C07K 2319/00 (20130101)
C07K 2319/02 (20130101)
C07K 2319/03 (20130101)
C07K 2319/30 (20130101)
C07K 2319/33 (20130101)
C07K 2319/74 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0636 (20130101)
C12N 7/00 (20130101)
C12N 15/85 (20130101)
C12N 2501/515 (20130101)
C12N 2510/00 (20130101)
C12N 2740/15034 (20130101)
C12N 2740/15043 (20130101)
C12N 2740/15071 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540448 Scheinberg et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) MEMORIAL SLOAN KETTERING CANCER CENTER (New York, New York);  EUREKA THERAPEUTICS, INC. (Emeryville, California)
ASSIGNEE(S) MEMORIAL SLOAN KETTERING CANCER CENTER (New York, New York);  EUREKA THERAPEUTICS, INC. (Emeryville, California)
INVENTOR(S) David Scheinberg (New York, New York);  Tao Dao (New York, New York);  Cheng Liu (Oakland, California);  Su Yan (State College, Pennsylvania)
ABSTRACT The present invention provides antigen binding proteins that specifically bind to Wilms' tumor protein (WT1), including humanized, chimeric and fully human antibodies against WT1, antibody fragments, chimeric antigen receptors (CARs), fusion proteins, and conjugates thereof. The antigen binding proteins and antibodies bind to HLA-A0201-restricted WT1 peptide. Such antibodies, fragments, fusion proteins and conjugates thereof are useful for the treatment of WT1 associated cancers, including for example, breast cancer, ovarian cancer, prostate cancer, chronic myelocytic leukemia, multiple myeloma, acute lymphoblastic leukemia (ALL), acute myeloid/myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). In more particular embodiments, the anti-WT1/A antibodies may comprise one or more framework region amino acid substitutions designed to improve protein stability, antibody binding and/or expression levels.
FILED Thursday, May 28, 2015
APPL NO 14/724155
ART UNIT 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/48561 (20130101)
A61K 47/48569 (20130101)
A61K 2039/505 (20130101)

Peptides
C07K 16/18 (20130101)
C07K 16/32 (20130101) Original (OR) Class
C07K 16/2833 (20130101)
C07K 2317/21 (20130101)
C07K 2317/34 (20130101)
C07K 2317/56 (20130101)
C07K 2317/565 (20130101)
C07K 2317/567 (20130101)
C07K 2317/622 (20130101)
C07K 2317/732 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5748 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540471 Hrabie et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Joseph A. Hrabie (Frederick, Maryland);  Larry K. Keefer (Bethesda, Maryland)
ABSTRACT Disclosed is a nitric oxide-releasing polyvinylpyrrolidone-based polymer derived from N-vinylpyrrolidone monomer and at least one nitric oxide releasing N2O2 group, in which the N2O2 group is attached to a 2 pyrrolidinone group or a group derived therefrom in the N-vinylpyrrolidone monomer, and the polymer is optionally in combination with a substrate. The NO-releasing polymer can be part of a medical device or pharmaceutical composition and is useful for treating a biological disorder, such as healing a wound, restenosis, and/or promoting angiogenesis.
FILED Wednesday, July 17, 2013
APPL NO 14/414765
ART UNIT 1615 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/79 (20130101)

Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 226/10 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540481 Wilson et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Lawrence Livermore National Security, LLC (Livermore, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Thomas S. Wilson (San Leandro, California);  Michael Keith Hearon, II (Livermore, California);  Jane P. Bearinger (Berwyn, Pennsylvania)
ABSTRACT This invention relates to chemical polymer compositions, methods of synthesis, and fabrication methods for devices regarding polymers capable of displaying shape memory behavior (SMPs) and which can first be polymerized to a linear or branched polymeric structure, having thermoplastic properties, subsequently processed into a device through processes typical of polymer melts, solutions, and dispersions and then crossed linked to a shape memory thermoset polymer retaining the processed shape.
FILED Monday, May 13, 2013
APPL NO 13/892719
ART UNIT 1765 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 47/00 (20130101)
B29C 47/0009 (20130101)
B29C 51/00 (20130101)
B29C 51/002 (20130101)
B29C 67/20 (20130101)
B29C 71/02 (20130101)
B29C 71/04 (20130101)

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 18/73 (20130101)
C08G 18/83 (20130101) Original (OR) Class
C08G 18/673 (20130101)
C08G 18/675 (20130101)
C08G 18/722 (20130101)
C08G 18/758 (20130101)
C08G 18/3206 (20130101)
C08G 63/52 (20130101)
C08G 2101/00 (20130101)
C08G 2280/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540619 Huang et al.
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) NOVARTIS AG (Basel, Switzerland);  DANA-FARBER CANCER INSTITUTE, INC. (Boston, Massachusetts)
ASSIGNEE(S) Novartis AG (Basel, Switzerland);  Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) Xizhong Huang (Cambridge, Massachusetts);  Jean J. Zhao (Brookline, Massachusetts);  Junxia Min (Cambridge, Massachusetts);  Yubao Wang (Newton, Massachusetts)
ABSTRACT Methods for inhibiting growth or proliferation of breast cancer cells are provided. The methods include administering to a subject in need thereof in an amount that is effective to inhibit growth or proliferation of the breast cancer cells a MELK inhibitor, wherein the breast cancer cells are estrogen receptor (ER) negative. In some aspects, the methods include administering to a subject in need thereof in an amount that is effective to inhibit growth or proliferation of the breast cancer cells a MELK inhibitor, a FoxM1 inhibitor or a MELK inhibitor and a FoxM1 inhibitor, wherein the breast cancer cells are estrogen receptor (ER) negative. Methods of treatment for breast cancer and methods of identifying patients having cancer that are likely to benefit from treatment with a MELK inhibitor, a FoxM1 inhibitor or a MELK inhibitor and a FoxM1 inhibitor are also provided.
FILED Wednesday, January 08, 2014
APPL NO 14/759889
ART UNIT 1674 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/7088 (20130101)
A61K 38/12 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/12 (20130101) Original (OR) Class
C12N 15/1135 (20130101)
C12N 15/1137 (20130101)
C12N 2310/14 (20130101)
C12N 2310/531 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101)
C12Q 2600/158 (20130101)

Enzymes
C12Y 207/11001 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540620 Sondek et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The University of North Carolina at Chapel Hill (Chapel Hill, North Carolina)
ASSIGNEE(S) The University of North Carolina at Chapel Hill (Chapel Hill, North Carolina)
INVENTOR(S) John Sondek (Chapel Hill, North Carolina);  Thomas Kendall Harden (Westfield, North Carolina);  Gary Lynn Waldo (Chapel Hill, North Carolina);  Matthew Owen Barrett (Carrboro, North Carolina);  Thomas Henry Charpentier (Chapel Hill, North Carolina)
ABSTRACT The present invention provides compositions and methods for modulating G-alpha-q activity and methods of screening of test substances for the ability to modulate G-alpha-q activity.
FILED Friday, March 08, 2013
APPL NO 14/398678
ART UNIT 1676 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/465 (20130101)
A61K 47/48046 (20130101)
A61K 47/48246 (20130101)

Peptides
C07K 14/4703 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/16 (20130101) Original (OR) Class

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/34 (20130101)

Enzymes
C12Y 301/04011 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 2333/914 (20130101)
G01N 2500/02 (20130101)
G01N 2500/04 (20130101)
G01N 2500/20 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540626 Lambris et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) John D. Lambris (Philadelphia, Pennsylvania);  Christoph Schmidt (Laugna, Germany);  Daniel Ricklin (Media, Pennsylvania)
ABSTRACT A potent complement regulator is disclosed. The complement regulator comprises a complement regulatory region connected by a flexible linker to a multifunctional binding region that enables binding to C3b activation/inactivation products and/or oxidation end products, as well as to polyanionic surface markers on host cells. An embodiment of the invention utilizes factor H SCRs 1-4 as the complement regulatory region and factor H SCRs 19 and 20 as the multifunctional binding region, linked together by a poly-Gly linker at least 12 residues in length. Pharmaceutical compositions comprising the complement regulator and methods of using the complement regulator are also disclosed.
FILED Friday, March 15, 2013
APPL NO 14/386043
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)
A61K 38/51 (20130101)

Peptides
C07K 14/472 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/88 (20130101) Original (OR) Class

Enzymes
C12Y 402/01002 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540634 Eberwine et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
NIH Office of the Director (NIHOD)
APPLICANT(S) James Eberwine (Philadelphia, Pennsylvania);  Ditte Lovatt (Swarthmore, Pennsylvania);  Julia Richards (Philadelphia, Pennsylvania);  Ivan Dmochowski (Philadelphia, Pennsylvania);  Brittani Ruble (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) James Eberwine (Philadelphia, Pennsylvania);  Ditte Lovatt (Swarthmore, Pennsylvania);  Julia Richards (Philadelphia, Pennsylvania);  Ivan Dmochowski (Philadelphia, Pennsylvania);  Brittani Ruble (Philadelphia, Pennsylvania)
ABSTRACT Provided are compositions and methods that permit a hybrid nucleic acid-peptide molecule to enter a cell and when specifically activated within the cell, the molecule anneals to endogenous cellular RNA and permits the isolation of the RNA.
FILED Tuesday, June 07, 2011
APPL NO 13/702415
ART UNIT 1675 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1003 (20130101) Original (OR) Class

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6806 (20130101)
C12Q 1/6806 (20130101)
C12Q 2525/205 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540646 Eugenin et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
APPLICANT(S) ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (Bronx, New York)
ASSIGNEE(S) Albert Einstein College of Medicine, Inc. (Bronx, New York)
INVENTOR(S) Eliseo Eugenin (Eastchester, New York);  Joan W. Berman (New York, New York)
ABSTRACT Methods and compositions are provided for treating HIV infection and for inhibiting HIV infection, and for identifying purinergic receptor antagonists or Panx 1 hemi-channel blockers useful therefor. The invention provides a method of treating a mammalian subject having an HIV infection, or suspected of having been exposed to HIV, comprising administering to the mammalian subject an amount of (i) an antagonist of a Panx 1 hemichannel, or (ii) of an inhibitor of a purinergic receptor, effective to inhibit (a) HIV fusion with a target cell, or (b) HIV replication, or (c) HIV entry into a target cell, or two or more of (a), (b) and (c).
FILED Thursday, February 28, 2013
APPL NO 14/381727
ART UNIT 1674 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/00 (20130101)
A61K 31/17 (20130101)
A61K 31/427 (20130101)
A61K 31/661 (20130101)
A61K 31/713 (20130101)
A61K 31/4439 (20130101)
A61K 31/7076 (20130101)
A61K 38/08 (20130101)
A61K 45/06 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1132 (20130101) Original (OR) Class
C12N 2310/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540647 Samant et al.
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) University of South Alabama (Mobile, Alabama)
ASSIGNEE(S) University of South Alabama (Mobile, Alabama)
INVENTOR(S) Lalita Samant (Vestavia Hills, Alabama);  Rajeev Samant (Vestavia Hills, Alabama);  Shamik Das (Vestavia Hills, Alabama);  Eddie Reed (Mobile, Alabama)
ABSTRACT Some embodiments of the present invention relate to methods and compositions for treating cancer. More embodiments include methods and compositions for modulating the activity of the Hedgehog pathway.
FILED Wednesday, October 21, 2015
APPL NO 14/919448
ART UNIT 1674 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/704 (20130101)
A61K 31/7088 (20130101)
A61K 33/24 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1135 (20130101) Original (OR) Class
C12N 2310/11 (20130101)
C12N 2310/14 (20130101)
C12N 2310/531 (20130101)
C12N 2320/30 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5008 (20130101)
G01N 33/5011 (20130101)
G01N 33/57415 (20130101)
G01N 2800/56 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540680 Eberwine et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
NIH Office of the Director (NIHOD)
APPLICANT(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) James Eberwine (Philadelphia, Pennsylvania);  Ditte Lovatt (Swarthmore, Pennsylvania);  Julia Richards (Philadelphia, Pennsylvania);  Ivan Dmochowski (Philadelphia, Pennsylvania);  Brittani Ruble (Philadelphia, Pennsylvania)
ABSTRACT The invention provides compositions and methods that permit a hybrid nucleic acid molecule to enter a cell and when specifically activated within the cell, the molecule anneals to endogenous cellular RNA and permits the isolation of the RNA.
FILED Friday, March 15, 2013
APPL NO 13/838504
ART UNIT 1675 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6806 (20130101) Original (OR) Class
C12Q 1/6876 (20130101)
C12Q 2600/124 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540685 Wu et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Chao-ting Wu (Brookline, Massachusetts);  Brian Beliveau (Cambridge, Massachusetts)
ABSTRACT The present invention relates to methods of hybridizing nucleic acid probes to genomic DNA.
FILED Tuesday, March 11, 2014
APPL NO 14/204498
ART UNIT 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6827 (20130101)
C12Q 1/6827 (20130101)
C12Q 1/6841 (20130101) Original (OR) Class
C12Q 1/6841 (20130101)
C12Q 2543/10 (20130101)
C12Q 2563/107 (20130101)
C12Q 2563/107 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540696 Bussemakers et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Stichting Katholieke Universiteit, more particularly The University Medical Centre Nijmegen (Nijmegen, Netherlands)
ASSIGNEE(S) Stichting Katholieke Universiteit, The University Medical Centre Nijmegen (Nijmegen, Netherlands);  The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Marion J. G. Bussemakers (Nijmegen, Netherlands);  William B. Isaacs (Glyndon, Maryland)
ABSTRACT The present invention relates, in general, to a prostate-specific antigen, PCA3. In particular, the present invention relates to nucleic acid molecules coding for the PCA3 protein; purified PCA3 proteins and polypeptides; recombinant nucleic acid molecules; cells containing the recombinant nucleic acid molecules; antibodies having binding affinity specifically to PCA3 proteins and polypeptides; hybridomas containing the antibodies; nucleic acid probes for the detection of nucleic acids encoding PCA3 proteins; a method of detecting nucleic acids encoding PCA3 proteins or polypeptides in a sample; kits containing nucleic acid probes or antibodies; bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess, or prognose a mammal afflicted with prostate cancer; therapeutic uses; and methods of preventing prostate cancer in an animal.
FILED Monday, September 23, 2013
APPL NO 14/033699
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 2217/05 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 14/47 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
C12Q 2600/112 (20130101)
C12Q 2600/136 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541546 Salogiannis et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) John Salogiannis (Jamaica Plain, Massachusetts);  Michael E. Greenberg (Brookline, Massachusetts);  Seth S. Margolis (Towson, Maryland)
ABSTRACT The invention provides methods of screening a compound that can increase spine/excitatory synapse formation and/or numbers. The compound is identified by contacting Ephexin5 with a test compound and selecting the compounds that inhibit Rho GEF activity of Ephexin5. Additionally, the invention also provides methods for increasing spine/excitatory synapse formation and/or numbers by contacting a neuron with an Ephexin5 inhibitor.
FILED Thursday, February 05, 2015
APPL NO 14/615083
ART UNIT 1649 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5058 (20130101) Original (OR) Class
G01N 2500/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541553 Picker et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Research Resources (NCRR)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) OREGON HEALTH AND SCIENCE UNIVERSITY (Portland, Oregon)
ASSIGNEE(S) Oregon Health and Science University (Portland, Oregon)
INVENTOR(S) Louis Picker (Portland, Oregon);  Klaus Frueh (Portland, Oregon);  Scott G. Hansen (Portland, Oregon);  Collin Powers (San Diego, California)
ABSTRACT This invention also relates to recombinant vectors expressing one or more of the human CMV (HCMV) glycoproteins US2, US3, US6 and US11 or corresponding functional rhesus CMV (RhCMV) homologues Rh182, Rh184, Rh185 or Rh189, methods of making them, uses for them, expression products from them, and uses for the expression products. This invention also relates to recombinant cytomegalovirus vectors vectors lacking one or more of the glycoproteins, methods of making them, uses for them, expression products from them, and uses for the expression products.
FILED Wednesday, February 12, 2014
APPL NO 14/179152
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/00 (20130101)
A61K 39/02 (20130101)
A61K 39/0011 (20130101)
A61K 39/12 (20130101)
A61K 39/21 (20130101)
A61K 39/245 (20130101)
A61K 2039/5254 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 2710/10343 (20130101)
C12N 2710/16134 (20130101)
C12N 2710/16143 (20130101)
C12N 2710/24143 (20130101)
C12N 2740/10034 (20130101)
C12N 2740/15043 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/56972 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541558 Clemons et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Science Foundation (NSF)
APPLICANT(S) California Institute of Technology (Pasadena, California)
ASSIGNEE(S) California Institute of Technology (Pasadena, California)
INVENTOR(S) William M. Clemons (Pasadena, California);  Kyoung-Soon Jang (Pasadena, California);  Roger Nani (Pasadena, California);  Sergiy Levin (North Wales, Pennsylvania);  Sarah Reisman (San Marino, California)
ABSTRACT A cysteine hydrazide nicotinamide (Cyhn) reagent designed for the enrichment of bacterial glycoproteins is provided. Methods for purification of free oligosaccharides and their analysis are also provided.
FILED Wednesday, September 04, 2013
APPL NO 14/017744
ART UNIT 1678 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6842 (20130101)
G01N 33/6848 (20130101) Original (OR) Class

Technical Subjects Covered by Former US Classification
Y10T 436/143333 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541560 Denson et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Children's Hospital Medical Center (Cincinnati, Ohio)
ASSIGNEE(S) Children's Hospital Medical Center (Cincinnati, Ohio)
INVENTOR(S) Lee Denson (Wyoming, Ohio);  Bruce Colston Trapnel (Hamilton, Ohio);  Kanji Uchida (Tokyo, Japan)
ABSTRACT Disclosed are novel biomarkers and methods related to diagnostic tests for the detection and characterization of inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. In particular, the instant invention relates to novel biomarkers and methods of using such biomarkers to predict disease behavior and severity, to differentiate among disease types, and to optimize selection of treatment options in individuals suspected of having an inflammatory bowel disease.
FILED Tuesday, April 14, 2015
APPL NO 14/686628
ART UNIT 1678 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/193 (20130101)

Peptides
C07K 16/241 (20130101)
C07K 2317/21 (20130101)
C07K 2317/24 (20130101)
C07K 2317/76 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/68 (20130101)
G01N 33/686 (20130101) Original (OR) Class
G01N 33/6863 (20130101)
G01N 2333/535 (20130101)
G01N 2800/50 (20130101)
G01N 2800/065 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541563 O'Connor et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Child Health and Human Development (NICHD)
National Institute of Environmental Health Sciences (NIEHS)
APPLICANT(S) The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S) THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York, New York)
INVENTOR(S) John F. O'Connor (New Rochelle, New York);  Galina I. Kovalevskaya (Bronx, New York);  Steven Birken (Dumont, New Jersey)
ABSTRACT The present invention provides a method of predicting pregnancy outcome in a subject by determining the amount of an early pregnancy associated molecular isoform of hCG in a sample. The present invention further provides a method for determining the amount of early pregnancy associated molecular isoforms of human chorionic gonadotropin (hCG) in a sample. The present invention also provides a diagnostic kit for determining the amount of early pregnancy associated hCG in a sample. The present invention additionally provides an antibody which specifically binds to an early pregnancy associated molecular isoform of human chorionic gonadotropin. Finally, the present invention provides methods for detecting trophoblast or non-trophoblast malignancy in a sample.
FILED Friday, March 28, 2014
APPL NO 14/228720
ART UNIT 1678 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 14/59 (20130101)
C07K 16/26 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/76 (20130101) Original (OR) Class
G01N 33/57434 (20130101)
G01N 33/57449 (20130101)
G01N 2333/59 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 435/971 (20130101)
Y10S 436/811 (20130101)
Y10S 436/814 (20130101)
Y10S 436/818 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541615 Idiyatullin et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Research Resources (NCRR)
APPLICANT(S) Djaudat Idiyatullin (New Brighton, Minnesota);  Curt Corum (Shoreview, Minnesota);  Michael Garwood (Medina, Minnesota);  Donald Nixdorf (St. Paul, Minnesota);  Gregor Adriany (Minneapolis, Minnesota)
ASSIGNEE(S) Regents of the University of Minnesota (Minneapolis, Minnesota)
INVENTOR(S) Djaudat Idiyatullin (New Brighton, Minnesota);  Curt Corum (Shoreview, Minnesota);  Michael Garwood (Medina, Minnesota);  Donald Nixdorf (St. Paul, Minnesota);  Gregor Adriany (Minneapolis, Minnesota)
ABSTRACT A system and method for producing an image using a radio frequency (RF) coil in a magnetic resonance imaging system (MRI). A static magnetic field (B0) extends across a first and second region of interest (ROI). A local radio frequency (RF) coil, shaped like a dental arch, is positioned proximate to the ROIs, the ROIs being the upper and lower jaw of a subject. The RF coil and the subject are oriented in the static magnetic field (B0) to align an axis extending through a loop of the coil with the B0 direction of the static magnetic field extending across the ROIs. A pulse sequence is then performed with the MRI system and the RF coil to acquire imaging data from the ROIs simultaneously while using a transverse component of an excitation field (B1). The image data is reconstructed to create an image of the ROIs.
FILED Friday, January 24, 2014
APPL NO 14/163447
ART UNIT 3768 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/055 (20130101)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/341 (20130101)
G01R 33/3415 (20130101)
G01R 33/34084 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541822 Folio
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) Les R. Folio (Alexandria, Virginia)
ASSIGNEE(S) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Les R. Folio (Alexandria, Virginia)
ABSTRACT The present invention provides methods/techniques and apparatus for displaying an angulation of a cassette and thus a patient at a time when an x-ray image is taken to provide for a better comparison of day to day improvement of the patient. More specifically, the present invention, allows a movable object to roll freely within in a passageway within an enclosure in relation to an angulation of a cassette. In order to correlate the position of the movable object in the enclosure with the angle at which the cassette is currently placed, a plurality of markers are disposed in or protruded from the inner surface of the passageway. Based upon the position of the movable object in relation to a particular marker at the time an x-ray is taken, the user can identify the angulation at which the cassette is currently positioned.
FILED Wednesday, March 14, 2012
APPL NO 14/005024
ART UNIT 2881 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 6/547 (20130101)
A61B 6/4283 (20130101)
A61B 90/39 (20160201)
A61B 2090/069 (20160201)
A61B 2090/3966 (20160201)

Measuring Distances, Levels or Bearings; Surveying; Navigation; Gyroscopic Instruments; Photogrammetry or Videogrammetry
G01C 9/10 (20130101)

Apparatus or Arrangements for Taking Photographs or for Projecting or Viewing Them; Apparatus or Arrangements Employing Analogous Techniques Using Waves Other Than Optical Waves; Accessories Therefor
G03B 42/04 (20130101)
G03B 42/047 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09542763 Bilgic et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Mental Health (NIMH)
APPLICANT(S) Berkin Bilgic (Boston, Massachusetts);  Kawin Setsompop (Charlestown, Massachusetts)
ASSIGNEE(S) The General Hospital Corporation (Boston, Massachusetts)
INVENTOR(S) Berkin Bilgic (Boston, Massachusetts);  Kawin Setsompop (Charlestown, Massachusetts)
ABSTRACT Described here are systems and methods for quantitative susceptibility mapping (“QSM”) using magnetic resonance imaging (“MRI”). Susceptibility maps are reconstructed from phase images using an automatic regularization technique based in part on variable splitting. Two different regularization parameters are used, one, λ, that controls the smoothness of the final susceptibility map and one, μ, that controls the convergence speed of the reconstruction. For instance, the regularization parameters can be determined using an L-curve heuristic to find the parameters that yield the maximum curvature on the L-curve. The μ parameter can be determined based on an l2-regularization and the λ parameter can be determined based on the iterative l1-regularization used to reconstruct the susceptibility map.
FILED Wednesday, April 22, 2015
APPL NO 14/693525
ART UNIT 2667 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/055 (20130101)
A61B 5/4082 (20130101)
A61B 5/4088 (20130101)
A61B 5/4848 (20130101)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/243 (20130101)
G01R 33/443 (20130101)
G01R 33/5602 (20130101)
G01R 33/56536 (20130101)

Image Data Processing or Generation, in General
G06T 11/206 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09542924 Kuo et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Deafness and Other Communication Disorders (NIDCD)
APPLICANT(S) NORTHERN ILLINOIS RESEARCH FOUNDATION (Dekalb, Illinois)
ASSIGNEE(S) Northern Illinois Research Foundation (Dekalb, Illinois)
INVENTOR(S) Sen M. Kuo (Dekalb, Illinois);  Lichuan Liu (Batavia, Illinois)
ABSTRACT Systems, apparatuses and methods for integrating adaptive noise cancellation (ANC) with communication features in an enclosure, such as an incubator, bed, and the like. Utilizing one or more error and reference microphones, a controller for a noise cancellation portion reduces noise within a quiet area of the enclosure. Voice communications are provided to allow external voice signals to be transmitted to the enclosure with minimized interference with noise processing. Vocal communications from within the enclosure may be processed to determine certain characteristics/features of the vocal communications. Using these characteristics, certain emotive and/or physiological states may be identified.
FILED Thursday, December 10, 2015
APPL NO 14/965176
ART UNIT 2688 — Dynamic Storage Systems; Mechanical parts of Disk Drives
CURRENT CPC
Household or Table Equipment
A47G 9/10 (20130101)
A47G 2009/006 (20130101)

Sound-producing Devices; Methods or Devices for Protecting Against, or for Damping, Noise or Other Acoustic Waves in General; Acoustics Not Otherwise Provided for
G10K 11/178 (20130101) Original (OR) Class
G10K 11/1786 (20130101)
G10K 2210/116 (20130101)
G10K 2210/1081 (20130101)

Loudspeakers, Microphones, Gramophone Pick-ups or Like Acoustic Electromechanical Transducers; Deaf-aid Sets; Public Address Systems
H04R 3/002 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09544136 Yao et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) CALIFORNIA INSTITUTE OF TECHNOLOGY (Pasadena, California);  PURDUE RESEARCH FOUNDATION (West Lafayette, Indiana)
ASSIGNEE(S) CALIFORNIA INSTITUTE OF TECHNOLOGY (Pasadena, California);  PURDUE RESEARCH FOUNDATION (West Lafayette, Indiana)
INVENTOR(S) Hongyi Yao (Pasadena, California);  Tracey C. Ho (Pasadena, California);  Cristina Nita-Rotaru (Chicago, Illinois)
ABSTRACT A network and related methods for transmitting processes in a network secretly and securely is described. The network use keys, through path-key establishment and a key pool bootstrapping, to ensure that packets are transmitted and received properly and secretly in the presence of one or more adversarial nodes.
FILED Monday, May 09, 2016
APPL NO 15/150322
ART UNIT 2493 — Cryptography and Security
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 9/0802 (20130101)
H04L 9/0827 (20130101) Original (OR) Class
H04L 9/0838 (20130101)
H04L 2209/34 (20130101)
H04L 2209/80 (20130101)

Wireless Communication Networks
H04W 12/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Defense (DOD) 

US 09538950 Bibian et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Army Medical Research Acquisition Activity (USAMRAA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) NeuroWave Systems Inc. (Cleveland, Ohio)
ASSIGNEE(S) NeuroWave Systems Inc. (Cleveland Heights, Ohio)
INVENTOR(S) Stéphane Bibian (Cleveland Heights, Ohio);  Tatjana Zikov (Cleveland Heights, Ohio);  Mo Modarres (Tampa, Florida)
ABSTRACT The present invention relates to a brain dysfunction and seizure detector monitor and system, and a method of detecting brain dysfunction and/or seizure of a subject. Preferably, the present invention also includes one or more seizure detection algorithms. The analysis method is specifically optimized to amplify abnormal brain activity and minimize normal background activity yielding a seizure index directly related to the current presence of ictal activity in the signal. Additionally, a seizure probability index based on historical values of the aforementioned seizure index, is derived for diagnostic purposes. The seizure probability index quantifies the probability that the patient has exhibited abnormal brain activity since the beginning of the recording. These indexes can be used in the context of emergency and/or clinical situations to assess the status and well-being of a patient's brain, or can be used to automatically administer treatment to stop the seizure before clinical signs appear.
FILED Monday, December 31, 2012
APPL NO 13/731315
ART UNIT 3735 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/048 (20130101)
A61B 5/0476 (20130101)
A61B 5/04012 (20130101)
A61B 5/4094 (20130101) Original (OR) Class
A61B 5/4839 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539321 Messmer et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Development Command (USAMRDC)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Davorka Messmer (San Diego, California);  Rebecca Saenz (San Diego, California)
ABSTRACT The invention provides an immtmostimulatory peptide containing the amino acid sequence SAFFLFCSE and uses thereof. The invention also provides an immunostimulatory peptide containing the amino acid sequence DPNAPKRPPSAFFLX1X2X3X4 or derivatives thereof. In one embodiment, when X1 is alanine (A), glycine (G), or valine (V) then X2 is C, X3 is S and X4 is E; wherein when X2 is alanine (A), glycine (G), or valine (V) then X1 is F, X3 is S and X4 is E; wherein when X3 is alanine (A), glycine (G), or valine (V) then X1 is F, X2 is C and X4 is E; or wherein when X4 is alanine (A), glycine (G), or valine (V) then X1 is F, X2 is C and X3 is S.
FILED Monday, March 09, 2015
APPL NO 14/642527
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 38/00 (20130101)
A61K 38/08 (20130101)
A61K 38/10 (20130101)
A61K 39/0011 (20130101)
A61K 39/39 (20130101) Original (OR) Class
A61K 2039/57 (20130101)
A61K 2039/575 (20130101)
A61K 2039/55505 (20130101)
A61K 2039/55516 (20130101)
A61K 2039/55555 (20130101)

Peptides
C07K 7/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539329 Yun et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
APPLICANT(S) The General Hospital Corporation (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Seok-Hyun Yun (Cambridge, Massachusetts);  Myunghwan Choi (Cambridge, Massachusetts)
ABSTRACT A hydrogel-lightguide based sensory system susceptible to a stimulus signal produced by ambient and stimulating sensory cells embedded in a hydrogel body of the system. Sensory cells generate an optical signal (in response to a user-defined triggering with excitation light or, alternatively, due to bioluminescence) the properties of which, determined based on detection of such signal with an optical detector device, provide characterization of the stimulus and information required for user-defined activation of emitter cells encapsulated in the hydrogel. When activated, emitter cells generate matter and/or light directed to interact with the ambient.
FILED Friday, October 17, 2014
APPL NO 14/516874
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0059 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0024 (20130101)
A61K 47/10 (20130101) Original (OR) Class
A61K 49/0054 (20130101)
A61K 49/0073 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/0601 (20130101)
A61N 2005/063 (20130101)
A61N 2005/0626 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539359 Bose et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical and Transport Systems (CTS)
APPLICANT(S) Washington State University (Pullman, Washington)
ASSIGNEE(S) Washington State University (Pullman, Washington)
INVENTOR(S) Susmita Bose (Pullman, Washington);  Amit Bandyopadhyay (Pullman, Washington);  Weichang Xue (Suzhou, China PRC)
ABSTRACT Mesoporous calcium silicate compositions for controlled release of bioactive agents and methods for producing such compositions are disclosed herein. In one embodiment, mesoporous calcium silicate is synthesized by acid modification of wollastonite particles using hydrochloric acid. A hydrated silica gel layer having abundant Si—OH functional groups can be formed on the surface of wollastonite after acid modification. Bruhauer-Emmett-Teller (BET) surface area increased significantly due to acid modification and, in one arrangement, reached over 350 m2/g. Acid modified mesoporous calcium silicate compositions show a higher ability to adsorb protein compared to unmodified particles and demonstrate controlled release kinetics of these proteins.
FILED Tuesday, November 11, 2014
APPL NO 14/538418
ART UNIT 1615 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/5115 (20130101)
A61K 47/48861 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/10 (20130101)
A61L 27/025 (20130101) Original (OR) Class
A61L 27/54 (20130101)
A61L 27/56 (20130101)
A61L 27/58 (20130101)
A61L 27/227 (20130101)
A61L 27/306 (20130101)
A61L 2300/45 (20130101)
A61L 2300/252 (20130101)
A61L 2300/254 (20130101)
A61L 2300/414 (20130101)
A61L 2300/428 (20130101)
A61L 2300/602 (20130101)
A61L 2430/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539372 Johnson
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Army (DOA)
APPLICANT(S) Ormco Corporation (Orange, California)
ASSIGNEE(S) Ormco Corporation (Orange, California)
INVENTOR(S) Alfred David Johnson (Berkeley, California)
ABSTRACT We describe herein biocompatible single crystal Cu-based shape memory alloys (SMAs). In particular, we show biocompatibility based on MEM elution cell cytotoxicity, ISO intramuscular implant, and hemo-compatibility tests producing negative cytotoxic results. This biocompatibility may be attributed to the formation of a durable oxide surface layer analogous to the titanium oxide layer that inhibits body fluid reaction to titanium nickel alloys, and/or the non-existence of crystal domain boundaries may inhibit corrosive chemical attack. Methods for controlling the formation of the protective aluminum oxide layer are also described, as are devices including such biocompatible single crystal copper-based SMAs.
FILED Tuesday, October 15, 2013
APPL NO 14/053744
ART UNIT 1733 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/047 (20130101)
A61L 27/50 (20130101)
A61L 31/14 (20130101) Original (OR) Class
A61L 31/022 (20130101)
A61L 2400/16 (20130101)

Alloys
C22C 9/01 (20130101)

Single-crystal-growth; Unidirectional Solidification of Eutectic Material or Unidirectional Demixing of Eutectoid Material; Refining by Zone-melting of Material; Production of a Homogeneous Polycrystalline Material With Defined Structure; Single Crystals or Homogeneous Polycrystalline Material With Defined Structure; After-treatment of Single Crystals or a Homogeneous Polycrystalline Material With Defined Structure; Apparatus Therefor
C30B 15/00 (20130101)
C30B 15/36 (20130101)
C30B 29/52 (20130101)
C30B 31/00 (20130101)
C30B 33/005 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539769 Bremmer et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Jonathan Bremmer (Glastonbury, Connecticut);  Jeffrey G. Sauer (Woodbury, Connecticut);  Edward Joseph Fabian (Oxford, Connecticut);  Paul H. Denavit (Woodbridge, Connecticut);  Darryl Mark Toni (Madison, Connecticut);  William E. Hovan, III (Oxford, Connecticut)
ASSIGNEE(S) SIKORSKY AIRCRAFT CORPORATION (Stratford, Connecticut)
INVENTOR(S) Jonathan Bremmer (Glastonbury, Connecticut);  Jeffrey G. Sauer (Woodbury, Connecticut);  Edward Joseph Fabian (Oxford, Connecticut);  Paul H. Denavit (Woodbridge, Connecticut);  Darryl Mark Toni (Madison, Connecticut);  William E. Hovan, III (Oxford, Connecticut)
ABSTRACT A composite structure includes a first laminate, a second laminate, and at least one core component located between the first laminate and the second laminate. The at least one core component includes a honeycomb core and at least one locking ply extending from the honeycomb core between the first laminate and the second laminate. The at least one locking ply is configured such that a pressure applied during a cure cycle of the composite structure retains the at least one locking ply between the first laminate and the second laminate thereby preventing movement of core component.
FILED Monday, October 17, 2011
APPL NO 13/274690
ART UNIT 1745 — Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 65/00 (20130101)
B29C 65/483 (20130101)
B29C 66/721 (20130101)
B29C 66/1142 (20130101)
B29C 70/30 (20130101)
B29C 70/34 (20130101) Original (OR) Class
B29C 70/342 (20130101)
B29C 70/865 (20130101)

Layered Products, i.e Products Built-up of Strata of Flat or Non-flat, e.g Cellular or Honeycomb, Form
B32B 3/12 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 428/24149 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540061 Albin et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Foster-Miller, Inc. (Waltham, Massachusetts)
ASSIGNEE(S) Foster-Miller, Inc. (Waltham, Massachusetts)
INVENTOR(S) Scott R. Albin (Carlisle, Massachusetts);  Anthony Chesna (Saugus, Massachusetts);  Geoffrey Blake Lansberry (Andover, Massachusetts);  David J. Shane (Cambridge, Massachusetts)
ABSTRACT A magnetic robot includes a chassis and at least one track assembly associated with the chassis. The track assembly has a linear series of non-circulating magnet modules displaceably mounted with respect to the chassis. A driven track circulates about the magnet modules and travels on guide portions of the magnet modules.
FILED Wednesday, May 27, 2015
APPL NO 14/722822
ART UNIT 3611 — Miscellaneous Articles, Stock Material
CURRENT CPC
Motor Vehicles; Trailers
B62D 55/202 (20130101) Original (OR) Class
B62D 55/265 (20130101)

Magnets; Inductances; Transformers; Selection of Materials for Their Magnetic Properties
H01F 7/0231 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540115 Garruba
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Jon F. Garruba (Dix Hills, New York)
ASSIGNEE(S) NORTHROP GRUMMAN SYSTEMS CORPORATION (Falls Church, Virginia)
INVENTOR(S) Jon F. Garruba (Dix Hills, New York)
ABSTRACT An in-flight refueling probe includes a first tubular member secured to an aircraft and a second tubular member having a releasable connection with the first tubular member such that the second tubular member detaches from the first tubular member in response to a predetermined force applied to the connection. A nozzle secured to the second tubular member can be coupled to a receptacle of a fuel dispensing aircraft. A tethering member is connected to the first tubular member and one of the second tubular member and the nozzle. The tethering member remains intact to connect the detached second tubular member to the first tubular member when a first tensile force is applied to the tethering member. The tethering member ruptures to disconnect the detached second tubular member from the first tubular member when a second tensile force greater than the first tensile force is applied to the tethering member.
FILED Tuesday, April 28, 2015
APPL NO 14/698515
ART UNIT 3644 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Equipment for Fitting in or to Aircraft; Flying Suits; Parachutes; Arrangements or Mounting of Power Plants or Propulsion Transmissions in Aircraft
B64D 39/04 (20130101)
B64D 39/06 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540462 Glassman et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Matthew J. Glassman (Yorba Linda, California);  Bradley D. Olsen (Arlington, Massachusetts)
ABSTRACT Monomers and polymers, and a method of making polymers that retain the ability of the polymer to form reversible and irreversible bonds are provided. Gels comprising the polymers have the ability to coordinate metal ions and bind biopolymers.
FILED Monday, December 07, 2015
APPL NO 14/960799
ART UNIT 1766 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Heterocyclic Compounds
C07D 207/452 (20130101)

Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 22/40 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540543 Iezzi
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Erick B. Iezzi (Alexandria, Virginia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Erick B. Iezzi (Alexandria, Virginia)
ABSTRACT A nonskid/nonslip composition having: a mixture or a reaction product of an amino-functional polysiloxane and a non-aromatic epoxy, a polyamide polymer, and an abrasive aggregate.
FILED Tuesday, April 21, 2015
APPL NO 14/691615
ART UNIT 1765 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 7/1283 (20130101)
C09D 183/06 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540619 Huang et al.
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) NOVARTIS AG (Basel, Switzerland);  DANA-FARBER CANCER INSTITUTE, INC. (Boston, Massachusetts)
ASSIGNEE(S) Novartis AG (Basel, Switzerland);  Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) Xizhong Huang (Cambridge, Massachusetts);  Jean J. Zhao (Brookline, Massachusetts);  Junxia Min (Cambridge, Massachusetts);  Yubao Wang (Newton, Massachusetts)
ABSTRACT Methods for inhibiting growth or proliferation of breast cancer cells are provided. The methods include administering to a subject in need thereof in an amount that is effective to inhibit growth or proliferation of the breast cancer cells a MELK inhibitor, wherein the breast cancer cells are estrogen receptor (ER) negative. In some aspects, the methods include administering to a subject in need thereof in an amount that is effective to inhibit growth or proliferation of the breast cancer cells a MELK inhibitor, a FoxM1 inhibitor or a MELK inhibitor and a FoxM1 inhibitor, wherein the breast cancer cells are estrogen receptor (ER) negative. Methods of treatment for breast cancer and methods of identifying patients having cancer that are likely to benefit from treatment with a MELK inhibitor, a FoxM1 inhibitor or a MELK inhibitor and a FoxM1 inhibitor are also provided.
FILED Wednesday, January 08, 2014
APPL NO 14/759889
ART UNIT 1674 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/7088 (20130101)
A61K 38/12 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/12 (20130101) Original (OR) Class
C12N 15/1135 (20130101)
C12N 15/1137 (20130101)
C12N 2310/14 (20130101)
C12N 2310/531 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101)
C12Q 2600/158 (20130101)

Enzymes
C12Y 207/11001 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540647 Samant et al.
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) University of South Alabama (Mobile, Alabama)
ASSIGNEE(S) University of South Alabama (Mobile, Alabama)
INVENTOR(S) Lalita Samant (Vestavia Hills, Alabama);  Rajeev Samant (Vestavia Hills, Alabama);  Shamik Das (Vestavia Hills, Alabama);  Eddie Reed (Mobile, Alabama)
ABSTRACT Some embodiments of the present invention relate to methods and compositions for treating cancer. More embodiments include methods and compositions for modulating the activity of the Hedgehog pathway.
FILED Wednesday, October 21, 2015
APPL NO 14/919448
ART UNIT 1674 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/704 (20130101)
A61K 31/7088 (20130101)
A61K 33/24 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1135 (20130101) Original (OR) Class
C12N 2310/11 (20130101)
C12N 2310/14 (20130101)
C12N 2310/531 (20130101)
C12N 2320/30 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5008 (20130101)
G01N 33/5011 (20130101)
G01N 33/57415 (20130101)
G01N 2800/56 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540694 Sukumar et al.
FUNDED BY
Department of Defense (DOD)
APPLICANT(S) Saraswati Sukumar (Columbia, Maryland);  Liangfeng Han (Baltimore, Maryland)
ASSIGNEE(S) The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Saraswati Sukumar (Columbia, Maryland);  Liangfeng Han (Baltimore, Maryland)
ABSTRACT The invention generally features compositions and methods that are useful for treating or diagnosing a neoplasia, in particular breast neoplasia. The invention is based in part on the observation that the basic helix loop helix transcription factor HEYL was found to be overexpressed in breast cancer cells. Accordingly, the invention provides therapeutic compositions and methods for altering the levels and expression of HEYL of the invention, thereby treating a neoplasia, as well as compositions and methods for diagnosing a neoplasia.
FILED Monday, May 21, 2007
APPL NO 12/227552
ART UNIT 1676 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Peptides
C07K 16/3015 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
C12Q 2600/118 (20130101)
C12Q 2600/136 (20130101)
C12Q 2600/158 (20130101)
C12Q 2600/178 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/574 (20130101)
G01N 2333/4703 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540952 Miller et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) Timothy J Miller (Jupiter, Florida);  Alex Pinera (Jupiter, Florida)
ASSIGNEE(S) S and J DESIGN, LLC (Jupiter, Florida)
INVENTOR(S) Timothy J Miller (Jupiter, Florida);  Alex Pinera (Jupiter, Florida)
ABSTRACT A turbocharger for an internal combustion engine, the turbocharger being supported by hydrostatic bearings in both a radial and an axial direction by a compressed air supplied from a compressor of the turbocharger and boosted in pressure by a separate boost pump to a high enough pressure to support the rotor of the turbocharger.
FILED Friday, April 04, 2014
APPL NO 14/245199
ART UNIT 3746 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 25/22 (20130101) Original (OR) Class

Internal-combustion Piston Engines; Combustion Engines in General
F02B 37/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541106 Patel et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
Air Force Research Laboratory (AFRL)
APPLICANT(S) Mehul Patel (Chandler, Arizona);  Thomas Corke (Granger, Indiana);  Alan B. Cain (Chesterfield, Missouri)
ASSIGNEE(S) Orbitel Research Inc. (Cleveland, Ohio);  The University of Notre Dame du Lac (Notre Dame, Indiana)
INVENTOR(S) Mehul Patel (Chandler, Arizona);  Thomas Corke (Granger, Indiana);  Alan B. Cain (Chesterfield, Missouri)
ABSTRACT The present invention relates to a method of designing or optimizing a control surface for use with plasma actuators for controlling an aircraft, missile, munition or automobile, and more particularly to controlling fluid flow across their surfaces or other surfaces using plasma actuators, which would benefit from such a method. The various embodiments provide the steps to increase the efficiency of aircraft, missiles, munitions and automobiles. The method of flow control also provides a means for reducing aircraft, missile's, munition's and automobile's power requirements. These methods also provide alternate means for aerodynamic control using low-power hingeless plasma actuator devices.
FILED Monday, February 26, 2007
APPL NO 11/710750
ART UNIT 3644 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Aeroplanes; Helicopters
B64C 21/00 (20130101)

Fluid Dynamics, i.e Methods or Means for Influencing the Flow of Gases or Liquids
F15D 1/0065 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541232 Santoro et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Robert J. Santoro (Cherry Hill, New Jersey);  Pinkesh Bharatia (Cherry Hill, New Jersey)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Robert J. Santoro (Cherry Hill, New Jersey);  Pinkesh Bharatia (Cherry Hill, New Jersey)
ABSTRACT A Bi-Pod cantilever mount and method for supporting laser metrology equipment on a surface. The cantilever mount includes an adjustable mast and legs for adjustably positioning the laser metrology equipment on one or more surfaces. The adjustability of the mount optimizes the ability to utilize the laser metrology equipment at locations where it has been traditionally difficult to take readings.
FILED Wednesday, December 17, 2014
APPL NO 14/573437
ART UNIT 2886 — Optics
CURRENT CPC
Ships or Other Waterborne Vessels; Equipment for Shipping
B63B 9/00 (20130101)
B63B 35/00 (20130101)

Frames, Casings or Beds of Engines, Machines or Apparatus, Not Specific to Engines, Machines or Apparatus Provided for Elsewhere; Stands; Supports
F16M 13/022 (20130101) Original (OR) Class

Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 11/16 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541235 Travis
FUNDED BY
Department of Defense (DOD)
Missile Defense Agency (MDA)
APPLICANT(S) Robert D. Travis (Tucson, Arizona)
ASSIGNEE(S) Raytheon Company (Waltham, Massachusetts)
INVENTOR(S) Robert D. Travis (Tucson, Arizona)
ABSTRACT A toroid pressure vessel includes a toroid body having an inner shell and an outer shell. The toroid body includes a toroid outer perimeter. The outer shell extends along the toroid outer perimeter. A planar exterior face extends along at least a portion of the outer shell and the toroid outer perimeter. A support belt circumscribes the toroid outer perimeter and is coupled along the planar exterior face. The support belt braces and supports the pressure vessel along the toroid outer perimeter against bulging force (and hoop stress) generated by pressurized fluids within the vessel. The support belt facilitates the use of thinner pressure vessel shells and thereby decreases the weight of the pressure vessel while providing a support to the outer shell that substantially prevents deformation of the planar exterior face.
FILED Thursday, February 17, 2011
APPL NO 13/029769
ART UNIT 3741 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Containers for Storage or Transport of Articles or Materials, e.g Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding Containers; Accessories, Closures, or Fittings Therefor; Packaging Elements; Packages
B65D 88/04 (20130101)

Vessels for Containing or Storing Compressed, Liquefied or Solidified Gases; Fixed-capacity Gas-holders; Filling Vessels With, or Discharging From Vessels, Compressed, Liquefied, or Solidified Gases
F17C 1/00 (20130101) Original (OR) Class
F17C 2201/0133 (20130101)
F17C 2203/067 (20130101)
F17C 2203/0619 (20130101)
F17C 2203/0639 (20130101)
F17C 2203/0643 (20130101)
F17C 2203/0648 (20130101)
F17C 2209/21 (20130101)
F17C 2209/2109 (20130101)
F17C 2221/014 (20130101)
F17C 2223/036 (20130101)
F17C 2223/0123 (20130101)
F17C 2270/0197 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 29/49346 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541374 Brueck et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Steven R.J. Brueck (Albuquerque, New Mexico);  Yuliya Kuznetsova (Albuquerque, New Mexico);  Alexander Neumann (Albuquerque, Minnesota)
ASSIGNEE(S) STC.UNM (Albuquerque, New Mexico)
INVENTOR(S) Steven R.J. Brueck (Albuquerque, New Mexico);  Yuliya Kuznetsova (Albuquerque, New Mexico);  Alexander Neumann (Albuquerque, Minnesota)
ABSTRACT In accordance with the aspects of the present disclosure, a method and apparatus is disclosed for three-dimensional imaging interferometric microscopy (IIM), which can use at least two wavelengths to image a three-dimensional object. The apparatus can include a first, a second, and a third optical system. The first optical system is disposed to provide a substantially coherent illumination to the 3D object, wherein the illumination is characterized by a plurality of wavelengths. The second optical system includes an optical image recording device and one or more additional optical components characterized by a numerical aperture NA. The third optical system provides interferometric reintroduction of a portion of the coherent illumination as a reference beam into the second optical system. An image recording device records each sub-image formed as a result of interference between the illumination that is scattered by the 3D object and the reference beam.
FILED Monday, March 31, 2014
APPL NO 14/230582
ART UNIT 2872 — Optics
CURRENT CPC
Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 9/04 (20130101)
G01B 9/02015 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/65 (20130101)
G01N 2021/653 (20130101)

Optical Elements, Systems, or Apparatus
G02B 21/06 (20130101)
G02B 21/18 (20130101)
G02B 21/0056 (20130101)
G02B 21/365 (20130101)

Image Data Processing or Generation, in General
G06T 3/4061 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541401 Brown et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Gerald G. Brown (Pebble Beach, California);  Alan R. Washburn (Monterey, California)
ABSTRACT The present application provides systems and methods for quickly determining the shortest route from one arbitrary point in the ocean X to another Y. Specifically, the present application discloses a routing method that accepts two arbitrary points on the ocean and dynamically finds the shortest route between them that avoids a known set of “obstacles”. According to an exemplary embodiment, each of these obstacles is a spherical polygon defined by its vertexes, with the adjacent pairs of vertexes connected to each other by bordering great-circle segments.
FILED Monday, September 14, 2015
APPL NO 14/853330
ART UNIT 3669 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
CURRENT CPC
Measuring Distances, Levels or Bearings; Surveying; Navigation; Gyroscopic Instruments; Photogrammetry or Videogrammetry
G01C 21/00 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541465 Marocchini et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Hamilton Sundstrand Corporation (Windsor Locks, Connecticut)
ASSIGNEE(S) HAMILTON SUNDSTRAND CORPORATION (Windsor Locks, Connecticut)
INVENTOR(S) Francis P. Marocchini (Somers, Connecticut);  Gregory DiVincenzo (Wethersfield, Connecticut);  Mike R. Lyon (South Windsor, Connecticut)
ABSTRACT A sensor assembly includes a first structure and a second structure disposed radially outwardly of the first structure. Also included is a sensor body extending through the first and second structures, the sensor body having first and second ends, the second end located radially outwardly of the second structure. Further included is a first sealing assembly configured to couple the sensor body to the second structure and to accommodate movement of the sensor body due to relative movement between the first and second structures. Yet further included is an interior cavity of the sensor body, a linear position sensor operatively coupled to the sensor body, and a rotary linkage assembly located within the interior cavity and coupled to a target. Also included is a rotary-to-linear interface disposed between the rotary linkage assembly and the sensor and configured to convert rotational motion of the rotary linkage assembly to linear motion.
FILED Thursday, October 30, 2014
APPL NO 14/528478
ART UNIT 2856 — Printing/Measuring and Testing
CURRENT CPC
Measuring Length, Thickness or Similar Linear Dimensions; Measuring Angles; Measuring Areas; Measuring Irregularities of Surfaces or Contours
G01B 21/22 (20130101)

Measuring Not Specially Adapted for a Specific Variable; Arrangements for Measuring Two or More Variables Not Covered in a Single Other Subclass; Tariff Metering Apparatus; Measuring or Testing Not Otherwise Provided for
G01D 5/04 (20130101)

Measuring Temperature; Measuring Quantity of Heat; Thermally-sensitive Elements Not Otherwise Provided for
G01K 13/00 (20130101)

Measuring Force, Stress, Torque, Work, Mechanical Power, Mechanical Efficiency, or Fluid Pressure
G01L 19/0092 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541492 Howard et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Paul L. Howard (Newmarket, New Hampshire);  John E. Tucker (Centreville, Virginia);  John F. Reintjes (Alexandria, Virginia)
ABSTRACT A high pressure optical flow cell system suitable for use in a real time optical particle monitoring system. The system is modular, with at least two housings joined together with removable mechanical attachment devices. Inlet and outlet passageways introduce and remove high pressure fluid into a flow cavity located between adjacent housing faces. An o-ring or other compliant member seal is provided between the faces to prevent leaks of the high pressure fluid. At least one optical window is provided with a substantially planar face flush with the flow cavity surface. An optical assembly maintains the face of the optical window flush with the flow cavity surface over a wide range of temperatures and pressures. A system and method for maintaining the face of the optical window flush with the flow cavity surface over a wide range of temperatures and pressures.
FILED Monday, June 01, 2015
APPL NO 14/727754
ART UNIT 2886 — Optics
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 15/0227 (20130101)
G01N 21/05 (20130101) Original (OR) Class
G01N 21/11 (20130101)
G01N 21/0317 (20130101)
G01N 33/2858 (20130101)
G01N 33/2888 (20130101)
G01N 2015/0053 (20130101)
G01N 2021/0389 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541528 Hossein-Zadeh
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
National Science Foundation (NSF)
APPLICANT(S) Mani Hossein-Zadeh (Albuquerque, New Mexico)
ASSIGNEE(S) STC.UNM (Albuquerque, New Mexico)
INVENTOR(S) Mani Hossein-Zadeh (Albuquerque, New Mexico)
ABSTRACT An optical microresonator based RF oscillator sensor for measuring mass, temperature, and particle/molecule concentration. An optical energy source is coupled to the optical microresonator to generate optical power oscillations at Rf frequencies. A stable or reference RF oscillation frequency is established which allows for measuring oscillation frequency variations induced by the interaction of the substance with the optical microresonator.
FILED Friday, March 14, 2014
APPL NO 14/213858
ART UNIT 2855 — Printing/Measuring and Testing
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/7746 (20130101)
G01N 29/036 (20130101)
G01N 29/2418 (20130101) Original (OR) Class
G01N 2291/014 (20130101)
G01N 2291/0256 (20130101)

Optical Elements, Systems, or Apparatus
G02B 6/29338 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541568 Braman et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Honeywell International Inc. (Morristown, New Jersey)
ASSIGNEE(S) Honeywell International Inc. (Morris Plains, New Jersey)
INVENTOR(S) Todd L Loren Braman (New Brighton, Minnesota);  Owen D. Grossman (Golden Valley, Minnesota);  Matthew Schlager (Maplewood, Minnesota);  Jason Daniel Graham (White Bear Lake, Minnesota);  Timothy J. Hanson (Plymouth, Minnesota)
ABSTRACT Systems and methods for isolated sensor device protection are provided. In one embodiment, an isolated sensor device comprises: a housing having an isolation chamber; an isolator sealed within the isolation chamber; an inertial sensor assembly sealed within the isolation chamber, the inertial sensor assembly coupled to an inner surface of the isolation chamber by the isolator; and at least one progressive impact interface applied to a periphery of the inertial sensor assembly, wherein the at least one progressive impact interface extends outward from the inertial sensor assembly towards the inner surface.
FILED Wednesday, October 08, 2014
APPL NO 14/509897
ART UNIT 2855 — Printing/Measuring and Testing
CURRENT CPC
Measuring Distances, Levels or Bearings; Surveying; Navigation; Gyroscopic Instruments; Photogrammetry or Videogrammetry
G01C 19/5783 (20130101)

Measuring Linear or Angular Speed, Acceleration, Deceleration, or Shock; Indicating Presence, Absence, or Direction, of Movement
G01P 1/003 (20130101)
G01P 1/023 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541982 Lipasti et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
National Science Foundation (NSF)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Mikko H. Lipasti (Lake Mills, Wisconsin);  Atif G. Hashmi (Madison, Wisconsin);  Andrew Nere (Madison, Wisconsin);  Giulio Tononi (Verona, Wisconsin)
ABSTRACT The present inventors have recognized that proper utilization of reconfigurable event driven hardware may achieve optimum power conservation in energy constrained environments including a low power general purpose primary processor and one or more electronic sensors. Aspects of neurobiology and neuroscience, for example, may be utilized to provide such reconfigurable event driven hardware, thereby achieving energy-efficient continuous sensing and signature reporting in conjunction with the one or more electronic sensors while the primary processor enters a low power consumption mode. Such hardware is event driven and operates with extremely low energy requirements.
FILED Friday, January 25, 2013
APPL NO 13/749854
ART UNIT 2115 — Computer Error Control, Reliability, & Control Systems
CURRENT CPC
Electric Digital Data Processing
G06F 1/3206 (20130101) Original (OR) Class
G06F 1/3209 (20130101)
G06F 1/3215 (20130101)
G06F 1/3293 (20130101)

Climate Change Mitigation Technologies Related to Buildings, e.g Housing, House Appliances or Related End-user Applications
Y02B 60/121 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09542231 Khan et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Rishi L. Khan (Wilmington, Delaware);  Daniel Orozco (Newark, Delaware);  Guang R. Gao (Newark, Delaware)
ASSIGNEE(S) ET International, Inc. (Newark, Delaware)
INVENTOR(S) Rishi L. Khan (Wilmington, Delaware);  Daniel Orozco (Newark, Delaware);  Guang R. Gao (Newark, Delaware)
ABSTRACT The present invention, known as runspace, relates to the field of computing system management, data processing and data communications, and specifically to synergistic methods and systems which provide resource-efficient computation, especially for decomposable many-component tasks executable on multiple processing elements, by using a metric space representation of code and data locality to direct allocation and migration of code and data, by performing analysis to mark code areas that provide opportunities for runtime improvement, and by providing a low-power, local, secure memory management system suitable for distributed invocation of compact sections of code accessing local memory. Runspace provides mechanisms supporting hierarchical allocation, optimization, monitoring and control, and supporting resilient, energy efficient large-scale computing.
FILED Wednesday, April 13, 2011
APPL NO 13/086132
ART UNIT 2196 — Interprocess Communication and Software Development
CURRENT CPC
Electric Digital Data Processing
G06F 8/451 (20130101)
G06F 9/5066 (20130101) Original (OR) Class
G06F 9/5094 (20130101)
G06F 2209/501 (20130101)

Climate Change Mitigation Technologies Related to Buildings, e.g Housing, House Appliances or Related End-user Applications
Y02B 60/142 (20130101)
Y02B 60/167 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09542647 Mirhaji
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Army Medical Research Acquisition Activity (USAMRAA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) Parsa Mirhaji (Pearland, Texas)
ASSIGNEE(S) Board of Regents, The University of Texas System (Austin, Texas)
INVENTOR(S) Parsa Mirhaji (Pearland, Texas)
ABSTRACT Embodiments of an informatics platform where collected data can be normalized, integrated and mapped to a knowledge source, such as medical vocabulary systems are disclosed. One example of such a knowledge source is Unified Medical Language System (UMLS) which is a knowledge source for biomedical applications. Embodiments as depicted herein may provided a method to convert the desired information from UMLS into an ontology representation to allow for its use in conjunction with an informatics system.
FILED Monday, December 13, 2010
APPL NO 12/928497
ART UNIT 2122 — AI & Simulation/Modeling
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 5/02 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09542839 Li
FUNDED BY
Department of Defense (DOD)
Missile Defense Agency (MDA)
APPLICANT(S) Dunling Li (Rockville, Maryland)
ASSIGNEE(S) BTS Software Solutions, LLC (Columbia, Maryland)
INVENTOR(S) Dunling Li (Rockville, Maryland)
ABSTRACT A method for compressing data is disclosed. The method may include classifying the data from a plurality of data sources into classifications including at least PCM-encoded data and data structure information. The method may also include determining data states associated with the PCM-encoded data and the data structure information. The method may further include compressing the PCM-encoded data and the data structure information into compressed bit-streams based on the determined data states. The method may also include shuffling the compressed bit-streams to introduce randomness.
FILED Tuesday, June 25, 2013
APPL NO 13/927043
ART UNIT 2631 — Digital Communications
CURRENT CPC
Transmission Systems for Measured Values, Control or Similar Signals
G08C 19/00 (20130101) Original (OR) Class

Coding; Decoding; Code Conversion in General
H03M 7/30 (20130101)
H03M 7/3059 (20130101)
H03M 7/6064 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09542861 Day et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Army Medical Research Acquisition Activity (USAMRAA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) LUNA INNOVATIONS INCORPORATED (Roanoke, Virginia)
ASSIGNEE(S) LUNA INNOVATIONS INCORPORATED (Roanoke, Virginia)
INVENTOR(S) Bradford L. Day (Palmyra, Virginia);  Michael J. Danilich (Charlottesville, Virginia)
ABSTRACT Medical training kits and methods include a simulated liquid blood which simulates mammalian whole blood and a simulated hemostatic component. The simulated liquid blood includes a gellable component, and a simulated hemostatic component includes a gelling agent. The gelling agent causes the gellable component in the simulated liquid blood to form a mass of semi-solid or solid material in response the simulated blood being brought into contact therewith to thereby simulate blood clotting. In certain embodiments, the gellable component is chitosan and/or an alginate compound and the gelling agent is at least one compound which causes the gellable component to desolubulize, polymerize, complex, precipitate, cross-link and the like so as to form a semi-solid or solid mass of chitosan in response to physical contact between the simulated blood and the simulated hemostatic agent.
FILED Friday, February 22, 2013
APPL NO 14/380276
ART UNIT 3715 — Amusement and Education Devices
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 33/06 (20130101)
A61K 33/14 (20130101)
A61K 35/12 (20130101)
A61K 35/14 (20130101)

Educational or Demonstration Appliances; Appliances for Teaching, or Communicating With, the Blind, Deaf or Mute; Models; Planetaria; Globes; Maps; Diagrams
G09B 23/30 (20130101)
G09B 23/303 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543168 Feigelson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Boris N. Feigelson (Springfield, Virginia);  Jordan Greenlee (Boise, Idaho);  Travis J. Anderson (Alexandria, Virginia);  Francis J. Kub (Arnold, Maryland)
ABSTRACT A symmetric multicycle rapid thermal annealing (SMRTA) method for annealing a semiconductor material without the material decomposing. The SMRTA method includes a first long-time annealing at a first temperature at which the material is thermodynamically stable, followed by multicycle rapid thermal annealing (MRTA) at temperatures at which the material is not thermodynamically stable, followed in turn by a second long-time annealing at a second temperature at which the material is thermodynamically stable. The SMRTA method can be used to form p-type and n-type semiconductor regions in doped III-nitride semiconductors, SiC, and diamond.
FILED Thursday, February 04, 2016
APPL NO 15/015381
ART UNIT 2896 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/0254 (20130101)
H01L 21/324 (20130101) Original (OR) Class
H01L 21/2258 (20130101)
H01L 21/02667 (20130101)
H01L 23/34 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543980 Huang et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computing and Communication Foundations (CCF)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusettes Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Ying-Zong Huang (Seattle, Washington);  Gregory W. Wornell (Wellesley, Massachusetts)
ABSTRACT An encoder generates a compressed data sequence from an original data sequence using many-to-one mapping independently of a source model associated with the original data sequence and without extracting the source model. A decoder uses both the source model associated with the original data sequence and the mapping applied during compression that is devoid of, in substance, the source model, to regenerate, at least in part, the original uncompressed data sequence from the compressed data sequence that does not include a significant portion of the source model.
FILED Friday, February 06, 2015
APPL NO 14/616248
ART UNIT 2845 — Electrical Circuits and Systems
CURRENT CPC
Coding; Decoding; Code Conversion in General
H03M 7/30 (20130101) Original (OR) Class
H03M 13/6312 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09544126 Zeger et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
Air Force Office of Scientific Research (AFOSR)
Office of the Under Secretary of Defense for Research and Engineering (OUSD R&E)
MIT Lincoln Laboratory (MITLL)
Federally Funded Research and Development Center (FFRDC)
Operated by Massachusetts Institute of Technology (MIT) at Lexington, MA
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Linda M. Zeger (Lexington, Massachusetts);  Jason M. Cloud (Cambridge, Massachusetts);  Muriel Medard (Belmont, Massachusetts)
ABSTRACT Network coding and multiple packet reception (MPR) are used together in a wireless network. In at least one implementation, a novel medium access control (MAC) protocol is provided that enhances throughput in a wireless mesh network that uses network coding and MPR by providing fairness to information flows, rather than fairness to individual nodes.
FILED Thursday, October 18, 2012
APPL NO 13/654953
ART UNIT 2469 — Multiplex and VoIP
CURRENT CPC
Transmission
H04B 7/155 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 1/0057 (20130101)
H04L 1/0075 (20130101)
H04L 1/0076 (20130101)
H04L 5/16 (20130101) Original (OR) Class
H04L 63/12 (20130101)
H04L 63/0428 (20130101)

Wireless Communication Networks
H04W 28/08 (20130101)
H04W 72/10 (20130101)
H04W 72/0466 (20130101)
H04W 72/0493 (20130101)
H04W 72/1263 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09544136 Yao et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) CALIFORNIA INSTITUTE OF TECHNOLOGY (Pasadena, California);  PURDUE RESEARCH FOUNDATION (West Lafayette, Indiana)
ASSIGNEE(S) CALIFORNIA INSTITUTE OF TECHNOLOGY (Pasadena, California);  PURDUE RESEARCH FOUNDATION (West Lafayette, Indiana)
INVENTOR(S) Hongyi Yao (Pasadena, California);  Tracey C. Ho (Pasadena, California);  Cristina Nita-Rotaru (Chicago, Illinois)
ABSTRACT A network and related methods for transmitting processes in a network secretly and securely is described. The network use keys, through path-key establishment and a key pool bootstrapping, to ensure that packets are transmitted and received properly and secretly in the presence of one or more adversarial nodes.
FILED Monday, May 09, 2016
APPL NO 15/150322
ART UNIT 2493 — Cryptography and Security
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 9/0802 (20130101)
H04L 9/0827 (20130101) Original (OR) Class
H04L 9/0838 (20130101)
H04L 2209/34 (20130101)
H04L 2209/80 (20130101)

Wireless Communication Networks
H04W 12/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09544381 Zafarani et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Reza Zafarani (Tempe, Arizona);  Huan Liu (Tempe, Arizona)
ASSIGNEE(S) Arizona Board of Regents on Behalf of Arizona State University (Scottsdale, Arizona)
INVENTOR(S) Reza Zafarani (Tempe, Arizona);  Huan Liu (Tempe, Arizona)
ABSTRACT Users may be identified across websites, such as social media websites. Prior user information data and candidate user information data may be received. An algorithm may identify a first plurality of behavioral patterns in the prior user information data and a second plurality of behavioral patterns in the candidate user information datum. The algorithm may determine whether the candidate user information datum and the prior user information data correspond to the same user based, at least in part, on the first and second pluralities of behavioral patterns.
FILED Thursday, March 13, 2014
APPL NO 14/210372
ART UNIT 2451 — Computer Networks
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 67/22 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US D776003 Lee et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) Chu-Hwa Lee (Troy, Michigan);  James A. Capouellez (Lake Orion, Michigan);  Demetrio M. Lacap (Shelby Township, Michigan);  Shawn J. Keller (Macomb, Michigan)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Chu-Hwa Lee (Troy, Michigan);  James A. Capouellez (Lake Orion, Michigan);  Demetrio M. Lacap (Shelby Township, Michigan);  Shawn J. Keller (Macomb, Michigan)
ABSTRACT
FILED Friday, November 07, 2014
APPL NO 29/508573
ART UNIT 2914 — Design
CURRENT CPC
Transportation
D12/12
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Energy (DOE) 

US 09539118 Leuthardt et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Neurolutions, Inc. (St Louis, Missouri)
ASSIGNEE(S) Neurolutions, Inc. (Clayton, Missouri)
INVENTOR(S) Eric C. Leuthardt (St. Louis, Missouri);  Lonnie J. Love (St Louis, Missouri);  Rob Coker (St Louis, Missouri);  Daniel W. Moran (Ballwin, Missouri)
ABSTRACT Methods, devices, systems, and apparatus, including computer programs encoded on a computer storage medium, for brain-controlled body movement assistance devices. In one aspect, a device includes a brain-controlled body movement assistance device with a brain-computer interface (BCI) component adapted to be mounted to a user, a body movement assistance component operably connected to the BCI component and adapted to be worn by the user, and a feedback mechanism provided in connection with at least one of the BCI component and the body movement assistance component, the feedback mechanism being configured to output information relating to a usage session of the brain-controlled body movement assistance device.
FILED Friday, March 15, 2013
APPL NO 13/842749
ART UNIT 3771 — Medical & Surgical Instruments, Treatment Devices, Surgery and Surgical Supplies
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0476 (20130101)
A61B 2505/09 (20130101)

Filters Implantable into Blood Vessels; Prostheses; Devices Providing Patency To, or Preventing Collapsing Of, Tubular Structures of the Body, e.g Stents; Orthopaedic, Nursing or Contraceptive Devices; Fomentation; Treatment or Protection of Eyes or Ears; Bandages, Dressings or Absorbent Pads; First-aid Kits
A61F 2/54 (20130101)
A61F 2/72 (20130101) Original (OR) Class
A61F 2002/6827 (20130101)

Physical Therapy Apparatus, e.g Devices for Locating or Stimulating Reflex Points in the Body; Artificial Respiration; Massage; Bathing Devices for Special Therapeutic or Hygienic Purposes or Specific Parts of the Body
A61H 1/0288 (20130101)
A61H 2230/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539149 Simpson et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) John T. Simpson (Clinton, Tennessee);  Brian R. D'Urso (Pittsburgh, Pennsylvania)
ASSIGNEE(S) UT-BATTELLE, LLC (Oak Ridge, Tennessee)
INVENTOR(S) John T. Simpson (Clinton, Tennessee);  Brian R. D'Urso (Pittsburgh, Pennsylvania)
ABSTRACT A bandage comprising a substrate having a first surface with a plurality of superhydrophobic particles attached to the first surface. The plurality of superhydrophobic particles can be porous diatomaceous earth particles having a hydrophobic layer conforming to the surfaces of the DE particles, where the hydrophobic layer is bound to the DE particles. The plurality of attached superhydrophobic particles can render the first surface superhydrophobic, while a second surface opposite the first surface can be hydrophilic or hydrophobic. The substrate can be breathable in order to maintain skin health for the tissue underlying the bandage. The substrate can be selected from porous films, apertured films, textiles, nonwoven materials, impregnated composites thereof, and combinations thereof.
FILED Wednesday, November 19, 2008
APPL NO 12/273823
ART UNIT 1787 — Miscellaneous Articles, Stock Material
CURRENT CPC
Filters Implantable into Blood Vessels; Prostheses; Devices Providing Patency To, or Preventing Collapsing Of, Tubular Structures of the Body, e.g Stents; Orthopaedic, Nursing or Contraceptive Devices; Fomentation; Treatment or Protection of Eyes or Ears; Bandages, Dressings or Absorbent Pads; First-aid Kits
A61F 13/022 (20130101)
A61F 13/0289 (20130101) Original (OR) Class
A61F 2013/004 (20130101)
A61F 2013/00255 (20130101)
A61F 2013/00319 (20130101)
A61F 2013/00863 (20130101)
A61F 2013/00885 (20130101)
A61F 2013/00889 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 15/40 (20130101)
A61L 15/42 (20130101)

Treatment, Not Provided for Elsewhere in Class D06, of Fibres, Threads, Yarns, Fabrics, Feathers or Fibrous Goods Made From Such Materials
D06M 11/79 (20130101)
D06M 15/19 (20130101)
D06M 23/08 (20130101)
D06M 23/10 (20130101)
D06M 2200/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539540 Elliott et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Exxonmobil Research and Engineering Company (Annadale, New Jersey);  TDA Research, Inc. (Wheat Ridge, Colorado)
ASSIGNEE(S) EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (Annandale, New Jersey);  TDA RESEARCH, INC. (Wheat Ridge, Colorado)
INVENTOR(S) Jeannine Elizabeth Elliott (Superior, Colorado);  Robert James Copeland (Arvada, Colorado);  Patrick P. McCall (Matawan, New Jersey)
ABSTRACT A rotary moving bed and process for separating a carbon dioxide from a gas stream is disclosed. The rotary moving bed can have a rotational assembly rotating on a vertical axis, and a plurality of sorbent cells positioned horizontally to the axis of rotation that fills a vertical space in the moving bed, where the sorbent cells adsorb the carbon dioxide by concentration swing adsorption and adsorptive displacement. The sorbent can be regenerated and the carbon dioxide recaptured by desorbing the carbon dioxide from the sorbent using concentration swing adsorption and desorptive displacement with steam. The gas flows in the system flow in a direction horizontal to the axis of rotation and in a direction opposite the rotational movement of the sorbent cells.
FILED Tuesday, July 08, 2014
APPL NO 14/325579
ART UNIT 1776 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Separation
B01D 53/62 (20130101)
B01D 53/83 (20130101) Original (OR) Class
B01D 2251/304 (20130101)
B01D 2251/306 (20130101)
B01D 2253/104 (20130101)
B01D 2258/0283 (20130101)
B01D 2259/4009 (20130101)

Capture, Storage, Sequestration or Disposal of Greenhouse Gases [GHG]
Y02C 10/04 (20130101)
Y02C 10/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540257 Cho et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Young I. Cho (Cherry Hill, New Jersey);  Daniel J. Cho (Wayne, Pennsylvania);  Alexander Fridman (Philadelphia, Pennsylvania);  Hyoungsup Kim (Lansdowne, Pennsylvania)
ASSIGNEE(S) Drexel University (Philadelphia, Pennsylvania)
INVENTOR(S) Young I. Cho (Cherry Hill, New Jersey);  Daniel J. Cho (Wayne, Pennsylvania);  Alexander Fridman (Philadelphia, Pennsylvania);  Hyoungsup Kim (Lansdowne, Pennsylvania)
ABSTRACT A plasma spark discharge reactor for treating water. The plasma spark discharge reactor comprises a HV electrode with a head and ground electrode that surrounds at least a portion of the HV electrode. A passage for gas may pass through the reactor to a location proximate to the head to provide controlled formation of gas bubbles in order to facilitate the plasma spark discharge in a liquid environment.
FILED Wednesday, November 04, 2015
APPL NO 14/932148
ART UNIT 2881 — Optics
CURRENT CPC
Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/32 (20130101)
C02F 1/4608 (20130101) Original (OR) Class
C02F 2303/04 (20130101)

Plasma Technique; Production of Accelerated Electrically-charged Particles or of Neutrons; Production or Acceleration of Neutral Molecular or Atomic Beams
H05H 1/52 (20130101)
H05H 2245/121 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540286 Cockeram
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) United States Department of Energy (Washington, District of Columbia)
ASSIGNEE(S) U.S. Department of Energy (Washington, District of Columbia)
INVENTOR(S) Brian V. Cockeram (North Huntingdon, Pennsylvania)
ABSTRACT A method for producing monolithic Zirconium Carbide (ZrC) is described. The method includes raising a pressure applied to a ZrC powder until a final pressure of greater than 40 MPa is reached; and raising a temperature of the ZrC powder until a final temperature of less than 2200° C. is reached.
FILED Tuesday, February 18, 2014
APPL NO 14/182844
ART UNIT 1741 — Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
CURRENT CPC
Lime, Magnesia; Slag; Cements; Compositions Thereof, e.g Mortars, Concrete or Like Building Materials; Artificial Stone; Ceramics; Refractories; Treatment of Natural Stone
C04B 35/645 (20130101) Original (OR) Class
C04B 35/5622 (20130101)
C04B 2235/77 (20130101)
C04B 2235/786 (20130101)
C04B 2235/6562 (20130101)
C04B 2235/6565 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540294 Long et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Jeffrey R. Long (Oakland, California);  Zoey R. Herm (Berkeley, California);  Brian M. Wiers (Berkeley, California);  Rajamani Krishna (Amsterdam, Netherlands)
ABSTRACT A metal organic framework Fe2(bdp)3 (BDP2−=1,4-benzenedipyrazolate) with triangular channels is particularly suited for C5-C7 separations of alkanes according to the number of branches in the molecule rather than by carbon number. The metal-organic framework can offer pore geometries that is unavailable in zeolites or other porous media, facilitating distinct types of shape-based molecular separations.
FILED Monday, May 04, 2015
APPL NO 14/703631
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/226 (20130101)

General Methods of Organic Chemistry; Apparatus Therefor
C07B 63/00 (20130101)

Acyclic or Carbocyclic Compounds
C07C 5/277 (20130101)
C07C 5/2732 (20130101)
C07C 7/12 (20130101) Original (OR) Class
C07C 7/12 (20130101)
C07C 9/16 (20130101)

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 15/02 (20130101)

Cracking Hydrocarbon Oils; Production of Liquid Hydrocarbon Mixtures, e.g by Destructive Hydrogenation, Oligomerisation, Polymerisation; Recovery of Hydrocarbon Oils From Oil-shale, Oil-sand, or Gases; Refining Mixtures Mainly Consisting of Hydrocarbons; Reforming of Naphtha; Mineral Waxes
C10G 25/003 (20130101)
C10G 2400/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540481 Wilson et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Lawrence Livermore National Security, LLC (Livermore, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Thomas S. Wilson (San Leandro, California);  Michael Keith Hearon, II (Livermore, California);  Jane P. Bearinger (Berwyn, Pennsylvania)
ABSTRACT This invention relates to chemical polymer compositions, methods of synthesis, and fabrication methods for devices regarding polymers capable of displaying shape memory behavior (SMPs) and which can first be polymerized to a linear or branched polymeric structure, having thermoplastic properties, subsequently processed into a device through processes typical of polymer melts, solutions, and dispersions and then crossed linked to a shape memory thermoset polymer retaining the processed shape.
FILED Monday, May 13, 2013
APPL NO 13/892719
ART UNIT 1765 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 47/00 (20130101)
B29C 47/0009 (20130101)
B29C 51/00 (20130101)
B29C 51/002 (20130101)
B29C 67/20 (20130101)
B29C 71/02 (20130101)
B29C 71/04 (20130101)

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 18/73 (20130101)
C08G 18/83 (20130101) Original (OR) Class
C08G 18/673 (20130101)
C08G 18/675 (20130101)
C08G 18/722 (20130101)
C08G 18/758 (20130101)
C08G 18/3206 (20130101)
C08G 63/52 (20130101)
C08G 2101/00 (20130101)
C08G 2280/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540652 Juminaga et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Lawrence Berkeley National Laboratory (LBNL)
Federally Funded Research and Development Center (FFRDC)
Operated by University of California (UC BERKELEY) at Berkeley, CA
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Engineering Education and Centers (EEC)
APPLICANT(S) Darmawi Juminaga (Albany, California);  Jay D. Keasling (Berkeley, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Darmawi Juminaga (Albany, California);  Jay D. Keasling (Berkeley, California)
ABSTRACT The present disclosure relates to engineered microorganisms that produce amino acids and amino acid intermediates. In particular, the disclosure relates to recombinant nucleic acids encoding operons that increase production of aromatic amino acids and the aromatic amino acid intermediate shikimate; microorganisms with increased production of aromatic amino acids and the aromatic amino acid intermediate shikimate; and methods related to the production of aromatic amino acids, the aromatic amino acid intermediate shikimate, and commodity chemicals derived therefrom.
FILED Friday, August 31, 2012
APPL NO 14/342335
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/001 (20130101)
C12N 9/88 (20130101)
C12N 15/52 (20130101)
C12N 15/70 (20130101) Original (OR) Class

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 7/42 (20130101)
C12P 13/22 (20130101)
C12P 13/225 (20130101)
C12P 13/227 (20130101)

Enzymes
C12Y 103/01012 (20130101)
C12Y 401/02 (20130101)

Climate Change Mitigation Technologies in the Production or Processing of Goods
Y02P 20/52 (20151101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540714 Holcomb et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) UT-Battelle, LLC (Oak Ridge, Tennessee)
ASSIGNEE(S) UT-BATTELLE, LLC (Oak Ridge, Tennessee)
INVENTOR(S) David E. Holcomb (Oak Ridge, Tennessee);  Govindarajan Muralidharan (Knoxville, Tennessee);  Dane F. Wilson (Oak Ridge, Tennessee)
ABSTRACT An essentially cobalt-free alloy consists essentially of, in terms of weight percent: 6.3 to 7.2 Cr, 0.5 to 2 Al, 0 to 5 Fe, 0.7 to 0.8 Mn, 9 to 12.5 Mo, 0 to 6 Ta, 0.75 to 3.5 Ti, 0.01 to 0.25 Nb, 0.2 to 0.6 W, 0.02 to 0.04 C, 0 to 0.001 B, 0.0001 to 0.002 N, balance Ni. The alloy is characterized by a γ′ microstructural component in the range of 3 to 17.6 weight percent of the total composition. The alloy is further characterized by, at 850° C., a yield strength of at least 60 Ksi, a tensile strength of at least 70 Ksi, a creep rupture life at 12 Ksi of at least 700 hours, and a corrosion rate, expressed in weight loss [g/(cm2sec)]10−11 during a 1000 hour immersion in liquid FLiNaK at 850° C., in the range of 5.5 to 17.
FILED Friday, March 15, 2013
APPL NO 13/834985
ART UNIT 1733 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Alloys
C22C 19/057 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540741 Ardo et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Joint Center for Artificial Photosynthesis (JCAP)
APPLICANT(S) California Institute of Technology (Pasadena, California)
ASSIGNEE(S) The California Institute of Technology (Pasadena, California)
INVENTOR(S) Shane Ardo (Irvine, California);  Nathan S. Lewis (La Canada Flintridge, California)
ABSTRACT This disclosure relates to photovoltaic and photoelectrosynthetic cells, devices, methods of making and using the same.
FILED Friday, September 06, 2013
APPL NO 14/020151
ART UNIT 1756 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Non-metallic Elements; Compounds Thereof;
C01B 3/042 (20130101)

Electrolytic or Electrophoretic Processes for the Production of Compounds or Non-metals; Apparatus Therefor
C25B 1/02 (20130101)
C25B 1/003 (20130101)
C25B 1/10 (20130101)
C25B 9/08 (20130101) Original (OR) Class

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 31/078 (20130101)
H01L 31/035227 (20130101)
H01L 31/035281 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/50 (20130101)
Y02E 60/364 (20130101)
Y02E 60/366 (20130101)
Y02E 70/10 (20130101)

Climate Change Mitigation Technologies in the Production or Processing of Goods
Y02P 20/135 (20151101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540945 Ebert et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Siemens Energy, Inc. (Orlando, Florida)
ASSIGNEE(S) SIEMENS ENERGY, INC. (Orlando, Florida)
INVENTOR(S) Todd A. Ebert (West Palm Beach, Florida);  Keith D. Kimmel (North Palm Beach, Florida)
ABSTRACT An active bypass flow control system for controlling bypass compressed air based upon leakage flow of compressed air flowing past an outer balance seal between a stator and rotor of a first stage of a gas turbine in a gas turbine engine is disclosed. The active bypass flow control system is an adjustable system in which one or more metering devices may be used to control the flow of bypass compressed air as the flow of compressed air past the outer balance seal changes over time as the outer balance seal between the rim cavity and the cooling cavity wears. In at least one embodiment, the metering device may include a valve formed from one or more pins movable between open and closed positions in which the one pin at least partially bisects the bypass channel to regulate flow.
FILED Friday, February 28, 2014
APPL NO 14/192974
ART UNIT 3745 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 5/081 (20130101)
F01D 11/001 (20130101)
F01D 11/04 (20130101)
F01D 11/06 (20130101)
F01D 17/105 (20130101) Original (OR) Class

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2270/58 (20130101)
F05D 2270/301 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541061 Sievers et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) Siemens Energy, Inc. (Orlando, Florida)
ASSIGNEE(S) SIEMENS ENERGY, INC. (Orlando, Florida)
INVENTOR(S) Ryan A. Sievers (Lyons, Colorado);  Justin L. Mullings (Golden, Colorado)
ABSTRACT A wind turbine blade (60) damped by viscoelastic material (54, 54A-F) sandwiched between stiffer load-bearing sublayers (52A, 52B, 56A, 56B) in portions of the blade effective to damp oscillations (38) of the blade. The viscoelastic material may be located in one or more of: a forward portion (54A) of the shell, an aft portion (54D) of the shell, pressure and suction side end caps (54B) of an internal spar, internal webbing walls (54C, 54E), and a trailing edge core (54F).
FILED Tuesday, March 04, 2014
APPL NO 14/195935
ART UNIT 3753 — Fluid Handling and Dispensing
CURRENT CPC
Gas-turbine Plants; Air Intakes for Jet-propulsion Plants; Controlling Fuel Supply in Air-breathing Jet-propulsion Plants
F02C 7/045 (20130101)

Wind Motors
F03D 1/0675 (20130101) Original (OR) Class

Indexing Scheme Relating to Wind, Spring, Weight, Inertia or Like Motors, to Machines or Engines for Liquids Covered by Subclasses F03B, F03D and F03G
F05B 2260/964 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/721 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541498 Partridge, Jr. et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) UT-Battelle, LLC (Oak Ridge, Tennessee)
ASSIGNEE(S) UT-Battelle, LLC (Oak Ridge, Tennessee)
INVENTOR(S) William P. Partridge, Jr. (Oak Ridge, Tennessee);  Gurneesh Singh Jatana (Knoxville, Tennessee);  Ji-Hyung Yoo (East Amherst, New York);  James E. Parks, II (Knoxville, Tennessee)
ABSTRACT A diagnostic system for measuring temperature, pressure, CO2 concentration and H2O concentration in a fluid stream is described. The system may include one or more probes that sample the fluid stream spatially, temporally and over ranges of pressure and temperature. Laser light sources are directed down pitch optical cables, through a lens and to a mirror, where the light sources are reflected back, through the lens to catch optical cables. The light travels through the catch optical cables to detectors, which provide electrical signals to a processer. The processer utilizes the signals to calculate CO2 concentration based on the temperatures derived from H2O vapor concentration. A probe for sampling CO2 and H2O vapor concentrations is also disclosed. Various mechanical features interact together to ensure the pitch and catch optical cables are properly aligned with the lens during assembly and use.
FILED Friday, August 21, 2015
APPL NO 14/831913
ART UNIT 2884 — Optics
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/3504 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541576 Kalinin et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) UT-Battelle, LLC (Oak Ridge, Tennessee)
ASSIGNEE(S) UT-Battelle, LLC (Oak Ridge, Tennessee)
INVENTOR(S) Sergei V. Kalinin (Knoxville, Tennessee);  Stephen Jesse (Knoxville, Tennessee);  Liam F. Collins (County Galway, Ireland);  Brian J. Rodriguez (Dublin, Ireland)
ABSTRACT A system and method for electrochemical force microscopy are provided. The system and method are based on a multidimensional detection scheme that is sensitive to forces experienced by a biased electrode in a solution. The multidimensional approach allows separation of fast processes, such as double layer charging, and charge relaxation, and slow processes, such as diffusion and faradaic reactions, as well as capturing the bias dependence of the response. The time-resolved and bias measurements can also allow probing both linear (small bias range) and non-linear (large bias range) electrochemical regimes and potentially the de-convolution of charge dynamics and diffusion processes from steric effects and electrochemical reactivity.
FILED Tuesday, July 28, 2015
APPL NO 14/810605
ART UNIT 2881 — Optics
CURRENT CPC
Scanning-probe Techniques or Apparatus; Applications of Scanning-probe Techniques, e.g Scanning Probe Microscopy [SPM]
G01Q 60/60 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09542248 Jacob et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) Arpith C. Jacob (Dobbs Ferry, New York);  Olivier H. Sallenave (Baldwin Place, New York)
ABSTRACT In one embodiment, a computer-implemented method for dispatching a function call includes receiving, at a supervisor processing element (PE) and from an origin PE, an identifier of a target device, a stack frame of the origin PE, and an address of a function called from the origin PE. The supervisor PE allocates a target PE of the target device. The supervisor PE copies the stack frame of the origin PE to a new stack frame on a call stack of the target PE. The supervisor PE instructs the target PE to execute the function. The supervisor PE receives a notification that execution of the function is complete. The supervisor PE copies the stack frame of the target PE to the stack frame of the origin PE. The supervisor PE releases the target PE of the target device. The supervisor PE instructs the origin PE to resume execution of the program.
FILED Tuesday, March 24, 2015
APPL NO 14/667009
ART UNIT 2194 — Interprocess Communication and Software Development
CURRENT CPC
Electric Digital Data Processing
G06F 9/466 (20130101)
G06F 9/547 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543046 Ham et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) Young S. Ham (Dublin, Virginia);  Shivakumar Sitaraman (San Jose, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Young S. Ham (Dublin, Virginia);  Shivakumar Sitaraman (San Jose, California)
ABSTRACT Detecting diversion of spent fuel from Pressurized Water Reactors (PWR) by determining possible diversion including the steps of providing a detector cluster containing gamma ray and neutron detectors, inserting the detector cluster containing the gamma ray and neutron detectors into the spent fuel assembly through the guide tube holes in the spent fuel assembly, measuring gamma ray and neutron radiation responses of the gamma ray and neutron detectors in the guide tube holes, processing the gamma ray and neutron radiation responses at the guide tube locations by normalizing them to the maximum value among each set of responses and taking the ratio of the gamma ray and neutron responses at the guide tube locations and normalizing the ratios to the maximum value among them and producing three signatures, gamma, neutron, and gamma-neutron ratio, based on these normalized values, and producing an output that consists of these signatures that can indicate possible diversion of the pins from the spent fuel assembly.
FILED Tuesday, November 17, 2009
APPL NO 12/619791
ART UNIT 3646 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Nuclear Reactors
G21C 17/06 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543048 Scaglione et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) John M. Scaglione (Knoxville, Tennessee);  John C. Wagner (Konxville, Tennessee)
ASSIGNEE(S) UT-BATTELLE, LLC (Oak Ridge, Tennessee)
INVENTOR(S) John M. Scaglione (Knoxville, Tennessee);  John C. Wagner (Konxville, Tennessee)
ABSTRACT An integrated storage, transportation and disposal system for used fuel assemblies is provided. The system includes a plurality of sealed canisters and a cask sized to receive the sealed canisters in side by side relationship. The plurality of sealed canisters include an internal basket structure to receive a plurality of used fuel assemblies. The internal basket structure includes a plurality of radiation-absorbing panels and a plurality of hemispherical ribs generally perpendicular to the canister sidewall. The sealed canisters are received within the cask for storage and transportation and are removed from the cask for disposal at a designated repository. The system of the present invention allows the handling of sealed canisters separately or collectively, while allowing storage and transportation of high burnup fuel and damaged fuel to the designated repository.
FILED Friday, July 20, 2012
APPL NO 13/554111
ART UNIT 3646 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Protection Against X-radiation, Gamma Radiation, Corpuscular Radiation or Particle Bombardment; Treating Radioactively Contaminated Material; Decontamination Arrangements Therefor
G21F 5/06 (20130101)
G21F 5/008 (20130101) Original (OR) Class
G21F 5/012 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543054 Ban et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
National Renewable Energy Laboratory (NREL)
Federally Funded Research and Development Center (FFRDC)
Operated by Alliance for Sustainable Energy, LLC (ASE) at Golden, CO
APPLICANT(S) Alliance for Sustainable Energy, LLC (Denver, Colorado)
ASSIGNEE(S) Alliance for Sustainable Energy, LLC (Golden, Colorado)
INVENTOR(S) Chunmei Ban (Littleton, Colorado);  Zhuangchun Wu (Lakewood, Colorado);  Anne C. Dillon (Boulder, Colorado)
ABSTRACT An electrode (110) is provided that may be used in an electrochemical device (100) such as an energy storage/discharge device, e.g., a lithium-ion battery, or an electrochromic device, e.g., a smart window. Hydrothermal techniques and vacuum filtration methods were applied to fabricate the electrode (110). The electrode (110) includes an active portion (140) that is made up of electrochemically active nanoparticles, with one embodiment utilizing 3d-transition metal oxides to provide the electrochemical capacity of the electrode (110). The active material (140) may include other electrochemical materials, such as silicon, tin, lithium manganese oxide, and lithium iron phosphate. The electrode (110) also includes a matrix or net (170) of electrically conductive nanomaterial that acts to connect and/or bind the active nanoparticles (140) such that no binder material is required in the electrode (110), which allows more active materials (140) to be included to improve energy density and other desirable characteristics of the electrode. The matrix material (170) may take the form of carbon nanotubes, such as single-wall, double-wall, and/or multi-wall nanotubes, and be provided as about 2 to 30 percent weight of the electrode (110) with the rest being the active material (140).
FILED Thursday, November 08, 2012
APPL NO 13/672486
ART UNIT 1727 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 19/08 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)

Cables; Conductors; Insulators; Selection of Materials for Their Conductive, Insulating or Dielectric Properties
H01B 1/00 (20130101)
H01B 1/04 (20130101) Original (OR) Class
H01B 1/08 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/02 (20130101)
H01M 4/48 (20130101)
H01M 4/52 (20130101)
H01M 4/131 (20130101)
H01M 4/0404 (20130101)
H01M 4/0471 (20130101)
H01M 4/485 (20130101)
H01M 4/625 (20130101)
H01M 10/0525 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 60/122 (20130101)

Climate Change Mitigation Technologies Related to Transportation
Y02T 10/7011 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543392 Jiang et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Industrial Innovation and Partnerships (IIP)
APPLICANT(S) SORAA, INC. (Fremont, California)
ASSIGNEE(S) Soraa, Inc. (Fremont, California)
INVENTOR(S) Wenkan Jiang (Corona, California);  Dirk Ehrentraut (Santa Barbara, California);  Mark P. D'Evelyn (Santa Barbara, California)
ABSTRACT Large-area, low-cost single crystal transparent gallium-containing nitride crystals useful as substrates for fabricating GaN devices for electronic and/or optoelectronic applications are disclosed. The gallium-containing nitride crystals are formed by controlling impurity concentrations during ammonothermal growth and processing to control the relative concentrations of point defect species.
FILED Friday, September 12, 2014
APPL NO 14/485516
ART UNIT 1781 — Miscellaneous Articles, Stock Material
CURRENT CPC
Single-crystal-growth; Unidirectional Solidification of Eutectic Material or Unidirectional Demixing of Eutectoid Material; Refining by Zone-melting of Material; Production of a Homogeneous Polycrystalline Material With Defined Structure; Single Crystals or Homogeneous Polycrystalline Material With Defined Structure; After-treatment of Single Crystals or a Homogeneous Polycrystalline Material With Defined Structure; Apparatus Therefor
C30B 7/105 (20130101)
C30B 29/403 (20130101)
C30B 29/406 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/0237 (20130101)
H01L 21/02458 (20130101)
H01L 21/02642 (20130101)
H01L 21/02647 (20130101)
H01L 29/36 (20130101)
H01L 29/045 (20130101)
H01L 29/2003 (20130101) Original (OR) Class
H01L 33/0075 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543468 Alberi et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
National Renewable Energy Laboratory (NREL)
Federally Funded Research and Development Center (FFRDC)
Operated by Alliance for Sustainable Energy, LLC (ASE) at Golden, CO
APPLICANT(S) Kirstin Alberi (Denver, Colorado);  Angelo Mascarenhas (Lakewood, Colorado);  Mark Wanlass (Golden, Colorado)
ASSIGNEE(S) Alliance for Sustainable Energy, LLC (Golden, Colorado)
INVENTOR(S) Kirstin Alberi (Denver, Colorado);  Angelo Mascarenhas (Lakewood, Colorado);  Mark Wanlass (Golden, Colorado)
ABSTRACT High bandgap alloys for high efficiency optoelectronics are disclosed. An exemplary optoelectronic device may include a substrate, at least one Al1-xInxP layer, and a step-grade buffer between the substrate and at least one Al1-xInxP layer. The buffer may begin with a layer that is substantially lattice matched to GaAs, and may then incrementally increase the lattice constant in each sequential layer until a predetermined lattice constant of Al1-xInxP is reached.
FILED Wednesday, October 12, 2011
APPL NO 13/878738
ART UNIT 2819 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 33/04 (20130101) Original (OR) Class
H01L 33/005 (20130101)
H01L 33/12 (20130101)
H01L 33/0066 (20130101)
H01L 33/305 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543496 Welp et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Argonne National Laboratory (ANL)
Federally Funded Research and Development Center (FFRDC)
Operated by UChicago Argonne, LLC (UCHICAGO) at Argonne, IL
APPLICANT(S) UChicago Argonne, LLC (Argonne, Illinois)
ASSIGNEE(S) UChicago Argonne, LLC (Chicago, Illinois)
INVENTOR(S) Ulrich Welp (Lisle, Illinois);  Dean J. Miller (Darien, Illinois);  Wai-Kwong Kwok (Downers Grove, Illinois);  Martin W. Rupich (Framingham, Massachusetts);  Steven Fleshler (Brookline, Massachusetts);  Alexis P. Malozemoff (Lexington, Massachusetts)
ABSTRACT A method comprising irradiating a polycrystalline rare earth metal-alkaline earth metal-transition metal-oxide superconductor layer with protons having an energy of 1 to 6 MeV. The irradiating process produces an irradiated layer that comprises randomly dispersed defects with an average diameter in the range of 1-10 nm.
FILED Monday, March 17, 2014
APPL NO 14/215947
ART UNIT 1735 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 39/126 (20130101) Original (OR) Class
H01L 39/143 (20130101)
H01L 39/2483 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 428/24413 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543537 Steirer et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
National Renewable Energy Laboratory (NREL)
Federally Funded Research and Development Center (FFRDC)
Operated by Alliance for Sustainable Energy, LLC (ASE) at Golden, CO
APPLICANT(S) Alliance for Sustainable Energy, LLC (Golden, Colorado)
ASSIGNEE(S) Alliance for Sustainable Energy, LLC (Golden, Colorado)
INVENTOR(S) K. Xerxes Steirer (Golden, Colorado);  Joseph J. Berry (Boulder, Colorado);  Jordan P. Chesin (Cambridge, Massachusetts);  Matthew T. Lloyd (Boulder, Colorado);  Nicodemus Edwin Widjonarko (Golden, Colorado);  Alexander Miedaner (Boulder, Colorado);  Calvin J. Curtis (Lakewood, Colorado);  David S. Ginley (Evergreen, Colorado);  Dana C. Olson (Boulder, Colorado)
ABSTRACT A method for the application of solution processed metal oxide hole transport layers in organic photovoltaic devices and related organic electronics devices is disclosed. The metal oxide may be derived from a metal-organic precursor enabling solution processing of an amorphous, p-type metal oxide. An organic photovoltaic device having solution processed, metal oxide, thin-film hole transport layer.
FILED Thursday, January 16, 2014
APPL NO 14/156712
ART UNIT 2812 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 51/0036 (20130101)
H01L 51/442 (20130101) Original (OR) Class
H01L 51/4253 (20130101)
H01L 51/4273 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/549 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543569 Worsley et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Lawrence Livermore National Laboratory (LLNL)
Federally Funded Research and Development Center (FFRDC)
Operated by Lawrence Livermore National Security LLC (LLNS) at Livermore, CA
APPLICANT(S) Lawrence Livermore National Security, LLC (Livermore, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Marcus A. Worsley (Hayward, California);  Theodore F. Baumann (Discovery Bay, California);  Juergen Biener (San Leandro, California);  Monika A. Biener (San Leandro, California);  Yinmin Wang (Tracy, California);  Jianchao Ye (Livermore, California);  Elijah Tylski (Platte City, Missouri)
ABSTRACT A composition comprising at least one graphene-supported metal oxide monolith, said monolith comprising a three-dimensional structure of graphene sheets crosslinked by covalent carbon bonds, wherein the graphene sheets are coated by at least one metal oxide such as iron oxide or titanium oxide. Also provided is an electrode comprising the aforementioned graphene-supported metal oxide monolith, wherein the electrode can be substantially free of any carbon-black and substantially free of any binder.
FILED Friday, March 15, 2013
APPL NO 13/844175
ART UNIT 1764 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)
B82Y 40/00 (20130101)

Capacitors; Capacitors, Rectifiers, Detectors, Switching Devices or Light-sensitive Devices, of the Electrolytic Type
H01G 11/36 (20130101)
H01G 11/46 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/131 (20130101) Original (OR) Class
H01M 4/1391 (20130101)
H01M 10/0525 (20130101)
H01M 2004/021 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 60/13 (20130101)
Y02E 60/122 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543860 Wang et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Basic Energy Sciences (BES)
APPLICANT(S) Zhong Lin Wang (Marietta, Georgia);  Guang Zhu (Atlanta, Georgia);  Quingshen Jing (Atlanta, Georgia)
ASSIGNEE(S) Georgia Tech Research Corporation (Atlanta, Georgia)
INVENTOR(S) Zhong Lin Wang (Marietta, Georgia);  Guang Zhu (Atlanta, Georgia);  Quingshen Jing (Atlanta, Georgia)
ABSTRACT A generator includes a first cylindrical member and a second cylindrical member. The first cylindrical member includes a first dielectric layer including a first material that has a first rating on a triboelectric series; and a first conductive strip disposed around an exterior surfaces of the first cylindrical member. The first conductive strip includes a second material that has a second rating on the triboelectric series that is different from the first rating. The second cylindrical member is disposed about the first cylindrical member and includes a second dielectric layer that includes the first material. The second cylindrical member also includes the second material and at least one second conductive strip disposed around an interior surface of the second cylindrical member. A sliding mechanism causes lateral relative motion between the first cylindrical member against the second cylindrical member, generating an electric potential imbalance between the first and second conductive strip.
FILED Wednesday, August 05, 2015
APPL NO 14/818982
ART UNIT 2834 — Electrical Circuits and Systems
CURRENT CPC
Electric Machines Not Otherwise Provided for
H02N 1/04 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

National Science Foundation (NSF) 

US 09538765 Johnson
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) NOVOZYMES BIOAG A/S (Bagsvaerd, Denmark)
ASSIGNEE(S) NOVOZYMES BIOAG A/S (Bagsvaerd, Denmark)
INVENTOR(S) Thomas D. Johnson (Buffalo, South Dakota)
ABSTRACT A seed treated with a fungal/bacterial antagonist combination and a seed assembly comprising a seed and a fungal/bacterial antagonist combination. The fungal/bacterial antagonist combination comprises a Trichoderma virens fungal antagonist and a Bacillus amyloliquefaciens bacterial antagonist for controlling plant pathogens as a biocontrol agent, bio-pesticide or bio-fungicide. In preferred embodiments, the invention produces an increase in plant yield. Control of early and late season stalk and root rot caused by fungi such as Fusarium, Phythium, Phytophthora and Penicillium in tomatoes, peppers, turf grass, soybeans, sunflower, wheat and corn is achieved.
FILED Monday, April 27, 2015
APPL NO 14/696628
ART UNIT 1653 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Planting; Sowing; Fertilising
A01C 1/06 (20130101)

Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 63/00 (20130101)
A01N 63/00 (20130101)
A01N 63/02 (20130101)
A01N 63/04 (20130101) Original (OR) Class
A01N 63/04 (20130101)
A01N 63/04 (20130101)
A01N 2300/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09538945 Cooks et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Purdue Research Foundation (West Lafayette, Indiana)
ASSIGNEE(S) PURDUE RESEARCH FOUNDATION (West Lafayette, Indiana)
INVENTOR(S) Robert Graham Cooks (West Lafayette, Indiana);  Zheng Ouyang (West Lafayette, Indiana);  Chien-Hsun Chen (West Lafayette, Indiana);  Ziqing Lin (West Lafayette, Indiana);  Livia Schiavinato Eberlin (Lafayette, Indiana)
ABSTRACT The invention generally relates to enclosed desorption electrospray ionization probes, systems, and methods. In certain embodiments, the invention provides a source of DESI-active spray, in which a distal portion of the source is enclosed within a transfer member such that the DESI-active spray is produced within the transfer member.
FILED Thursday, April 16, 2015
APPL NO 14/688496
ART UNIT 2881 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/1477 (20130101) Original (OR) Class

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 11/00 (20130101)
A61M 25/00 (20130101)
A61M 2202/0468 (20130101)

Electric Discharge Tubes or Discharge Lamps
H01J 49/0022 (20130101)
H01J 49/34 (20130101)
H01J 49/167 (20130101)
H01J 49/0445 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539058 Tsekos et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) University of Houston System (Houston, Texas)
ASSIGNEE(S)
INVENTOR(S) Nikolaos V. Tsekos (Houston, Texas);  Nicholas C. von Sternberg (Spring, Texas)
ABSTRACT Provided herein are robotic systems, for example, MRI guided robots, for image-guided robot-assisted surgical procedures and methods for using the same to perform such surgical procedures on a patient. The robotic systems comprise a robotic manipulator device or global positioner, means for actuating the robotic manipulator or global positioner that is mechanically linked thereto and a computer having a memory, a processor and at least one network connection in electronic communication with the robotic system. The actuating means comprises at least one transmission line having a flexible component comprising a displaceable medium, a rigid component comprising rigid pistons or a combination through which actuation is transmitted to the robotic manipulator or global positioner. The computer tangibly stores in memory software modules comprising processor-executable instructions to provide interfaces between the robotic system, an imaging system and an operator and to control operation thereof.
FILED Monday, August 26, 2013
APPL NO 14/010155
ART UNIT 3777 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 19/2203 (20130101) Original (OR) Class
A61B 34/30 (20160201)
A61B 90/39 (20160201)
A61B 2034/306 (20160201)
A61B 2090/374 (20160201)
A61B 2090/378 (20160201)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 901/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539329 Yun et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
APPLICANT(S) The General Hospital Corporation (Boston, Massachusetts)
ASSIGNEE(S)
INVENTOR(S) Seok-Hyun Yun (Cambridge, Massachusetts);  Myunghwan Choi (Cambridge, Massachusetts)
ABSTRACT A hydrogel-lightguide based sensory system susceptible to a stimulus signal produced by ambient and stimulating sensory cells embedded in a hydrogel body of the system. Sensory cells generate an optical signal (in response to a user-defined triggering with excitation light or, alternatively, due to bioluminescence) the properties of which, determined based on detection of such signal with an optical detector device, provide characterization of the stimulus and information required for user-defined activation of emitter cells encapsulated in the hydrogel. When activated, emitter cells generate matter and/or light directed to interact with the ambient.
FILED Friday, October 17, 2014
APPL NO 14/516874
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0059 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0024 (20130101)
A61K 47/10 (20130101) Original (OR) Class
A61K 49/0054 (20130101)
A61K 49/0073 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/0601 (20130101)
A61N 2005/063 (20130101)
A61N 2005/0626 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539359 Bose et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical and Transport Systems (CTS)
APPLICANT(S) Washington State University (Pullman, Washington)
ASSIGNEE(S) Washington State University (Pullman, Washington)
INVENTOR(S) Susmita Bose (Pullman, Washington);  Amit Bandyopadhyay (Pullman, Washington);  Weichang Xue (Suzhou, China PRC)
ABSTRACT Mesoporous calcium silicate compositions for controlled release of bioactive agents and methods for producing such compositions are disclosed herein. In one embodiment, mesoporous calcium silicate is synthesized by acid modification of wollastonite particles using hydrochloric acid. A hydrated silica gel layer having abundant Si—OH functional groups can be formed on the surface of wollastonite after acid modification. Bruhauer-Emmett-Teller (BET) surface area increased significantly due to acid modification and, in one arrangement, reached over 350 m2/g. Acid modified mesoporous calcium silicate compositions show a higher ability to adsorb protein compared to unmodified particles and demonstrate controlled release kinetics of these proteins.
FILED Tuesday, November 11, 2014
APPL NO 14/538418
ART UNIT 1615 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/5115 (20130101)
A61K 47/48861 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 27/10 (20130101)
A61L 27/025 (20130101) Original (OR) Class
A61L 27/54 (20130101)
A61L 27/56 (20130101)
A61L 27/58 (20130101)
A61L 27/227 (20130101)
A61L 27/306 (20130101)
A61L 2300/45 (20130101)
A61L 2300/252 (20130101)
A61L 2300/254 (20130101)
A61L 2300/414 (20130101)
A61L 2300/428 (20130101)
A61L 2300/602 (20130101)
A61L 2430/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539726 Simaan et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
APPLICANT(S) Vanderbilt University (Nashville, Tennessee)
ASSIGNEE(S) Vanderbilt University (Nashville, Tennessee)
INVENTOR(S) Nabil Simaan (Nashville, Tennessee);  Andrea Bajo (Fort Lauderdale, Florida);  James L. Netterville (Nashville, Tennessee);  C. Gaelyn Garrett (Nashville, Tennessee);  Roger E. Goldman (New York, New York)
ABSTRACT Methods and systems are described for controlling movement of a continuum robot that includes a plurality of independently controlled segments along the length of the continuum robot. The continuum robot is inserted into a cavity of unknown dimensions or shape. A plurality of forces acting upon the continuum robot by the surrounding cavity are estimated. A positioning command indicating a desired movement of the distal end of the continuum robot is received from a manipulator control. The desired movement is augmented based, at least in part, on the estimated plurality of forces acting on the continuum robot such that movement is restricted to within safe boundaries of the surrounding cavity. The positioning of the continuum robot is then adjusted based on the augmented desired movement.
FILED Tuesday, May 06, 2014
APPL NO 14/271418
ART UNIT 3664 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 34/30 (20160201)
A61B 2017/00314 (20130101)
A61B 2017/00323 (20130101)
A61B 2034/306 (20160201)
A61B 2090/064 (20160201)

Manipulators; Chambers Provided With Manipulation Devices
B25J 9/1625 (20130101) Original (OR) Class

Control or Regulating Systems in General; Functional Elements of Such Systems; Monitoring or Testing Arrangements for Such Systems or Elements
G05B 2219/40184 (20130101)
G05B 2219/40299 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 901/01 (20130101)
Y10S 901/30 (20130101)
Y10S 901/50 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539788 Nealey et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Paul Franklin Nealey (Madison, Wisconsin);  Mark Petar Stoykovich (Dover, New Hampshire);  Konstantinos C. Daoulas (Goettingen, United Kingdom);  Marcus Muller (Goettingen, United Kingdom);  Juan J. De Pablo (Madison, Wisconsin);  SangMin Park (Madison, Wisconsin)
ABSTRACT Methods of fabricating complex three-dimensional structures on patterned substrates and related compositions are provided. The methods involve depositing on the substrate a block copolymer material that is “mismatched” to the substrate pattern, and then ordering the material to form a complex three-dimensional structure. According to various embodiments, the copolymer material mismatches the substrate pattern in that the symmetry and/or length scale of its bulk morphology differs from that of the pattern. When ordered, a balance between the physics that determines the bulk block copolymer morphology and the physics that determines the substrate surface interfacial interactions results in a thermodynamically stable complex three-dimensional film that varies in a direction perpendicular to the substrate and has a morphology that differs from its bulk morphology.
FILED Wednesday, November 27, 2013
APPL NO 14/092551
ART UNIT 1783 — Miscellaneous Articles, Stock Material
CURRENT CPC
Separation
B01D 69/10 (20130101)
B01D 71/40 (20130101)
B01D 71/80 (20130101)
B01D 2323/225 (20130101)

Processes for Applying Fluent Materials to Surfaces, in General
B05D 5/00 (20130101)

Layered Products, i.e Products Built-up of Strata of Flat or Non-flat, e.g Cellular or Honeycomb, Form
B32B 3/30 (20130101) Original (OR) Class

Processes or Apparatus Specially Adapted for the Manufacture or Treatment of Microstructural Devices or Systems
B81C 1/00031 (20130101)
B81C 2201/0149 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)

Photomechanical Production of Textured or Patterned Surfaces, e.g for Printing, for Processing of Semiconductor Devices; Materials Therefor; Originals Therefor; Apparatus Specially Adapted Therefor;
G03F 7/70408 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 428/269 (20150115)
Y10T 428/24322 (20150115)
Y10T 428/24331 (20150115)
Y10T 428/24612 (20150115)
Y10T 428/24802 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540235 Sureshkumar et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
APPLICANT(S) Radhakrishna Sureshkumar (Syracuse, New York);  Tao Cong (Syracuse, New York);  Satvik Wani (Syracuse, New York)
ASSIGNEE(S) SYRACUSE UNIVERSITY (Syracuse, New York)
INVENTOR(S) Radhakrishna Sureshkumar (Syracuse, New York);  Tao Cong (Syracuse, New York);  Satvik Wani (Syracuse, New York)
ABSTRACT There is set forth herein a method for providing a nanoparticle array. A nanoparticle network can be provided by nanoparticles combined with surfactant micelle chains. The nanoparticle network can be provided by distributing metal nanoparticles in a surfactant solution and agitating the surfactant solution comprising the nanoparticles to form a gel comprising the nanoparticle network which can be characterized by a distributed array of nanoparticles combined with surfactant micelle chains within a fluid. The gel can comprise a fluid in a continuous phase and the nanoparticles in a discontinuous phase. Apparatus having arrays of nanoparticles are also set forth herein.
FILED Friday, March 16, 2012
APPL NO 13/422741
ART UNIT 1763 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 13/006 (20130101)
B01J 13/0052 (20130101)
B01J 13/0056 (20130101)
B01J 13/0065 (20130101)
B01J 13/0069 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101) Original (OR) Class
B82Y 40/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540284 McElwee-White et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (Gainesville, Florida)
ASSIGNEE(S) UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (Gainesville, Florida)
INVENTOR(S) Lisa McElwee-White (Gainesville, Florida);  Timothy James Anderson (Amherst, Massachusetts);  K. Randall McClain (Gainesville, Florida);  Christopher O'Donohue (Conshohocken, Pennsylvania)
ABSTRACT Embodiments of the invention are directed to a method of preparing a WNx, WNxCy, WNxOz, and WNxCyOz solid by the deposition of a WNx precursor at a temperature below 300° C. The WNx precursor is a tungsten nitrido complex. The deposition can be carried out using a tungsten nitrido complex as a single-source metal organic precursor. In an embodiment of the invention, the deposition can be performed to form a plurality of WNx, WNxCy, WNxOz, WNxCyOz nanoparticles.
FILED Thursday, December 18, 2014
APPL NO 14/575026
ART UNIT 1671 — Optics
CURRENT CPC
Lime, Magnesia; Slag; Cements; Compositions Thereof, e.g Mortars, Concrete or Like Building Materials; Artificial Stone; Ceramics; Refractories; Treatment of Natural Stone
C04B 35/58007 (20130101) Original (OR) Class

Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 11/005 (20130101)

Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 16/30 (20130101)
C23C 16/34 (20130101)
C23C 16/36 (20130101)
C23C 16/308 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540652 Juminaga et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Lawrence Berkeley National Laboratory (LBNL)
Federally Funded Research and Development Center (FFRDC)
Operated by University of California (UC BERKELEY) at Berkeley, CA
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Engineering Education and Centers (EEC)
APPLICANT(S) Darmawi Juminaga (Albany, California);  Jay D. Keasling (Berkeley, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Darmawi Juminaga (Albany, California);  Jay D. Keasling (Berkeley, California)
ABSTRACT The present disclosure relates to engineered microorganisms that produce amino acids and amino acid intermediates. In particular, the disclosure relates to recombinant nucleic acids encoding operons that increase production of aromatic amino acids and the aromatic amino acid intermediate shikimate; microorganisms with increased production of aromatic amino acids and the aromatic amino acid intermediate shikimate; and methods related to the production of aromatic amino acids, the aromatic amino acid intermediate shikimate, and commodity chemicals derived therefrom.
FILED Friday, August 31, 2012
APPL NO 14/342335
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/001 (20130101)
C12N 9/88 (20130101)
C12N 15/52 (20130101)
C12N 15/70 (20130101) Original (OR) Class

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 7/42 (20130101)
C12P 13/22 (20130101)
C12P 13/225 (20130101)
C12P 13/227 (20130101)

Enzymes
C12Y 103/01012 (20130101)
C12Y 401/02 (20130101)

Climate Change Mitigation Technologies in the Production or Processing of Goods
Y02P 20/52 (20151101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540701 Olesberg et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) ASL Analytical, Inc. (Coralville, Iowa)
ASSIGNEE(S) ASL ANALYTICAL, INC. (Coralville, Iowa)
INVENTOR(S) Jonathon Todd Olesberg (Iowa City, Iowa);  Mark Allen Arnold (Iowa City, Iowa);  Gary Wray Small (Coralville, Iowa);  Edwin John Koerperick (North Liberty, Iowa);  Christine Esther Evans (North Liberty, Iowa)
ABSTRACT A system and method for continuous, real-time process monitoring and control by means of near-infrared (NIR) spectroscopy provides analysis of static or flowing fluid streams which may range from clear to highly optically dense, including fluids primarily of aqueous composition. A NIR source passes through a wavelength selector to select one or more spectral segments, which are passed through the fluid stream at a fluid sampling interface and received at a sensor. A wavelength reference material is positioned in the optical path for calibration. Quantification of a plurality of characteristics or parameters of a fluid and suspended solids or cells contained therein may be performed. An all-solid-state implementation of the optical system ensures high robustness in laboratory and industrial settings.
FILED Thursday, February 26, 2015
APPL NO 14/631917
ART UNIT 2884 — Optics
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 3/00 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/39 (20130101)
G01N 21/51 (20130101)
G01N 21/65 (20130101)
G01N 21/314 (20130101)
G01N 21/359 (20130101)
G01N 21/645 (20130101)
G01N 21/3577 (20130101)
G01N 2021/399 (20130101)
G01N 2201/067 (20130101)
G01N 2201/0846 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540730 Winter
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) WAYNE STATE UNIVERSITY (Detroit, Michigan)
ASSIGNEE(S) WAYNE STATE UNIVERSITY (Detroit, Michigan)
INVENTOR(S) Charles H. Winter (Bloomfield Hills, Michigan)
ABSTRACT A method comprises contacting a compound having formulae (1) with a compound having formula MLo to form a metal:
[M(SiR3)m(L1)p]n  (1)
wherein M is Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Al, a second row transition metal or a third row transition metal; R are each independently H, C1-C6 alkyl or —Si(R″)3; R″ are each independently H or C1-C6 alkyl; m is an integer from 1 to 3; n is a number representing the formation of aggregates or polymeric material; L1 is a neutral donor ligand;
L is a ligand;
p is an integer from 0 to 6; and o is an integer representing the number of ligands bonded to MLo.
FILED Monday, September 23, 2013
APPL NO 14/430282
ART UNIT 1715 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Acyclic, Carbocyclic or Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium or Tellurium
C07F 19/00 (20130101)

Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 16/06 (20130101)
C23C 16/45553 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541528 Hossein-Zadeh
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
National Science Foundation (NSF)
APPLICANT(S) Mani Hossein-Zadeh (Albuquerque, New Mexico)
ASSIGNEE(S) STC.UNM (Albuquerque, New Mexico)
INVENTOR(S) Mani Hossein-Zadeh (Albuquerque, New Mexico)
ABSTRACT An optical microresonator based RF oscillator sensor for measuring mass, temperature, and particle/molecule concentration. An optical energy source is coupled to the optical microresonator to generate optical power oscillations at Rf frequencies. A stable or reference RF oscillation frequency is established which allows for measuring oscillation frequency variations induced by the interaction of the substance with the optical microresonator.
FILED Friday, March 14, 2014
APPL NO 14/213858
ART UNIT 2855 — Printing/Measuring and Testing
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/7746 (20130101)
G01N 29/036 (20130101)
G01N 29/2418 (20130101) Original (OR) Class
G01N 2291/014 (20130101)
G01N 2291/0256 (20130101)

Optical Elements, Systems, or Apparatus
G02B 6/29338 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541558 Clemons et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Science Foundation (NSF)
APPLICANT(S) California Institute of Technology (Pasadena, California)
ASSIGNEE(S) California Institute of Technology (Pasadena, California)
INVENTOR(S) William M. Clemons (Pasadena, California);  Kyoung-Soon Jang (Pasadena, California);  Roger Nani (Pasadena, California);  Sergiy Levin (North Wales, Pennsylvania);  Sarah Reisman (San Marino, California)
ABSTRACT A cysteine hydrazide nicotinamide (Cyhn) reagent designed for the enrichment of bacterial glycoproteins is provided. Methods for purification of free oligosaccharides and their analysis are also provided.
FILED Wednesday, September 04, 2013
APPL NO 14/017744
ART UNIT 1678 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6842 (20130101)
G01N 33/6848 (20130101) Original (OR) Class

Technical Subjects Covered by Former US Classification
Y10T 436/143333 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541829 Robello et al.
FUNDED BY
National Science Foundation (NSF)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Orthogonal, Inc. (Rochester, New York)
ASSIGNEE(S) Orthogonal, Inc. (Rochester, New York)
INVENTOR(S) Douglas Robert Robello (Webster, New York);  Charles Warren Wright (Fairport, New York)
ABSTRACT A photosensitive composition comprises a fluorinated solvent, a photo-acid generator and a copolymer. The copolymer comprises at least three distinct repeating units, including a first repeating unit having a fluorine-containing group, a second repeating unit having an acid-catalyzed cross-linkable group, and a third repeating unit having a sensitizing dye. The composition is useful in the fabrication of electronic devices, especially organic electronic and bioelectronic devices.
FILED Friday, July 18, 2014
APPL NO 14/335406
ART UNIT 1722 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 220/18 (20130101)
C08F 220/22 (20130101)
C08F 220/24 (20130101)
C08F 220/24 (20130101)
C08F 222/18 (20130101)
C08F 2220/325 (20130101)
C08F 2220/1891 (20130101)
C08F 2222/185 (20130101)

Photomechanical Production of Textured or Patterned Surfaces, e.g for Printing, for Processing of Semiconductor Devices; Materials Therefor; Originals Therefor; Apparatus Specially Adapted Therefor;
G03F 7/0007 (20130101)
G03F 7/32 (20130101)
G03F 7/038 (20130101)
G03F 7/40 (20130101)
G03F 7/0045 (20130101)
G03F 7/0046 (20130101)
G03F 7/0048 (20130101)
G03F 7/0388 (20130101) Original (OR) Class

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/0274 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541982 Lipasti et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
National Science Foundation (NSF)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Mikko H. Lipasti (Lake Mills, Wisconsin);  Atif G. Hashmi (Madison, Wisconsin);  Andrew Nere (Madison, Wisconsin);  Giulio Tononi (Verona, Wisconsin)
ABSTRACT The present inventors have recognized that proper utilization of reconfigurable event driven hardware may achieve optimum power conservation in energy constrained environments including a low power general purpose primary processor and one or more electronic sensors. Aspects of neurobiology and neuroscience, for example, may be utilized to provide such reconfigurable event driven hardware, thereby achieving energy-efficient continuous sensing and signature reporting in conjunction with the one or more electronic sensors while the primary processor enters a low power consumption mode. Such hardware is event driven and operates with extremely low energy requirements.
FILED Friday, January 25, 2013
APPL NO 13/749854
ART UNIT 2115 — Computer Error Control, Reliability, & Control Systems
CURRENT CPC
Electric Digital Data Processing
G06F 1/3206 (20130101) Original (OR) Class
G06F 1/3209 (20130101)
G06F 1/3215 (20130101)
G06F 1/3293 (20130101)

Climate Change Mitigation Technologies Related to Buildings, e.g Housing, House Appliances or Related End-user Applications
Y02B 60/121 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09542162 Gazzillo et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computing and Communication Foundations (CCF)
Division of Computer and Network Systems (CNS)
APPLICANT(S) New York University (New York, New York)
ASSIGNEE(S) New York University (New York, New York)
INVENTOR(S) Paul Gazzillo (Titusville, New Jersey);  Robert Grimm (New York, New York)
ABSTRACT Methods, systems, and apparatuses, including computer programs encoded on computer readable media, for generating a plurality of tokens from one or more source files. The one or more source files include source code in a first programming language. The source code includes one or more static conditionals that include a conditional expression and branch code that is operative when the conditional expression is true. Various configurations are possible based upon the conditionals. A first static conditional that includes one or more nested static conditionals within the branch code associated with the first static conditional is determined. Each of the one or more nested static conditionals is hoisted to a beginning of the branch code associated with the first static conditional. Each innermost branch code does not contain a static conditional, and each possible configuration is preserved.
FILED Wednesday, July 06, 2016
APPL NO 15/203667
ART UNIT 2193 — Interprocess Communication and Software Development
CURRENT CPC
Electric Digital Data Processing
G06F 8/31 (20130101) Original (OR) Class
G06F 8/425 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09542216 Srivastava et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) AT and T Intellectual Property I, LP (Atlanta, Georgia);  Rutgers, The State University of New Jersey (New Brunswick, New Jersey)
ASSIGNEE(S) AT and T INTELLECTUAL PROPERTY I, L.P. (Atlanta, Georgia);  RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (New Brunswick, New Jersey)
INVENTOR(S) Abhinav Srivastava (Edison, New Jersey);  Vinod Ganapathy (Bridgewater, New Jersey)
ABSTRACT In a cloud app market, a cloud infrastructure customer can purchase apps for performing services such as rootkit detection and network security for a customer virtual machine run by the cloud infrastructure customer. A cloud infrastructure provider executes a provider virtual machine monitor or hypervisor on cloud infrastructure. The cloud app is provided with a customer virtual machine monitor nested on the provider virtual machine monitor. The customer virtual machine, together with a nested management domain of the customer, execute on the customer virtual machine monitor.
FILED Tuesday, October 15, 2013
APPL NO 14/054430
ART UNIT 2196 — Interprocess Communication and Software Development
CURRENT CPC
Electric Digital Data Processing
G06F 8/60 (20130101)
G06F 9/50 (20130101)
G06F 9/455 (20130101)
G06F 9/4555 (20130101)
G06F 9/45533 (20130101)
G06F 9/45545 (20130101)
G06F 9/45558 (20130101) Original (OR) Class
G06F 2009/45566 (20130101)
G06F 2009/45587 (20130101)
G06F 2009/45591 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543392 Jiang et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Industrial Innovation and Partnerships (IIP)
APPLICANT(S) SORAA, INC. (Fremont, California)
ASSIGNEE(S) Soraa, Inc. (Fremont, California)
INVENTOR(S) Wenkan Jiang (Corona, California);  Dirk Ehrentraut (Santa Barbara, California);  Mark P. D'Evelyn (Santa Barbara, California)
ABSTRACT Large-area, low-cost single crystal transparent gallium-containing nitride crystals useful as substrates for fabricating GaN devices for electronic and/or optoelectronic applications are disclosed. The gallium-containing nitride crystals are formed by controlling impurity concentrations during ammonothermal growth and processing to control the relative concentrations of point defect species.
FILED Friday, September 12, 2014
APPL NO 14/485516
ART UNIT 1781 — Miscellaneous Articles, Stock Material
CURRENT CPC
Single-crystal-growth; Unidirectional Solidification of Eutectic Material or Unidirectional Demixing of Eutectoid Material; Refining by Zone-melting of Material; Production of a Homogeneous Polycrystalline Material With Defined Structure; Single Crystals or Homogeneous Polycrystalline Material With Defined Structure; After-treatment of Single Crystals or a Homogeneous Polycrystalline Material With Defined Structure; Apparatus Therefor
C30B 7/105 (20130101)
C30B 29/403 (20130101)
C30B 29/406 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/0237 (20130101)
H01L 21/02458 (20130101)
H01L 21/02642 (20130101)
H01L 21/02647 (20130101)
H01L 29/36 (20130101)
H01L 29/045 (20130101)
H01L 29/2003 (20130101) Original (OR) Class
H01L 33/0075 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543980 Huang et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computing and Communication Foundations (CCF)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusettes Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Ying-Zong Huang (Seattle, Washington);  Gregory W. Wornell (Wellesley, Massachusetts)
ABSTRACT An encoder generates a compressed data sequence from an original data sequence using many-to-one mapping independently of a source model associated with the original data sequence and without extracting the source model. A decoder uses both the source model associated with the original data sequence and the mapping applied during compression that is devoid of, in substance, the source model, to regenerate, at least in part, the original uncompressed data sequence from the compressed data sequence that does not include a significant portion of the source model.
FILED Friday, February 06, 2015
APPL NO 14/616248
ART UNIT 2845 — Electrical Circuits and Systems
CURRENT CPC
Coding; Decoding; Code Conversion in General
H03M 7/30 (20130101) Original (OR) Class
H03M 13/6312 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09544136 Yao et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) CALIFORNIA INSTITUTE OF TECHNOLOGY (Pasadena, California);  PURDUE RESEARCH FOUNDATION (West Lafayette, Indiana)
ASSIGNEE(S) CALIFORNIA INSTITUTE OF TECHNOLOGY (Pasadena, California);  PURDUE RESEARCH FOUNDATION (West Lafayette, Indiana)
INVENTOR(S) Hongyi Yao (Pasadena, California);  Tracey C. Ho (Pasadena, California);  Cristina Nita-Rotaru (Chicago, Illinois)
ABSTRACT A network and related methods for transmitting processes in a network secretly and securely is described. The network use keys, through path-key establishment and a key pool bootstrapping, to ensure that packets are transmitted and received properly and secretly in the presence of one or more adversarial nodes.
FILED Monday, May 09, 2016
APPL NO 15/150322
ART UNIT 2493 — Cryptography and Security
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 9/0802 (20130101)
H04L 9/0827 (20130101) Original (OR) Class
H04L 9/0838 (20130101)
H04L 2209/34 (20130101)
H04L 2209/80 (20130101)

Wireless Communication Networks
H04W 12/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09544167 Katabi et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) Dina Katabi (Cambridge, Massachusetts);  Haitham Z. Al-Hassanieh (Cambridge, Massachusetts);  Lixin Shi (Cambridge, Massachusetts);  Omid Salehi-Abari (Cambridge, Massachusetts);  Ezzeldin Hamed (Cambridge, Massachusetts)
ASSIGNEE(S) MASSACHUSETTS INSTITUTE OF TECHNOLOGY (Cambridge, Massachusetts)
INVENTOR(S) Dina Katabi (Cambridge, Massachusetts);  Haitham Z. Al-Hassanieh (Cambridge, Massachusetts);  Lixin Shi (Cambridge, Massachusetts);  Omid Salehi-Abari (Cambridge, Massachusetts);  Ezzeldin Hamed (Cambridge, Massachusetts)
ABSTRACT Methods and apparatus for monitoring wideband GHz spectrum for wireless communication, and sensing and decoding respective frequency components of a time-varying signal corresponding to the monitored spectrum. Concepts relating to sparse Fast Fourier Transform (sFFT) techniques facilitate identification of one or more frequency components of a sparsely occupied spectrum by sub-sampling the signal corresponding to the monitored spectrum at a sampling rate below the Nyquist criterion. The disclosed methods and apparatus may be implemented using conventional relatively low-power wireless receivers and using off-the-shelf relatively inexpensive low-speed and low-power analog-to-digital converters (ADCs) typically employed in WiFi devices or cellular phones, in tandem with unique processing techniques based on sFFTs and sub-Nyquist criterion sampling, and have demonstrated efficacy even in scenarios where the monitored spectrum is not sparse.
FILED Wednesday, November 19, 2014
APPL NO 14/548231
ART UNIT 2634 — Digital Communications
CURRENT CPC
Transmission
H04B 1/16 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 25/024 (20130101) Original (OR) Class

Wireless Communication Networks
H04W 16/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09544235 Rhee et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
Division of Information and Intelligent Systems (IIS)
APPLICANT(S) North Carolina State University (Raleigh, North Carolina)
ASSIGNEE(S) North Carolina State University (Raleigh, North Carolina)
INVENTOR(S) Injong Rhee (Raleigh, North Carolina);  Jeongki Min (Raleigh, North Carolina)
ABSTRACT A network device connecting a client station with a TCP/IP server, the device includes a transmitter configured to transmit signals from at least one of the server and the client station, and a receiver configured to receive signals from at least one of the server and the client station. The device also includes a controller. The controller is configured to determine a priority level of the network device based on a dynamic traffic load of the network device, and assign a high priority setting to a first data packet received during a predetermined period of time. Duration of the predetermined period of time is based on the priority level of the network device.
FILED Friday, October 17, 2014
APPL NO 14/517488
ART UNIT 2472 — Multiplex and VoIP
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 47/125 (20130101)
H04L 47/193 (20130101) Original (OR) Class

Wireless Communication Networks
H04W 72/1252 (20130101)
H04W 84/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Agriculture (USDA) 

US 09539352 Keener et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) Purdue Research Foundation (West Lafayette, Indiana)
ASSIGNEE(S) Purdue Research Foundation (West Lafayette, Indiana)
INVENTOR(S) Kevin M. Keener (Attica, Indiana);  Paul A. Klockow (South Bend, Indiana)
ABSTRACT A system and method for decontamination of product is described. An object to be treated, which may be a food product or a medical device, is placed in a substantially closed dielectric container with a working gas. The container is placed in an apparatus capable of producing a controlled electrical discharge so as to create reactive ion species within the package. The object to be treated may be exposed either the immediate products of the electrical discharge or the long lasting reactive ion species, or both, so as to treat the object to reduce or eliminate specific contaminants, which may be biological pathogens or the cause of product spoilage, or inorganic contaminants. The reactive ion species may result from an atmospheric non-equilibrium plasma (ANEP) formed by the apparatus and the treatment may be performed without significantly increasing the bulk temperature of the object being treated.
FILED Monday, March 11, 2013
APPL NO 13/793342
ART UNIT 1799 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preserving, e.g by Canning, Meat, Fish, Eggs, Fruit, Vegetables, Edible Seeds; Chemical Ripening of Fruit or Vegetables; the Preserved, Ripened, or Canned Products
A23B 7/01 (20130101)
A23B 7/015 (20130101)

Foods, Foodstuffs, or Non-alcoholic Beverages, Not Covered by Subclasses A23B - A23J; Their Preparation or Treatment, e.g Cooking, Modification of Nutritive Qualities, Physical Treatment; Preservation of Foods or Foodstuffs, in General
A23L 3/01 (20130101)
A23L 3/32 (20130101)
A23L 3/263 (20130101)

Methods or Apparatus for Sterilising Materials or Objects in General; Disinfection, Sterilisation, or Deodorisation of Air; Chemical Aspects of Bandages, Dressings, Absorbent Pads, or Surgical Articles; Materials for Bandages, Dressings, Absorbent Pads, or Surgical Articles
A61L 2/20 (20130101) Original (OR) Class
A61L 2/22 (20130101)

Plasma Technique; Production of Accelerated Electrically-charged Particles or of Neutrons; Production or Acceleration of Neutral Molecular or Atomic Beams
H05H 1/2406 (20130101)
H05H 2001/2412 (20130101)
H05H 2245/1225 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540244 Zhang et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) Mississippi State University (Starkville, Mississippi)
ASSIGNEE(S) Mississippi State University (Starkville, Mississippi);  The United States of America as Represented by Secretary of Agriculture (Washington, District of Columbia)
INVENTOR(S) Jilei Zhang (Starkville, Mississippi);  Zhiyong Cai (Madison, Wisconsin)
ABSTRACT Embodiments of the presently-disclosed subject matter include methods for synthesizing carbon nanomaterials from a lignin and/or source thereof. Exemplary methods comprise a process of thermal treating a lignin and/or source thereof in the presence of a catalyst to synthesize graphene nanosheets.
FILED Thursday, June 05, 2014
APPL NO 14/297275
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Non-metallic Elements; Compounds Thereof;
C01B 31/0446 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540264 Murray et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) The United States of America, as represented by the Secretary of Agriculture (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as Represented by the Secretary of Agriculture (Washington, District of Columbia)
INVENTOR(S) Rex E. Murray (Peoria, Illinois);  Grigor B. Bantchev (Peoria, Illinois);  Kenneth M. Doll (Peoria, Illinois);  Robert O. Dunn (Peoria, Illinois);  Kim L. Ascherl (Peoria, Illinois)
ABSTRACT We have now discovered a novel process for the removal or extraction of metal species from a variety of solid, liquid or gas phase materials. Metal species may be removed by contacting the material suspected of containing one or more metals with a thiolated fatty acid or ester thereof for a period of time and under conditions effective far the sequestration of the metal species by the thiolated fatty acid or ester thereof. The thiolated fatty acid or ester thereof comprising sequestered metal species may then be separated and recovered from the treated material. Moreover, following the treatment of aqueous liquids or mixtures, or suspensions or dispersions of solids in aqueous liquids, the resultant thiolated fatty acid or ester thereof comprising the sequestered metal species is insoluble in water and forms a separate layer from the aqueous liquid phase, which layer may be readily removed.
FILED Monday, August 03, 2015
APPL NO 14/816429
ART UNIT 1672 — Optics
CURRENT CPC
Separation
B01D 15/08 (20130101)
B01D 53/1425 (20130101)
B01D 53/1493 (20130101)
B01D 2252/205 (20130101)
B01D 2252/2056 (20130101)
B01D 2257/60 (20130101)

Separating Solid Materials Using Liquids or Using Pneumatic Tables or Jigs
B03B 5/00 (20130101)

Reclamation of Contaminated Soil
B09C 1/08 (20130101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/54 (20130101)
C02F 1/285 (20130101)
C02F 1/286 (20130101)
C02F 1/683 (20130101)
C02F 1/5263 (20130101) Original (OR) Class
C02F 2101/20 (20130101)
C02F 2101/103 (20130101)
C02F 2101/108 (20130101)

Acyclic or Carbocyclic Compounds
C07C 321/02 (20130101)
C07C 323/50 (20130101)
C07C 323/52 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540415 Gonzalez et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
Department of Agriculture (USDA)
APPLICANT(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia);  The Penn State Research Foundation (University Park, Pennsylvania)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia);  The Penn State Research Foundation (University Park, Pennsylvania)
INVENTOR(S) Frank J. Gonzalez (Bethesda, Maryland);  Changtao Jiang (Beijing, China PRC);  Cen Xie (Rockville, Maryland);  Andrew D. Patterson (State College, Pennsylvania);  Fei Li (Rockville, Maryland);  James B. Mitchell (Damascus, Maryland)
ABSTRACT Disclosed are inhibitors of the farnesoid X receptor, for example of formula (I), wherein R1, R2, R4, X, Y, Z, m, and n are as defined herein, which are useful in treating or preventing obesity, type 2 diabetes/insulin resistance and non alcoholic fatty liver disease in a mammal in need thereof. Also disclosed is a composition comprising a pharmaceutically suitable carrier and at least Cone compound of the invention, a method of method of inhibiting a farnesoid X receptor in a mammal, and a method of treating or preventing obesity in a mammal.
FILED Friday, August 01, 2014
APPL NO 14/909263
ART UNIT 1672 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Steroids
C07J 9/005 (20130101)
C07J 41/0055 (20130101)
C07J 41/0061 (20130101) Original (OR) Class
C07J 41/0066 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540642 Inberg et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) Monsanto Technology LLC (St. Louis, Missouri);  Beeologics, Inc. (St. Louis, Missouri);  The United States of America, as represented by the Secretary of Agriculture (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of Agriculture (Washington, District of Columbia);  Beeologics, Inc. (St. Louis, Missouri);  Monsanto Technology LLC (St. Louis, Missouri)
INVENTOR(S) Alex Inberg (Ballwin, Missouri);  Mahak Kapoor (Chesterfield, Missouri);  Jay Evans (Harwood, Maryland)
ABSTRACT This application provides and discloses anti-parasitic, anti-pest or insecticidal nucleic acid molecules and their calmodulin target genes for the control of arthropod parasites and pests. This application further provides methods and compositions for the control and treatment of parasites and pests in Apis mellifera (honey bee) hives.
FILED Tuesday, November 04, 2014
APPL NO 14/532596
ART UNIT 1674 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 51/00 (20130101)

Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 37/46 (20130101)
A01N 63/02 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 31/713 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101) Original (OR) Class
C12N 2310/14 (20130101)
C12N 2310/14 (20130101)
C12N 2310/531 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US PP27531 NeSmith
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) University of Georgia Research Foundation, Inc. (Athens, Georgia)
ASSIGNEE(S) University of Georgia Research Foundation, Inc. (Athens, Georgia)
INVENTOR(S) D. Scott NeSmith (Molena, Georgia)
ABSTRACT The new variety ‘TH-917’ is provided. The new and distinct variety ripens around mid May in southern Georgia and late May in middle Georgia. The fruit of the new variety ‘TH-917’ are large, firm, have good flavor and scar. The new variety ‘TH-917’ is vigorous with an estimated chilling requirement of about 500 to 550 hours at or below approximately 7° C. The asexually reproduced variety is reliably propagated vegetatively.
FILED Friday, July 10, 2015
APPL NO 14/545947
ART UNIT 1661 — Plants
CURRENT CPC
Plants
PLT/157
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Commerce (DOC) 

US 09540763 Grunlan
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S) Jaime C. Grunlan (College Station, Texas)
ASSIGNEE(S) The Texas A and M University System (College Station, Texas)
INVENTOR(S) Jaime C. Grunlan (College Station, Texas)
ABSTRACT A method includes coating a substrate to provide a flame resistant substrate. In an embodiment, the method includes exposing the substrate to a cationic solution to produce a cationic layer deposited on the substrate. The cationic solution includes cationic materials. The cationic materials include polymers, nanoparticles, or any combinations thereof. The method further includes exposing the cationic layer to an anionic solution to produce an anionic layer deposited on the cationic layer to produce a bilayer. The bilayer is the anionic layer and the cationic layer. The anionic solution includes layerable materials.
FILED Wednesday, March 03, 2010
APPL NO 12/716658
ART UNIT 1712 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Use of Inorganic or Non-macromolecular Organic Substances as Compounding Ingredients
C08K 3/346 (20130101)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 5/18 (20130101)
C09D 7/1216 (20130101)

Treatment, Not Provided for Elsewhere in Class D06, of Fibres, Threads, Yarns, Fabrics, Feathers or Fibrous Goods Made From Such Materials
D06M 11/73 (20130101)
D06M 11/79 (20130101)
D06M 15/53 (20130101)
D06M 15/61 (20130101)
D06M 15/263 (20130101)
D06M 15/285 (20130101)
D06M 15/643 (20130101)
D06M 15/3562 (20130101)
D06M 23/00 (20130101) Original (OR) Class
D06M 23/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540764 Grunlan
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S) Jaime C. Grunlan (College Station, Texas)
ASSIGNEE(S) The Texas A and M University System (College Station, Texas)
INVENTOR(S) Jaime C. Grunlan (College Station, Texas)
ABSTRACT A method includes coating a substrate to provide a flame resistant substrate. In an embodiment, the method includes exposing the substrate to a cationic solution to produce a cationic layer deposited on the substrate. The cationic solution comprises cationic materials. The cationic materials comprise a polymer, a colloidal particle, a nanoparticle, a nitrogen-rich molecule, or any combinations thereof. The method further includes exposing the cationic layer to an anionic solution to produce an anionic layer deposited on the cationic layer to produce a layer comprising the anionic layer and the cationic layer. The anionic solution comprises a layerable material.
FILED Monday, July 30, 2012
APPL NO 13/562069
ART UNIT 1712 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Processes for Applying Fluent Materials to Surfaces, in General
B05D 1/36 (20130101)
B05D 1/185 (20130101)
B05D 7/52 (20130101)
B05D 7/56 (20130101)

Use of Inorganic or Non-macromolecular Organic Substances as Compounding Ingredients
C08K 3/346 (20130101)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 5/18 (20130101)
C09D 7/1216 (20130101)

Treatment, Not Provided for Elsewhere in Class D06, of Fibres, Threads, Yarns, Fabrics, Feathers or Fibrous Goods Made From Such Materials
D06M 11/73 (20130101)
D06M 11/79 (20130101)
D06M 15/53 (20130101)
D06M 15/61 (20130101)
D06M 15/263 (20130101)
D06M 15/285 (20130101)
D06M 15/643 (20130101)
D06M 15/3562 (20130101)
D06M 23/00 (20130101) Original (OR) Class
D06M 23/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541512 Walsworth et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S) Ronald Walsworth (Newton, Massachusetts);  Jeff Lichtman (Cambridge, Massachusetts);  Narayanan Kasthuri (Cambridge, Massachusetts);  David Glenn (Cambridge, Massachusetts);  Huiliang Zhang (Cambridge, Massachusetts);  Richard Schalek (Wakefield, Massachusetts)
ASSIGNEE(S) PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, Massachusetts)
INVENTOR(S) Ronald Walsworth (Newton, Massachusetts);  Jeff Lichtman (Cambridge, Massachusetts);  Narayanan Kasthuri (Cambridge, Massachusetts);  David Glenn (Cambridge, Massachusetts);  Huiliang Zhang (Cambridge, Massachusetts);  Richard Schalek (Wakefield, Massachusetts)
ABSTRACT Multi-color CL images of nanoparticle samples may be generated, by irradiating with a scanning electron beam a nanoparticle sample that containing a plurality of spectrally distinct optical emitters configured to generate CL light at respective different color channels, then detecting the CL light from the nanoparticles to generate multi-color NP-CL images of the nanoparticle sample. In some embodiments, SE (secondary electron) images of the sample may be acquire, substantially simultaneously with the acquisition of the CL images, so as to generate correlative NP-CL and SE images of the nanoparticle sample. In some embodiments, the nanoparticles may be surface-functionalized so that the nanoparticles selectively bind only to particular structures of interest.
FILED Wednesday, June 13, 2012
APPL NO 14/125934
ART UNIT 1677 — Optics
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 23/2254 (20130101) Original (OR) Class
G01N 33/54373 (20130101)
G01N 2223/403 (20130101)
G01N 2223/418 (20130101)
G01N 2223/612 (20130101)

Electric Discharge Tubes or Discharge Lamps
H01J 37/22 (20130101)
H01J 37/244 (20130101)
H01J 2237/225 (20130101)
H01J 2237/2808 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09542393 Morton et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S) Streamsage, Inc. (Washington, District of Columbia)
ASSIGNEE(S) Streamsage, Inc. (Washington, District of Columbia)
INVENTOR(S) Michael Scott Morton (Washington, District of Columbia);  Sibley Verbeck Simon (Wahington, District of Columbia);  Noam Carl Unger (Somerville, Massachusetts);  Robert Rubinoff (Potomac, Maryland);  Anthony Ruiz Davis (Takoma Park, Maryland);  Kyle Aveni-Deforge (Columbia, South Carolina)
ABSTRACT A method and system for indexing, searching, and retrieving information from timed media files based upon relevance intervals. The method and system for indexing, searching, and retrieving this information is based upon relevance intervals so that a portion of a timed media file is returned, which is selected specifically to be relevant to the given information representations, thereby eliminating the need for a manual determination of the relevance and avoiding missing relevant portions. The timed media includes streaming audio, streaming video, timed HTML, animations such as vector-based graphics, slide shows, other timed media, and combinations thereof.
FILED Wednesday, September 02, 2015
APPL NO 14/843912
ART UNIT 2155 — Interprocess Communication and Software Development
CURRENT CPC
Electric Digital Data Processing
G06F 17/274 (20130101)
G06F 17/275 (20130101)
G06F 17/2705 (20130101)
G06F 17/3002 (20130101) Original (OR) Class
G06F 17/30029 (20130101)
G06F 17/30064 (20130101)
G06F 17/30424 (20130101)
G06F 17/30613 (20130101)
G06F 17/30684 (20130101)
G06F 17/30796 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 707/913 (20130101)
Y10S 707/99931 (20130101)
Y10S 707/99935 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543142 Song et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
Advanced Technology Program (NIST-ATP)
APPLICANT(S) QD VISION, INC. (Lexington, Massachusetts)
ASSIGNEE(S) QD VISION, INC. (Lexington, Massachusetts)
INVENTOR(S) Inja Song (Watertown, Massachusetts);  Craig Breen (Somerville, Massachusetts)
ABSTRACT In one embodiment, a method for forming a coating comprising a semiconductor material on at least a portion of a population of semiconductor nanocrystals comprises providing a first mixture including semiconductor nanocrystals and an aromatic solvent, introducing one or more cation precursors and one or more anion precursors into the first mixture to form a reaction mixture for forming the semiconductor material, reacting the precursors in the reaction mixture, without the addition of an acid compound, under conditions sufficient to grow a coating comprising the semiconductor material on at least a portion of an outer surface of at least a portion of the semiconductor nanocrystals, and wherein an amide compound is formed in situ in the reaction mixture prior to isolating the coated semiconductor nanocrystals. In another embodiment, method for forming a coating comprising a semiconductor material on at least a portion of a population of semiconductor nanocrystals comprises providing a first mixture including semiconductor nanocrystals and a solvent, introducing an amide compound, one or more cation precursors and one or more anion precursors into the first mixture to form a reaction mixture for forming the semiconductor material, and reacting the precursors in the reaction mixture in the presence of the amide compound, under conditions sufficient to grow a coating comprising the semiconductor material on at least a portion of an outer surface of at least a portion of the semiconductor nanocrystals. Semiconductor nanocrystals including coatings grown in accordance with the above methods are also disclosed.
FILED Monday, February 17, 2014
APPL NO 14/182076
ART UNIT 1715 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 13/22 (20130101)

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/02518 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

National Aeronautics and Space Administration (NASA) 

US 09541148 DeMange et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) The United States of America as represented by the Administrator of NASA (Washington, District of Columbia)
ASSIGNEE(S) The United States of America as Represented by the Administrator of National Aeronautics and Space Administration (Washington, District of Columbia)
INVENTOR(S) Jeffrey J DeMange (Cleveland, Ohio);  Frank J Ritzert (North Ridgeville, Ohio);  Michael V Nathal (Strongsville, Ohio);  Patrick H Dunlap (Strongsville, Ohio);  Bruce M Steinetz (Westlake, Ohio)
ABSTRACT A process for forming a high temperature single crystal canted spring is provided. In one embodiment, the process includes fabricating configurations of a rapid prototype spring to fabricate a sacrificial mold pattern to create a ceramic mold and casting a canted coiled spring to form at least one canted coil spring configuration based on the ceramic mold. The high temperature single crystal canted spring is formed from a nickel-based alloy containing rhenium using the at least one coil spring configuration.
FILED Thursday, August 15, 2013
APPL NO 13/968000
ART UNIT 3726 — Manufacturing Devices & Processes, Machine Tools & Hand Tools Group Art Units
CURRENT CPC
Foundry Moulding
B22C 7/02 (20130101)
B22C 9/04 (20130101)

Casting of Metals; Casting of Other Substances by the Same Processes or Devices
B22D 19/12 (20130101)
B22D 27/045 (20130101)

Metal-working Not Otherwise Provided For; Combined Operations; Universal Machine Tools
B23P 19/048 (20130101)

Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 39/02 (20130101)

Springs; Shock-absorbers; Means for Damping Vibration
F16F 1/00 (20130101) Original (OR) Class
F16F 1/021 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 29/49609 (20150115)
Y10T 29/49611 (20150115)
Y10T 29/49988 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09542531 Chmiel et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
Glenn Research Center (GLENN)
APPLICANT(S) ZIN TECHNOLOGIES, INC. (Middleburg Heights, Ohio)
ASSIGNEE(S) Ztech, Inc. (Middleburg Heights, Ohio)
INVENTOR(S) Alan J. Chmiel (Avon Lake, Ohio);  Bradley T. Humphreys (Lakewood, Ohio)
ABSTRACT A modular system for acquiring biometric data includes a plurality of data acquisition modules configured to sample biometric data from at least one respective input channel at a data acquisition rate. A representation of the sampled biometric data is stored in memory of each of the plurality of data acquisition modules. A central control system is in communication with each of the plurality of data acquisition modules through a bus. The central control system is configured to control communication of data, via the bus, with each of the plurality of data acquisition modules.
FILED Monday, June 30, 2014
APPL NO 14/319768
ART UNIT 3769 — Interprocess Communication and Software Development
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0002 (20130101)
A61B 5/0022 (20130101)
A61B 5/0432 (20130101)
A61B 2505/01 (20130101)
A61B 2505/07 (20130101)
A61B 2560/0475 (20130101)

Electric Digital Data Processing
G06F 3/05 (20130101)
G06F 5/12 (20130101)
G06F 12/0623 (20130101)
G06F 13/18 (20130101)
G06F 13/26 (20130101)
G06F 13/38 (20130101)
G06F 13/4213 (20130101)
G06F 13/4226 (20130101)
G06F 13/4239 (20130101)
G06F 19/36 (20130101)
G06F 19/3406 (20130101)
G06F 19/3418 (20130101) Original (OR) Class
G06F 19/3431 (20130101)

Technical Subjects Covered by Former USPC Cross-reference Art Collections [XRACs] and Digests
Y10S 128/92 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543575 Yushin et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
Glenn Research Center (GLENN)
APPLICANT(S) Gleb Nikolayevich Yushin (Atlanta, Georgia);  Igor Luzinov (Clemson, South Carolina);  Bogdan Zdyrko (Clemson, South Carolina);  Alexandre Magasinski (Atlanta, Georgia)
ASSIGNEE(S) Georgia Tech Research Corporation (Atlanta, Georgia);  Clemson University (Clemson, South Carolina)
INVENTOR(S) Gleb Nikolayevich Yushin (Atlanta, Georgia);  Igor Luzinov (Clemson, South Carolina);  Bogdan Zdyrko (Clemson, South Carolina);  Alexandre Magasinski (Atlanta, Georgia)
ABSTRACT A silicon-based anode comprising silicon, a carbon coating that coats the surface of the silicon, a polyvinyl acid that binds to at least a portion of the silicon, and vinylene carbonate that seals the interface between the silicon and the polyvinyl acid. Because of its properties, polyvinyl acid binders offer improved anode stability, tunable properties, and many other attractive attributes for silicon-based anodes, which enable the anode to withstand silicon cycles of expansion and contraction during charging and discharging.
FILED Tuesday, November 16, 2010
APPL NO 13/510038
ART UNIT 1729 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/366 (20130101)
H01M 4/386 (20130101)
H01M 4/0404 (20130101)
H01M 4/625 (20130101)
H01M 4/1395 (20130101) Original (OR) Class

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 60/122 (20130101)

Climate Change Mitigation Technologies in the Production or Processing of Goods
Y02P 70/54 (20151101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Veterans Affairs (DVA) 

US 09539117 Herr et al.
FUNDED BY
Department of Veterans Affairs (DVA)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Hugh M. Herr (Somerville, Massachusetts);  Hartmut Geyer (Pittsburgh, Pennsylvania);  Michael Frederick Eilenberg (Port Washington, New York)
ABSTRACT A model-based neuromechanical controller for a robotic limb having at least one joint includes a finite state machine configured to receive feedback data relating to the state of the robotic limb and to determine the state of the robotic limb, a muscle model processor configured to receive state information from the finite state machine and, using muscle geometry and reflex architecture information and a neuromuscular model, to determine at least one desired joint torque or stiffness command to be sent to the robotic limb, and a joint command processor configured to command the biomimetic torques and stiffnesses determined by the muscle model processor at the robotic limb joint. The feedback data is preferably provided by at least one sensor mounted at each joint of the robotic limb. In a preferred embodiment, the robotic limb is a leg and the finite state machine is synchronized to the leg gait cycle.
FILED Tuesday, October 21, 2014
APPL NO 14/520091
ART UNIT 3774 — Medical & Surgical Instruments, Treatment Devices, Surgery and Surgical Supplies
CURRENT CPC
Filters Implantable into Blood Vessels; Prostheses; Devices Providing Patency To, or Preventing Collapsing Of, Tubular Structures of the Body, e.g Stents; Orthopaedic, Nursing or Contraceptive Devices; Fomentation; Treatment or Protection of Eyes or Ears; Bandages, Dressings or Absorbent Pads; First-aid Kits
A61F 2/64 (20130101)
A61F 2/66 (20130101)
A61F 2/68 (20130101) Original (OR) Class
A61F 2/605 (20130101)
A61F 5/0123 (20130101)
A61F 5/0127 (20130101)
A61F 2002/701 (20130101)
A61F 2002/704 (20130101)
A61F 2002/705 (20130101)
A61F 2002/764 (20130101)
A61F 2002/7625 (20130101)
A61F 2002/7635 (20130101)
A61F 2002/7645 (20130101)
A61F 2005/0155 (20130101)

Manipulators; Chambers Provided With Manipulation Devices
B25J 9/0006 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09539220 Charney et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) Icahn School of Medicine at Mount Sinai (New York, New York);  Yale University (New Haven, Connecticut);  The United States of America, as represented by the Secretary, Department of Health and Human Services (Rockville, Maryland)
ASSIGNEE(S) Icahn School of Medicine at Mount Sinai (New York, New York);  Yale University (New Haven, Connecticut);  The United States of America, as represented by The Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Dennis S. Charney (New York, New York);  Sanjay J. Mathew (New York, New York);  Husseini K. Manji (Rockville, Maryland);  Carlos A. Zarate (Rockville, Maryland);  John H. Krystal (New Haven, Connecticut)
ABSTRACT Methods and compositions for the treatment of treatment-resistant depression are described. More specifically, the invention demonstrates that intranasal administration of ketamine is effective to ameliorate the symptoms of depression in a patient who has not responded to an adequate trial of one antidepressant in the current episode and has recurrent or chronic depressive symptoms (>2 years).
FILED Wednesday, March 05, 2014
APPL NO 14/197767
ART UNIT 1628 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 9/0043 (20130101)
A61K 9/7023 (20130101)
A61K 31/135 (20130101) Original (OR) Class
A61K 31/137 (20130101)
A61K 45/06 (20130101)

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 15/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Small Business Administration (SBA) 

US 09540430 Schellenberger et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Amunix Operating Inc. (Mountain View, California)
ASSIGNEE(S) Amunix Operating Inc. (Mountain View, California)
INVENTOR(S) Volker Schellenberger (Palo Alto, California);  Joshua Silverman (Sunnyvale, California);  Willem P. Stemmer (Los Gatos, California);  Chia-wei Wang (Milpitas, California);  Nathan Geething (Santa Clara, California);  Jeffrey L. Cleland (San Carlos, California)
ABSTRACT The present invention relates to compositions comprising glucose regulating peptides linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of glucose regulating peptide-related diseases, disorders, and conditions.
FILED Friday, December 05, 2014
APPL NO 14/562406
ART UNIT 1676 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 14/575 (20130101)
C07K 14/605 (20130101) Original (OR) Class
C07K 14/57563 (20130101)
C07K 2319/00 (20130101)
C07K 2319/31 (20130101)
C07K 2319/50 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/70 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 21/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541829 Robello et al.
FUNDED BY
National Science Foundation (NSF)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Orthogonal, Inc. (Rochester, New York)
ASSIGNEE(S) Orthogonal, Inc. (Rochester, New York)
INVENTOR(S) Douglas Robert Robello (Webster, New York);  Charles Warren Wright (Fairport, New York)
ABSTRACT A photosensitive composition comprises a fluorinated solvent, a photo-acid generator and a copolymer. The copolymer comprises at least three distinct repeating units, including a first repeating unit having a fluorine-containing group, a second repeating unit having an acid-catalyzed cross-linkable group, and a third repeating unit having a sensitizing dye. The composition is useful in the fabrication of electronic devices, especially organic electronic and bioelectronic devices.
FILED Friday, July 18, 2014
APPL NO 14/335406
ART UNIT 1722 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 220/18 (20130101)
C08F 220/22 (20130101)
C08F 220/24 (20130101)
C08F 220/24 (20130101)
C08F 222/18 (20130101)
C08F 2220/325 (20130101)
C08F 2220/1891 (20130101)
C08F 2222/185 (20130101)

Photomechanical Production of Textured or Patterned Surfaces, e.g for Printing, for Processing of Semiconductor Devices; Materials Therefor; Originals Therefor; Apparatus Specially Adapted Therefor;
G03F 7/0007 (20130101)
G03F 7/32 (20130101)
G03F 7/038 (20130101)
G03F 7/40 (20130101)
G03F 7/0045 (20130101)
G03F 7/0046 (20130101)
G03F 7/0048 (20130101)
G03F 7/0388 (20130101) Original (OR) Class

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/0274 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

U.S. State Government 

US 09539342 Pettit et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
U.S. State Government
State of Arizona
APPLICANT(S) ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (Scottsdale, Arizona)
ASSIGNEE(S) Arizona Board of Regents, a body corporate of the State of Arizona, acting for and on behlaf of Arizona State University (Scottsdale, Arizona)
INVENTOR(S) George R. Pettit (Paradise Valley, Arizona);  Fiona Hogan (Gilbert, Arizona);  Steven Toms (Wellington, New Zealand)
ABSTRACT The present invention relates to new auristatin compounds and prodrugs thereof, compositions comprising them and uses thereof.
FILED Wednesday, May 06, 2015
APPL NO 14/705651
ART UNIT 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/472 (20130101)
A61K 31/472 (20130101)
A61K 31/4709 (20130101)
A61K 31/4709 (20130101)
A61K 38/00 (20130101)
A61K 38/08 (20130101)
A61K 45/06 (20130101)
A61K 47/48415 (20130101) Original (OR) Class
A61K 47/48715 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Heterocyclic Compounds
C07D 207/12 (20130101)
C07D 401/12 (20130101)

Peptides
C07K 5/0205 (20130101)
C07K 7/02 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5014 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540102 Levien et al.
FUNDED BY
U.S. State Government
State of Delaware
APPLICANT(S) Elwha LLC, a limited liability corporation of the State of Delaware (Bellevue, Washington)
ASSIGNEE(S) Elwha LLC (Bellevue, Washington)
INVENTOR(S) Royce A. Levien (Lexington, Massachusetts);  Robert W. Lord (Seattle, Washington);  Richard T. Lord (Tacoma, Washington);  Mark A. Malamud (Seattle, Washington);  John D. Rinaldo, Jr. (Bellevue, Washington);  Lowell L. Wood, Jr. (Bellevue, Washington)
ABSTRACT Disclosed herein are example embodiments for base station multi-vehicle coordination. For certain example embodiments, at least one machine, such as a base station, may: (i) effectuate one or more communications with at least a first UFV and a second UFV; or (ii) transmit to a first UFV at least one command based at least partially on one or more communications with at least a first UFV and a second UFV. However, claimed subject matter is not limited to any particular described embodiments, implementations, examples, or so forth.
FILED Wednesday, March 13, 2013
APPL NO 13/800391
ART UNIT 3667 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
CURRENT CPC
Aeroplanes; Helicopters
B64C 39/024 (20130101) Original (OR) Class
B64C 2201/141 (20130101)
B64C 2201/143 (20130101)
B64C 2201/146 (20130101)

Systems for Controlling or Regulating Non-electric Variables
G05D 1/0027 (20130101)

Traffic Control Systems
G08G 5/0069 (20130101)
G08G 5/0091 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Environmental Protection Agency (EPA) 

US 09541432 Kertesz et al.
FUNDED BY
Environmental Protection Agency (EPA)
APPLICANT(S) U.S. Environmental Protection Agency (Washington, District of Columbia);  Urbanalta Technology (Cincinnati, Ohio)
ASSIGNEE(S) THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE U.S. ENVIRONMENTAL PROTECTION AGENCY (Washington, District of Columbia);  URBANALTA CORP (, Ohio)
INVENTOR(S) Ruben Kertesz (Cincinnati, Ohio);  Daniel Murray (Cincinnati, Ohio);  Michael Bolan (Cincinnati, Ohio);  Ryan Anderson (Cincinnati, Ohio);  Chunsheng Fang (Redwood City, California)
ABSTRACT A flow imaging and monitoring system for synchronized management of wide area drainage that includes an interposer for supporting monitoring and management equipment in a manhole, a module for illuminating water flowing in pipes at the base of the manhole, a module for monitoring responses to reflected light, a sealed and rechargeable battery pack, and a data analysis and management system to interpret data streams in real time. The interposer can be adjusted to fit the diameter of the manhole and can be adjusted to be placed under the manhole cover. The module for illuminating the flowing water can be adjusted to generate various frequencies. The support structures for the modules can be adjusted for varying pitch, roll and yaw with respect to the manhole. The data analysis and management system is supported by cloud computing.
FILED Monday, May 19, 2014
APPL NO 14/281757
ART UNIT 2855 — Printing/Measuring and Testing
CURRENT CPC
Sewers; Cesspools
E03F 7/00 (20130101)
E03F 2201/20 (20130101)
E03F 2201/40 (20130101)

Frames, Casings or Beds of Engines, Machines or Apparatus, Not Specific to Engines, Machines or Apparatus Provided for Elsewhere; Stands; Supports
F16M 13/02 (20130101)

Measuring Volume, Volume Flow, Mass Flow or Liquid Level; Metering by Volume
G01F 1/66 (20130101)
G01F 1/661 (20130101)
G01F 1/662 (20130101) Original (OR) Class
G01F 1/666 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 2/1022 (20130101)
H01M 10/4257 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 137/8158 (20150401)
Y10T 137/8359 (20150401)
VIEW PATENT @ USPTO:  Full Text   PDF 

United States Postal Service (USPS) 

US 09540132 Lee
FUNDED BY
United States Postal Service (USPS)
APPLICANT(S) United States Postal Service (Washington, District of Columbia)
ASSIGNEE(S) United States Postal Service (Washington, District of Columbia)
INVENTOR(S) Jim E. Lee (Washington, District of Columbia)
ABSTRACT Embodiments of a reusable stackable shipping box are provided herein. The reusable stackable shipping box may be reused and cleaned without causing harm to the integrity of the box. In addition, the box is slightly tapered in shape such that the box may be stacked upon and within other boxes for ease in shipping and organization.
FILED Thursday, September 01, 2016
APPL NO 15/254380
ART UNIT 3782 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Containers for Storage or Transport of Articles or Materials, e.g Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding Containers; Accessories, Closures, or Fittings Therefor; Packaging Elements; Packages
B65D 5/001 (20130101)
B65D 5/14 (20130101)
B65D 5/0245 (20130101)
B65D 5/0281 (20130101) Original (OR) Class
B65D 5/563 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Government Rights Acknowledged 

US 09539246 Kishore et al.
FUNDED BY
APPLICANT(S) Bellamkonda K. Kishore (Sandy, Utah);  Noel G. Carlson (Salt Lake City, Utah);  Yue Zhang (Salt Lake City, Utah)
ASSIGNEE(S) UNIVERSITY OF UTAH RESEARCH FOUNDATION (Salt Lake City, Utah)
INVENTOR(S) Bellamkonda K. Kishore (Sandy, Utah);  Noel G. Carlson (Salt Lake City, Utah);  Yue Zhang (Salt Lake City, Utah)
ABSTRACT Disclosed is a treatment of diabetes insipidus. Methods of treating diabetes insipidus disorders associated with P2Y receptors using the compounds and compositions are also disclosed.
FILED Wednesday, August 29, 2012
APPL NO 14/241720
ART UNIT 1629 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/64 (20130101)
A61K 31/64 (20130101)
A61K 31/519 (20130101)
A61K 31/519 (20130101)
A61K 31/4365 (20130101) Original (OR) Class
A61K 31/4365 (20130101)
A61K 31/7076 (20130101)
A61K 31/7076 (20130101)
A61K 33/00 (20130101)
A61K 33/00 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09540092 Miller
FUNDED BY
APPLICANT(S) Raytheon Company (Waltham, Massachusetts)
ASSIGNEE(S) Raytheon Company (Waltham, Massachusetts)
INVENTOR(S) Kirk A. Miller (Dallas, Texas)
ABSTRACT A single monotlithic moving window may follow the free aperture of an optical sensor contained in a housing over a reasonable field of regard by translating the window with respect to the sensor and/or a pod cover. Because the window angle of attack is unvarying, near field turbulence is minimized over the envelope of operation.
FILED Wednesday, September 10, 2014
APPL NO 14/482319
ART UNIT 2878 — Optics
CURRENT CPC
Aeroplanes; Helicopters
B64C 1/14 (20130101) Original (OR) Class

Measuring Not Specially Adapted for a Specific Variable; Arrangements for Measuring Two or More Variables Not Covered in a Single Other Subclass; Tariff Metering Apparatus; Measuring or Testing Not Otherwise Provided for
G01D 11/26 (20130101)

Apparatus or Arrangements for Taking Photographs or for Projecting or Viewing Them; Apparatus or Arrangements Employing Analogous Techniques Using Waves Other Than Optical Waves; Accessories Therefor
G03B 15/006 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09541468 Ehinger et al.
FUNDED BY
APPLICANT(S) Bell Helicopter Textron Inc. (Fort Worth, Texas)
ASSIGNEE(S) BELL HELICOPTER TEXTRON INC. (Fort Worth, Texas)
INVENTOR(S) Ryan T. Ehinger (Southlake, Texas);  Ron Woods (Weatherford, Texas);  David Bockmiller (Keller, Texas)
ABSTRACT A method of modifying a workpiece includes providing a workpiece, determining a load stress profile associated with a load condition, the load stress profile comprising a load stress greater than a material stress limit of the workpiece, determining a residual stress profile, the residual stress profile comprising a residual stress less than the material stress limit of the workpiece, and providing the workpiece with the residual stress profile, wherein a sum of the load stress and the residual stress is less than the material stress limit of the workpiece.
FILED Thursday, April 16, 2015
APPL NO 14/688091
ART UNIT 2855 — Printing/Measuring and Testing
CURRENT CPC
Soldering or Unsoldering; Welding; Cladding or Plating by Soldering or Welding; Cutting by Applying Heat Locally, e.g Flame Cutting; Working by Laser Beam
B23K 26/0069 (20130101)

Abrasive or Related Blasting With Particulate Material
B24C 1/10 (20130101)

Modifying the Physical Structure of Ferrous Metals; General Devices for Heat Treatment of Ferrous or Non-ferrous Metals or Alloys; Making Metal Malleable, e.g by Decarburisation or Tempering
C21D 7/02 (20130101)
C21D 7/04 (20130101)
C21D 9/32 (20130101)
C21D 10/005 (20130101)
C21D 11/00 (20130101)

Gearing
F16H 55/17 (20130101)
F16H 2057/0087 (20130101)

Testing Static or Dynamic Balance of Machines or Structures; Testing of Structures or Apparatus, Not Otherwise Provided for
G01M 13/021 (20130101) Original (OR) Class

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 3/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09543915 Bonebright et al.
FUNDED BY
APPLICANT(S) The Boeing Company (Chicago, Illinois)
ASSIGNEE(S) The Boeing Company (Chicago, Illinois)
INVENTOR(S) Rodney K. Bonebright (Bellevue, Washington);  Jacob C. Killens (Auburn, Washington);  Mark W. Steeds (Auburn, Washington)
ABSTRACT Systems and methods according to one or more embodiments are provided for stacked active RF circuits implemented as amplification stages in high gain phased array antenna systems. Stacked active RF circuits may be implemented, for example, as an amplification stage of an element electronic circuit. Stacked active RF circuits may be implemented, for example, as a second amplification stage to maintain amplification in a high gain phased array antenna system. In one example, a system comprises a substrate comprising a plurality of substrate layers and one or more input ports and output ports. A plurality of amplification stages comprising a plurality of amplifiers, attenuators, and phase shifters are integrated within the plurality of substrate layers, the amplification stage coupled between the input and output ports. One or more monitor circuits are coupled to the plurality of amplification stages. Additional systems and methods are also provided.
FILED Tuesday, August 25, 2015
APPL NO 14/835649
ART UNIT 2647 — Telecommunications: Analog Radio Telephone; Satellite and Power Control; Transceivers, Measuring and Testing; Bluetooth; Receivers and Transmitters; Equipment Details
CURRENT CPC
Amplifiers
H03F 3/68 (20130101) Original (OR) Class
H03F 3/195 (20130101)
H03F 2200/451 (20130101)

Transmission
H04B 1/0475 (20130101)
H04B 2001/0408 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09544562 Schachter et al.
FUNDED BY
APPLICANT(S) Bruce J. Schachter (Clarksville, Maryland);  Peter J. Vanmaasdam (Baltimore, Maryland);  Jack Gordon Riddle (Columbia, Maryland)
ASSIGNEE(S) Northrop Grumman Systems Corporation (Falls Church, Virginia)
INVENTOR(S) Bruce J. Schachter (Clarksville, Maryland);  Peter J. Vanmaasdam (Baltimore, Maryland);  Jack Gordon Riddle (Columbia, Maryland)
ABSTRACT One embodiment describes a method for converting a dual-band image to a visible color image. The method includes converting the dual-band image to data in a placeholder image in a placeholder color space. The placeholder color space employs a wavelet-based image fusion technique while mimicking the oppositional color processing technique of the human visual system. The placeholder image is further mapped into visible color space, generating the visible color image.
FILED Thursday, October 17, 2013
APPL NO 14/056306
ART UNIT 2481 — Recording and Compression
CURRENT CPC
Image Data Processing or Generation, in General
G06T 5/50 (20130101)
G06T 2207/10024 (20130101)
G06T 2207/10048 (20130101)
G06T 2207/20221 (20130101)

Pictorial Communication, e.g Television
H04N 5/33 (20130101)
H04N 9/77 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 09544797 Berenberg
FUNDED BY
APPLICANT(S) CUBIC CORPORATION (San Diego, California)
ASSIGNEE(S)
INVENTOR(S) Paul Berenberg (Los Altos, California)
ABSTRACT Systems and methods that enable scalable, cost-effective payment reconciliation between owners of devices at least temporarily connected in or to a particular low-power, ad hoc mesh network.
FILED Wednesday, November 26, 2014
APPL NO 14/555307
ART UNIT 2477 — Multiplex and VoIP
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 12/14 (20130101)
H04L 12/1403 (20130101)
H04L 12/1435 (20130101)
H04L 12/1453 (20130101)
H04L 41/082 (20130101)

Telephonic Communication
H04M 15/50 (20130101)
H04M 15/51 (20130101)
H04M 15/68 (20130101)
H04M 15/8061 (20130101)
H04M 15/8214 (20130101)

Wireless Communication Networks
H04W 24/08 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

How To Use This Page 

THE FEDINVENT PATENT DETAILS PAGE

Each week, FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding by the US Federal Government. The FedInvent Patent Details page is a companion to the weekly FedInvents Patents Report.

This week's information is published in the FedInvent Patents report for Tuesday, January 10, 2017.

The FedInvent Weekly Patent Details Page contains a subset of patent information to provide a deeper dive into the week’s taxpayer-funded patents to help the reader better understand where a patent fits in the federal innovation ecosphere.

HOW IS THE INFORMATION ORGANIZED?

Patents are organized by the funding agency. Within each group, the patents are organized in numeric order. A patent funded by more than one agency will appear in the section of each of the agencies that funded the research and development that resulted in the invention. This approach gives the reader a complete view of the department or agency activity for the week.

WHAT INFORMATION WILL I FIND?

THE PANEL
There is a panel for each patent that contains the patent number and the title of the patent. When you click the panel, it opens to reveal the following information:

FUNDED BY
The agencies that funded the grants, contracts, or other research agreements that resulted in the patent. FedInvent includes as much information on the source of the funding as possible. The information is presented in a hierarchy going from the Federal Department down to the agencies, subagencies, and offices that funded the work. Here are two examples:

Department of Health and Human Services (HHS)
     National Institutes of Health (NIH)
         National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Department of Defense (DOD)
     Defense Advanced Research Projects Agency (DARPA)
         Army Research Office (ARO)

We do our best to provide detailed information about the funding. In some cases, the patent only reports limited information on the origins of the funding. FedInvents presents what it can confirm. We add the patents without the information required by the Bayh-Dole Act to our list of patents worthy of further investigation.

APPLICANT(S) and ASSIGNEES
FedInvent includes both the Applicants and the Assignees because having both provides more information about where the inventive work was done and by what organizations. Many organizations — universities, corporations, and federal agencies — standardize the Assignee/Owner information by the time a patent is granted. In the case of federal patents, many of the patents use the agency headquarters information for patent assignment.

Showing just the headquarters address would make Washington, DC the epicenter of all taxpayer-funded research and development. Providing both the applicant information and the assignee information provides a more accurate picture of where important taxpayer funded innovation is happening in America. Here are two examples from two different patents:

APPLICANT: U.S. Army Research Laboratory, Adelphi, MD
ASSIGNEE: The United States of America as represented by the Secretary of the Army Washington, DC

APPLICANT: Optech Ventures, LLC (Torrance, California)
ASSIGNEE(S): The Regents of the University of California (Oakland, California); Optech Ventures, LLC (Torrance, California)

INVENTOR(S)
The inventors appear in the same order as they appear on the patent. FedInvents presents the names in first name/last name order because they are easier to read than the last name/first name order of the names on the USPTO patent documents.

ABSTRACT
The abstract as it appears on the patent.

FILED
The date of the patent application including the day of the week.

APPL NO
This is the patent application serial number. If you’d like to learn more about how application serial numbers work you can go to the Lists Page.

ART UNIT
Patent data includes the Art Unit where a patent was examined. (The Art Unit isn’t available for published patent applications.) The Art Unit provides insight into what group of patent examiners prosecuted the patent application and the subject matter that the examiners work on. For example:

3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices

You can learn more about ART UNITS on the FedInvent Patents Weekly panel called About Tech Center or you can find information on the FedInvent Lists Page.

CURRENT CPC
Current CPC provides a list of the Cooperative Patent Classification symbols assigned to the patent. These are the CPC symbols assigned at the time the patent was granted.

The FedInvent Project is a patent classification maximalist endeavor or put another way, we believe that more you understand about patent classification the more you'll learn about the nature of the invention and the types of work that the federal government is funding.

The symbol presented in BOLD is the symbol identified as the "first" classification which is the most relevant classification on the patent. The date that follows the symbol is the date of the most recent revision to the art classed there.

  • A61B 1/149 (20130101)
  • A61B 1/71 (20130101)
  • A61B 1/105 (20130101)

The CPC symbols match the classifications found on the PDF version of the patent. Over time, the classifications on the full-text version of the patent change to reflect how USPTO organizes patent art to support its examiners. The two sets of CPCs don’t always match.

VIEW PATENT
As of June 2021, we include two ways to view a patent at USPTO. FedInvent provides a link to the Full-Text Version of the patent and a link to the PDF version of the patent.

HOW DO I FIND A SPECIFIC PATENT ON A PAGE?

You can use the Command F or Control F to find a specific patent you are interested in.

HOW DO I GET HERE?

You navigate to the details of a patent by clicking the information icon that follows a patent on the FedInvent Patents Weekly Report.

You can also reach this page using the weekly page link that looks like this:

https://wayfinder.digital/fedinvent/patents-2017/fedinvent-patents-20170110.html

Just update the date portion of the URL. Tuesdays for patents. Thursdays for pre-grant publication of patent applications.

Download a copy of the How To Use This Page

HAVE MORE QUESTIONS?

info@wayfinder.digital